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I. Introduction 
I. Introduction 
I.1. Resistance and immunity 
Living organisms fight an everlasting battle with pathogens. The immune system 
provides protection against exploration and destruction of the host by these aggressors. 
Its destination is to recognize and to eliminate bacteria, viruses, fungi and other 
parasites. The fundamental skill of the immune system is to distinguish between self 
and non-self. During evolution the innate and the adaptive immune system emerged. 
Components of the innate immune system can be found in all multicellular organisms 
animals and plants. The adaptive immune system is a newcomer, from the evolutionary 
point of view, it can be only found in vertebrates (Janeway, 2001; Janeway et al., 2001). 
 
Epithelia are the first effective barrier which pathogens have to overcome in order to 
infect organisms. The innate immune system provides the second line of defence, it is 
bases on an extensive but limited number of germline-encoded receptors which 
recognise conserve pathogen-associated molecular patterns (PAMPs), as 
lipopolysaccharide (LPS), lipoprotein, peptidoglycan, flagellin, double-stranded RNA, 
or unmethylated CpG DNA. The pattern recognition receptors (PRRs), like macrophage 
scavenger receptor, Toll-like receptors (TLRs), or NOD proteins, can be found on the 
cell surface, in intracellular compartments, in the bloodstream and tissue fluids. Their 
functions include activation of the complement system, activation of phagocytosis, 
induction of apoptosis, induction of antimicrobial genes and activation of 
proinflammatory cytokine and chemokine secretion (Janeway, 2001; Janeway and 
Medzhitov, 2002; Janeway et al., 2001; Medzhitov, 2007). 
The innate immune system is immediately active upon infection, in contrast 
adaptive immunity requires days to establish an effective response after the contact with 
a new pathogen. This time is necessary for the clonal expansion and differentiation to 
effector lymphocytes. The adaptive immune system is based on an antigen-specific 
immune response mediated by B- and T-lymphocytes. The specificity results from 
somatic recombination and hypermutation of gene elements coding for the B- and T-cell 
receptor. This gives a rise to a nearly unlimited variation of potential receptors. Cells 
1 
I. Introduction 
with receptors that recognize alien, but not self, antigens are selected and mediate the 
immune response, in an interplay with further cells of the immune system (Janeway, 
2001; Janeway and Medzhitov, 2002; Janeway et al., 2001; Medzhitov, 2007). 
The innate and the adaptive immune system do not pose two independent units, 
rather there is a regulative crosstalk between them (Janeway and Medzhitov, 1998). 
I.2. Interferons 
The activation and maintenance of the immune response is regulated by small proteins 
so-called cytokines - interleukins, interferons (IFNs) - and chemokines. They provide 
intercellular communication and attract lymphocytes to sites of inflammation (Janeway 
et al., 2001). 
 
Figure 1. JAK-STAT signal transduction in response to type I and II IFNs. Upon binding of ligand, 
IFN receptor-associated Janus kinases (JAKs) are activated and phosphorylate receptor chains on 
tyrosine. Cytoplasmic signal transducers and activators of transcription (STATs) bind to the 
phosphorylated receptors. JAKs associated with the type I IFN receptor then phosphorylate STAT1 and 
STAT2 on tyrosine, causing the formation of predominantly STAT1-STAT2 heterodimers, and of STAT1 
homodimers. IFNγ receptor-associated JAKs phosphorylate STAT1, leading to the formation of STAT1 
homodimers. STAT dimers translocate to the cell nucleus. Thereafter, STAT1-STAT2 heterodimers 
associate with a third protein, IRF9, and bind one class of type I IFN response elements, the ISRE, 
whereas STAT1 homodimers activate gene expression by binding to another class of IFN response 
elements, the GAS. From (Decker et al., 2002); modified. 
IFNs are important signal mediators of the immune and the adaptive immune system; 
they play a key role the defence against viruses and other intracellular pathogens. Type I 
IFNs (α, β and other) can be secreted by almost all cell types on viral infection and 
induce antiviral programs. Type II IFN (γ) can be only secreted by certain cell types, 
2 
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natural killer, T-lymphocytes and dendritic cells, and activates a large number of genes 
also involved in defence against intracellular bacteria and protozoa (Boehm et al., 1997; 
Decker et al., 2002; Katze et al., 2002; Medzhitov, 2007). 
Binding of type I and II IFNs to their respective IFN receptor on the cell surface 
stimulate transcriptions of genes controlled by IFN-stimulated response element (ISRE) 
and IFNγ-activated site (GAS) via the activation of the JAK-STAT signal transduction 
pathway (Figure 1) (Decker et al., 2002). 
I.3. Cell-autonomous immunity 
Immunity is not only mediated by lymphocytes in a complex interplay of cells. 
Cytokines and most potently IFNs induce antimicrobial mechanisms which mediate 
cell-autonomous immunity in ordinary tissue cells. 
Some of these, mechanisms that function at a single cell level are: Mx protein-
mediated inhibition of viral replication (Haller et al., 2007; Staeheli et al., 1986), 
activity against intracellular bacteria and protozoa of the immunity-related GTPases 
(IRGs) (Martens and Howard, 2006; Taylor, 2007), tryptophan depletion by indole 2,3-
dioxygenase (IDO) (Murray et al., 1989; Pfefferkorn et al., 1986; Saito et al., 1991), 
depletion of arginine and production of nitric oxide (NO) by inducible nitric oxide 
synthase (iNOS) (Adams et al., 1990; Scharton-Kersten et al., 1997), production of 
reactive oxygen species (ROS), which, like NO, have cytostatic an cytotoxic effects, by 
the phagocyte oxidase (phox) complex (Cassatella et al., 1990; Vazquez-Torres and 
Fang, 2001). 
I.4. Toxoplasma gondii 
Toxoplasma gondii (T. gondii), as also the Malaria agent Plasmodium falciparum, is a 
protozoan pathogen of the phylum Apicomplexa. It is an obligate intracellular parasite 
that can infect nearly any warm blooded animal, including human, and invade most 
types of nucleated cells. The penetration of the host cell is an active process in which 
specialised secretory organelles of the apical complex, micronemes, rhoptries and dense 
granules, are engaged to form the nonfusogenic parasitophorous vacuole (PV). In this 
compartment the parasite resides and proliferates within the host cell (Dubey, 2008; 
Plattner and Soldati-Favre, 2008). 
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T. gondii has a complex life cycle; during the asexual proliferation the rapidly 
multiplying tachyzoite differentiates into the slowly dividing bradyzoite that can form 
persistent cysts in brain, heart and other tissues. In contrast to the asexual proliferation, 
which occurs in every host, the sexual reproduction occurs only in the guts of felines 
(Dubey, 1998; Plattner and Soldati-Favre, 2008). 
In Europe and North America three major genotypes (I, II and III) of T. gondii 
are found. Mice die after infection with a small number of the virulent type I T. gondii, 
in contrast mice can resist even high numbers of the avirulent type II and III strains 
(Boothroyd and Grigg, 2002; Konen-Waisman and Howard, 2007). 
Mouse immunity-related GTPases (IRGs) are required for resistance to avirulent 
T. gondii, on the whole organism level (Collazo et al., 2002; Collazo et al., 2001; Henry 
et al., 2009; Taylor et al., 2000; Zhao et al., 2009c) as well as on the cell-autonomous 
level (Butcher et al., 2005; Halonen et al., 2001; Martens et al., 2005). It is of great 
interest that IRG proteins accumulate on the parasitophorous vacuole membrane (PVM) 
of avirulent T. gondii, but fail to populate the PVM of virulent strains efficiently (Zhao 
et al., 2009a; Zhao et al., 2009c) (Khaminets et al., manuscript in preparation), 
suggesting that different virulence types interact differently with the IRG system. 
I.5. Guanosine triphosphatases 
Guanosine triphosphatases (GTPases) are enzymes that can bind and hydrolyse 
guanosine 5'-triphosphate (GTP). They are present in all living creatures, and are 
involved in diverse cellular functions: like signal transduction, endocytosis, vesicle 
trafficking, nuclear transport, cytoskeleton regulation, synthesis and translocation of 
proteins and cell division (Leipe et al., 2002; Takai et al., 2001). 
 
GTPases often work as molecular switches. A conformational rearrangement, primarily 
in the switch regions, between the inactive guanosine 5'-diphosphate (GDP) and active 
GTP-bound form, enables GTPases to interact specifically with different downstream 
factors. The so-called classical small GTPases are very inefficient enzymes; they bind 
nucleotides very tightly and have a very slow GTP hydrolysis rate. Guanine nucleotide 
exchange factors (GEFs) facilitate the exchange of bound GDP to GTP, and activate 
GTPases (Figure 2). Likewise GTPase activating proteins (GAPs) stimulate GTP 
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hydrolysis and thereby return GTPases to the inactive state (Bernards and Settleman, 
2004; Bourne et al., 1990; Bourne et al., 1991; Gamblin and Smerdon, 1998; Geyer and 
Wittinghofer, 1997; Paduch et al., 2001; Scheffzek et al., 1998; Vetter and 
Wittinghofer, 2001; Wittinghofer and Nassar, 1996). GDP dissociation inhibitors 
(GDIs), were found for Rho, Rab and heterotrimeric G-proteins (Gα) (Sasaki and Takai, 
1998; Siderovski and Willard, 2005; Wu et al., 1996); GDIs inhibit the release of bound 
GDP and maintain GTPases in the inactive state. The GTPase cycle (Figure 2) can be 
further regulated by upstream factors. 
GTPases are diverse. In addition to the classical small GTPases, there is a 
growing number of GTPases, often of a higher molecular mass, which generally have a 
low nucleotide-binding affinity and do not require GFEs for activation. Furthermore the 
enzymes have often a build in GAP function that is frequently activated upon complex 
formation (Egea et al., 2004; Gasper et al., 2009; Gasper et al., 2006; Ghosh et al., 
2006; Gotthardt et al., 2008; Hubbard et al., 2007; Leipe et al., 2002; Low and Lowe, 
2006; Martens and Howard, 2006; Mohr et al., 2002; Praefcke and McMahon, 2004; 
Savelsbergh et al., 2000; Scrima and Wittinghofer, 2006; Shan et al., 2009; Sirajuddin 
et al., 2007; Sun et al., 2002; Uthaiah et al., 2003). 
GTPase
GTPase
Regulatory
signals
GTPase
Effector
targets
Pi
GDI
GTP GDP
GAP
GEF
GTP
GDI
GDP
GDP
 
Figure 2. The GTPase cycle. GTPases are regulated as they cycle between their inactive GTP-bound and 
active GTP-bound forms. The activated GTPase can interact with so-called effector targets that ultimately 
produce a biological consequence. Regulation of cycling is largely accomplished through the coordinated 
action of GTPase activating proteins (GAPs), guanine nucleotide exchange factors (GEFs) and guanine 
nucleotide dissociation inhibitors (GDIs), the activity of each of which is potentially modulated in 
response to various signals. Inactive GTPase or GTPase inactivators are coloured red, active GTPase or 
GTPase activators are coloured green. From (Bernards and Settleman, 2004); modified. 
Nearly all GTPases have a more or less modified Ras-like GTPase domain (G-domain). 
A classical G-domain, with a molecular mass of roughly 20 kDa, is build up of six β-
strands which are surrounded by five α-helices; the structural elements are connected by 
loops (Figure 3). The G-domain harbours five (G1 to G5) nucleotide-binding motifs, of 
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which three (G1, G3 and G4) are highly conserved, and two flexible regions, switch I 
and II, which undergo nucleotide-dependent conformational rearrangements. The G1-
motif, also known as phosphate-binding loop (P-loop) and Walker A motif, with the 
consensus sequence GxxxxGK(S/T), interacts with the β- and γ-phosphate of the bound 
nucleotide. There is no universal consensus sequence of the G2-motif; it contains 
usually a threonine which can contact the Mg2+ cofactor and the γ-phosphate. The G3-
motif, also known as Walker B motif, with the consensus sequence DxxG, is involved 
in the binding of the Mg2+ ion. The G4-motif, with the consensus sequence (N/T)KxD, 
is responsible for the specific binding of guanine nucleotides. The G5-motif is involved 
in the binding of the nucleotide base (Bourne et al., 1991; Dever et al., 1987; Kjeldgaard 
et al., 1996; Pai et al., 1989; Saraste et al., 1990; Vetter and Wittinghofer, 2001; Walker 
et al., 1982). 
G1
G2
G3
G4
switch I
switch II
G5
 
Figure 3. Ras; the prototype of a G-domain. Ribbon plot of the minimal G-domain, with the conserved 
sequence elements and the switch regions in different colours as indicated. The nucleotide and Mg2+ ion 
are shown in ball-and-stick representation. From (Vetter and Wittinghofer, 2001); modified. 
Two major topologies of the G-domain can be distinguished which primarily differ in 
respect to the orientation of one of the β-strands. On this basis GTPases fall into the 
TRAFAC (translation factor) and the SIMIBI (SRP, MinD and BioD) classes (Leipe et 
al., 2002). 
From the evolutionary point of view the case of circularly permutated GTPases 
is interesting, where the order of the G-motifs is exchanged. YlqF carries the G-motifs 
in the order G4-G5-G1-G2-G3 (Kim do et al., 2008), the pattern in cpRAS is G3-G4-
G5-G1-G2 (Elias and Novotny, 2008); these variants arose probably through a 
duplication of G-domains with subsequent elimination of the termini (Leipe et al., 
2002). 
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Unrelated GTP-binding domains, that lack the classical G-motifs, can be found 
in Tubulin / FtsZ and among metabolic enzymes (Kull and Fletterick, 1998; Lowe and 
Amos, 1998; Nogales et al., 1998a; Nogales et al., 1998b; Poland et al., 1993; Schweins 
and Wittinghofer, 1994). 
I.6. Ras superfamily 
The Ras superfamily, of so-called classical small GTPases, is extensive and includes far 
more than 100 members in eukaryotes. Most of the proteins of this family have a 
molecular mass of about 20 kDa, and consist of not much more that the G-domain. 
Many are post-translationally modified by lipids; the modifications facilitate membrane 
association and subcellular localisation, and are critical for biological function. Ras 
superfamily GTPases function mostly as molecular switches, and are paradigmatic for 
the GTPase cycle with the GAPs, GEFs and GDIs as regulators (Figure 2). 
The superfamily can be subdivided into the Ras, Rho/Rac/Cdc42, Rab, Ran and 
Sar1/Arf families. The Ras family is involved in signal transduction, and control cell 
proliferation, differentiation, and survival. The founder of the family, Ras, is involved in 
the prominent MAP kinase cascade, and is an important factor in oncogenesis. The 
Rho/Rac/Cdc42 family primarily regulates the actin cytoskeleton organisation, and is 
therefore important for cell motility, cell shape and cell adhesion. The Rab family 
regulates intracellular vesicle transport. The Ran family functions in nucleocytoplasmic 
transport. The Sar1/Arf family is involved in regulation of vesicular transport (Takai et 
al., 2001; Wennerberg et al., 2005). ARF1 is N-terminally myristoylated; the lipid 
moiety is exposed in the GTP state, and is involved in membrane binding and curvature 
generation (Antonny et al., 1997; Beck et al., 2008; Gillingham and Munro, 2007; 
Goldberg, 1998; Lundmark et al., 2008). 
I.7. Heterotrimeric G proteins 
The heterotrimeric G proteins are built-up of three subunits Gα, Gβ and Gγ. They are 
involved in signal transduction from G protein-coupled receptors (GPCRs). GPCRs, 
like rhodopsin, have an extracellular N-terminus, seven transmembrane helices and an 
intracellular C-terminus; they sense numerous hormones, neurotransmitter, chemokines 
and sensory stimuli. Heterotrimeric G proteins can also participate in signal 
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transduction from single transmembrane spanning receptors, such as epidermal growth 
factor (EGF) receptor, insulin receptor and T cell receptor. 
The Gα subunit is a GTPase. In the resting state it is GDP bound and associated 
with the Gβγ subunits; this heterotrimer is coupled to the GPCR. Upon ligand binding 
the GPCR act as a GEF and activates GDP GTP exchange in the Gα subunit. The active, 
GTP-bound, Gα subunit dissociates from the Gβγ subunits; the two moieties activate 
their respective downstream effectors. The GTPase activity of the Gα subunit can by 
regulated by regulators of G protein signalling (RGS), which function as GAPs. Gα 
contains both a G-domain and a helical-domain; the latter contains a cis arginine-finger. 
RGS proteins do not supplement missing catalytic residues, but rather stabilize the 
catalytic machinery present in Gα. The Gα subunit can be further regulated by GoLoco 
motif containing proteins, which can bind to GDP-bound Giα, and function in a GDI 
fashion (Cabrera-Vera et al., 2003; Patel, 2004; Siderovski and Willard, 2005). 
I.8. Signal recognition particle 
The signal recognition particle (SRP) and its receptor (SR) target nascent secretory and 
integral membrane proteins to the endoplasmic reticulum (ER) and plasma membrane in 
both eukaryota and prokaryota. 
The SRP (Ffh) is a cytoplasmic ribonucleoprotein in eukaryotes and 
prokaryotes; it comprises two domains, N- and G-domain. The membrane-bound 
eukaryotic SR is assembled from two subunits, SRα and SRβ; the prokaryotic SR (FtsY) 
consists of one subunit homologous to eukaryotic SRα. SRα comprises three domains, 
N-, G- and M-domain; the G-domains of SRP and SRα are homologous. SRβ is a small 
GTPase related to the Sar1/Arf family. 
The SRP recognises and binds the signal sequence of a nascent protein at the 
ribosome and arrests further elongation. The ribosome-nascent-protein-SRP complex is 
targeted to the ER in eukaryota or plasma membrane in bacteria where the SRP interact 
with the SR; the ribosome-nascent-protein complex associates with the translocon and 
protein synthesis continues; the SRP-SR complex disassembles (Doudna and Batey, 
2004; Keenan et al., 2001). 
The SRP SRα GTPases have micromolar nucleotide-binding affinities (Jagath et 
al., 2000; Moser et al., 1997; Shan and Walter, 2003; Shan and Walter, 2005b) and 
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function as mutual GAPs in the heterodimeric SRP-SRα complex (Powers and Walter, 
1995). No external GEFs or GAPs are known. There is a third SRP-like GTPase, FlhF, 
in bacteria, which form homodimers and is involved in flagella assembly. The 
heterodimeric Ffh-FtsY (Egea et al., 2004; Focia et al., 2006; Focia et al., 2004; 
Gawronski-Salerno and Freymann, 2007) and the homodimeric FlhF-FlhF (Bange et al., 
2007) complex have a unique feature; the interface formed between the subunits 
contains the two bound GTP molecules in an antiparallel orientation; whereby a direct 
reciprocal trans interaction of the 3'hydroxyl, of nucleotide ribose, with the γ-phosphate 
is crucial for the catalytic activity (Egea et al., 2004; Shan et al., 2004; Shan and Walter, 
2005a). 
I.9. Dynamin 
Dynamins are large GTPases with molecular mass of approximately 100 kDa; they are 
composed of an extended N-terminal G-domain, a middle domain, a pleckstrin 
homology (PH) domain mediating membrane targeting, a GTPase effector domain 
(GED), and a proline-rich domain (PRD) mediating protein-protein interactions. The 
middle domain and the GED are involved in oligomerisation and GTPase activity 
stimulation (Praefcke and McMahon, 2004). Dynamin has a micromolar nucleotide-
binding affinity (Binns et al., 2000; Marks et al., 2001; Stowell et al., 1999). In absence 
of nucleotide, under physiological salt conditions, dynamin is in a monomer-tetramer 
equilibrium in solution (Binns et al., 1999; Eccleston et al., 2002; Hinshaw and Schmid, 
1995; Tuma and Collins, 1995). The crystal structure of a bacterial dynamin-like protein 
(DLP) (BDLP) in the GDP state revealed a G-domain to G-domain dimer (Low and 
Lowe, 2006). The high basal GTPase activity of dynamin is further stimulated by 
oligomer formation and by lipid binding (Hinshaw and Schmid, 1995; Muhlberg et al., 
1997; Praefcke and McMahon, 2004; Song and Schmid, 2003; Tuma and Collins, 1994; 
Tuma et al., 1993). Dynamin forms spirals and ring-like structures in solution and on 
membranes (Hinshaw and Schmid, 1995; Marks et al., 2001; Stowell et al., 1999; Tuma 
and Collins, 1994; Tuma et al., 1993). Dynamin binds and tubulates membranes in 
presence of non-hydrolysable GTP analogues, however scission requires GTP 
hydrolysis (Hinshaw and Schmid, 1995; Marks et al., 2001; Stowell et al., 1999; 
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Sweitzer and Hinshaw, 1998). GTP binding is not required for membrane binding itself 
(Burger et al., 2000; Tuma and Collins, 1995). 
GTP
Budding
clathrin-coated
vesicle
Dynamin
hydrolysis
 
Figure 4. Model of dynamin function as a mechanochemical enzyme. Dynamin is recruited to the 
neck of a budding vesicle. Following the concerted hydrolysis of GTP, the dynamin spring extends, 
shearing the lipid neck. From (Stowell et al., 1999); modified. 
Dynamins and their relatives, DLPs, are involved in various cellular processes including 
vesicle budding (endocytosis), vesicle transport, organelle division, and cytokinesis 
(Hinshaw, 2000; Praefcke and McMahon, 2004). Dynamin is suggested to be a 
mechanochemical enzyme that mediates membrane scission at the necks of budding 
vesicles. Diverse modes of dynamin action were suggested; it is not clear if the scission 
is mediated by an increase in the helical pitch (Figure 4), or by a constriction of the 
helical dynamin oligomer (Bashkirov et al., 2008; Hinshaw and Schmid, 1995; Kozlov, 
1999; Marks et al., 2001; Pucadyil and Schmid, 2008; Roux et al., 2006; Smirnova et 
al., 1999; Stowell et al., 1999; Sweitzer and Hinshaw, 1998; Takei et al., 1998; Zhang 
and Hinshaw, 2001). An alternative mode of dynamin function, as a regulatory GTPase 
is under discussion (Sever et al., 2000; Sever et al., 1999; Song and Schmid, 2003). 
I.10. Mx proteins 
Myxovirus resistance (Mx) proteins are induced by type I IFN and mediate resistance 
against a wide range of RNA viruses, including influenza viruses, on cell-autonomous 
level (Arnheiter et al., 1990; Chieux et al., 2001; Haller et al., 1998; Haller et al., 2007; 
Hefti et al., 1999; Jin et al., 1999; Krug et al., 1985; Landis et al., 1998; Lindenmann et 
al., 1978; Lindenmann et al., 1963; Pavlovic et al., 1992; Staeheli et al., 1986; Zurcher 
et al., 1992a; Zurcher et al., 1992b; Zurcher et al., 1992c). 
Mx proteins are large, dynamin related, GTPases with a molecular mass of 70 - 
80 kDa and consist of a N-terminal G-domain, a central interactive domain (CID), and a 
C-terminal effector domain (Haller et al., 2007). They have micromolar nucleotide-
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binding affinities and a high intrinsic GTPase activity (Haller et al., 2007; Richter et al., 
1995; Staeheli et al., 1993). Furthermore Mx proteins show nucleotide-dependent 
oligomerisation and cooperative GTP hydrolysis. Assembly of the proteins into ring-
like and helical structures in solution was reported in the presence of non-hydrolysable 
GDP and GTP analogues respectively (Accola et al., 2002; Haller and Kochs, 2002; 
Kochs et al., 2002a; Melen et al., 1992; Nakayama et al., 1993). MxA binds und 
tubulates vesicle in a nucleotide independent manner (Accola et al., 2002). 
The antiviral mode of action of Mx proteins is not clarified. However a direct 
interaction of MxA with viral nucleocapsid proteins was demonstrated (Janzen et al., 
2000; Kochs and Haller, 1999a; Kochs and Haller, 1999b; Kochs et al., 2002b; Kochs et 
al., 1998; Turan et al., 2004). A model was suggested where inactive MxA is stored in 
oligomers in the absence of infection; in infected cells viral components are trapped in 
MxA copolymers and directed for degradation (Di Paolo et al., 1999; Haller and Kochs, 
2002; Haller et al., 2007; Janzen et al., 2000). 
I.11. Guanylate-binding proteins 
Guanylate-binding proteins (GBPs) (p65 GTPases) are large GTPases with a molecular 
mass of approximately 65 kDa, and are built-up of an extended N-terminal G-domain 
and a C-terminal helical-domain (Prakash et al., 2000a; Prakash et al., 2000b). GBPs are 
considered to belong to the dynamin superfamily, although they are not as closely 
related to dynamin as Mx proteins (Praefcke and McMahon, 2004). GBPs harbour an 
unusual T(L/V)RD G4-motif. hGBP1 binds GTP, GDP and GMP with micromolar 
affinity (Cheng et al., 1985; Cheng et al., 1991; Praefcke et al., 1999; Schwemmle and 
Staeheli, 1994). hGBP1 shows GTP-dependent complex formation and cooperative 
GTP hydrolysis (Ghosh et al., 2006; Prakash et al., 2000a). The dimer formation is 
mediated by the interaction of two G-domains (Ghosh et al., 2006). GTP is hydrolysed 
to GDP and further to GMP, in two linked, constitutive hydrolysis steps (Ghosh et al., 
2006; Kunzelmann et al., 2006; Neun et al., 1996; Schwemmle and Staeheli, 1994). The 
hydrolysis of GTP and GDP employs the same catalytic machinery, including a cis 
arginine-finger, in which the substrate is shifted after the first hydrolysis reaction 
(Ghosh et al., 2006). GDP from solution does not serve as a substrate (Schwemmle and 
Staeheli, 1994). 
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GBPs are mainly induced by type II, and to a lower extent by type I IFNs 
(Boehm et al., 1998; Cheng et al., 1986; Cheng et al., 1983; Lubeseder-Martellato et al., 
2002; Nantais et al., 1996; Tripal et al., 2007; Vestal et al., 1996; Vestal et al., 1995); 
but their function is unknown. Although small antiviral effects were reported (Anderson 
et al., 1999; Carter et al., 2005; Itsui et al., 2006), the most sticking observation is the 
accumulation of numerous murine GBPs at the PV of avirulent, but not virulent, T. 
gondii (Degrandi et al., 2007). Interesting, also in context of possible relevance for 
immunity against T. gondii (Zhao et al., 2009b), is the proposed involvement of mGBP5 
in Salmonella enterica serovar Typhimurium induced rapid death (pyroptosis) of 
infected cells (Rupper and Cardelli, 2008). Remarkable mGBP5, although absent from 
the T. gondii PV (Degrandi et al., 2007), was reported to localise with the membrane of 
phagosomes containing this bacterium (Rupper and Cardelli, 2008). However mGBP5 
was also found to be enriched at phagosomes after IFNγ stimulation (Jutras et al., 2008). 
Furthermore regulative functions, in cell proliferation and vasculogenesis, of GBPs 
were proposed (Gorbacheva et al., 2002; Guenzi et al., 2001; Guenzi et al., 2003). 
I.12. Very large inducible GTPases 
Very large inducible GTPase 1 (VLIG1) is the largest known GTPase with a molecular 
mass of 280 kDa. VLIG1 is induced by type I and II IFNs and localises to the cytoplasm 
and the nucleus. The G-domain contains the conserved G1- and G3-motif, but the 
canonical G4-motif is absent. VLIG1 binds strongly to GDP-, but only very weak to 
GTP- and GMP-agarose (Klamp et al., 2003). 
Nothing is known about the function of VLIGs. A potential immunological role 
of the proteins seems to be lost in the human lineage (Li et al., 2009), as also reported 
for the immunity-related GTPases (IRGs) (Bekpen et al., 2005). 
I.13. Immunity-related GTPases 
Immunity-related GTPases (IRGs) (p47 GTPases) have a relatively high molecular 
mass of approximately 47 kDa, and are involved in cell-autonomous resistance to 
intracellular bacteria and protozoa (MacMicking, 2004; MacMicking, 2005; Martens 
and Howard, 2006; Taylor, 2007; Taylor et al., 2004; Zhao et al., 2009c). 
Mycobacterium tuberculosis (M. tuberculosis) (MacMicking et al., 2003), 
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Mycobacterium avium (Feng et al., 2004), Salmonella typhimurium (Henry et al., 2007), 
Listeria monocytogenes (Collazo et al., 2001), Chlamydia trachomatis (C. trachomatis) 
(Bernstein-Hanley et al., 2006; Nelson et al., 2005), Chlamydia psittaci (Miyairi et al., 
2007), Tripanosoma cruzi (Santiago et al., 2005), Leishmania major (Feng et al., 2004) 
and T. gondii (Butcher et al., 2005; Collazo et al., 2001; Halonen et al., 2001; Henry et 
al., 2009; Ling et al., 2006; Martens et al., 2005; Taylor et al., 2000) were found to be 
resisted by mouse IRG proteins. 
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Figure 5. Immunity-related GTPases in the mouse. Unrooted tree (p-distance based on neighbour-
joining method) of nucleotide sequences of the G-domains of the 23 mouse (C57BL/6) IRGs, including 
the two presumed pseudo-genes Irga5 and Irgb7. Former names of the IRGs (Boehm et al., 1998) are 
shown in green. The GMS subfamily is highlighted with a red ellipse. From (Bekpen et al., 2005); 
modified. 
The six founding members, Irgm1 (LRG47) (Sorace et al., 1995), Irgm2 (GTPI) 
(Boehm et al., 1998), Irgm3 (IGTP) (Taylor et al., 1996; Taylor et al., 1997), Irgb6 
(TGTP / Mg21) (Carlow et al., 1995; Carlow et al., 1998; Lafuse et al., 1995), Irga6 
(IIGP1 / IIGP) (Boehm et al., 1998) and Irgd (IRG47) (Gilly and Wall, 1992), and one 
newcomer, Irgb10 (Bernstein-Hanley et al., 2006; Miyairi et al., 2007), of the family 
were investigated in context of immunity in some detail. Three members, Irgm1, Irgm2 
and Irgm3, carry a unique substitution of the, elsewhere conserved, P-loop lysine to 
methionine (Figure 12); giving rise to the GMS name of the subfamily; the other IRG 
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proteins with the classical P-loop are called GKS (Bekpen et al., 2005; Boehm et al., 
1998). 
 
Figure 6. Structure of Irga6. One molecule of the Irga6 GDP dimer (ribbon presentation) is shown with 
the G-domain (S1 - H5) coloured in light-blue, and the N- and C-terminal helical regions coloured in cyan 
(αA - αC) and dark-blue (αF - αL) respectively. The linker-helix αE connecting the G-domain and C-
terminal helical region is shown in gray. GDP and Mg2+ are shown as atomic stick figure and yellow 
sphere respectively. From (Ghosh et al., 2004); modified. 
The C57BL/6 mouse has 23 IRG genes (Figure 5), typically encoded on one long exon, 
and containing GAS and ISRE motifs in the promoter (Bekpen et al., 2005). The genes 
cluster on chromosome 11 and 18, with the exception of Irgc (CINEMA) which is 
located on chromosome 7 (Bekpen et al., 2005). IRGs are found to be mainly induced 
by IFNγ and to a lesser extent also by IFNα/β in all cell types analysed (Bafica et al., 
2007; Bekpen et al., 2005; Boehm et al., 1998; Carlow et al., 1998; Collazo et al., 2002; 
Gavrilescu et al., 2004; Gilly et al., 1996; Gilly and Wall, 1992; Lafuse et al., 1995; 
Lapaque et al., 2006; MacMicking et al., 2003; Martens and Howard, 2006; Sorace et 
al., 1995; Taylor et al., 1996; Zerrahn et al., 2002). Irga6 was found to be constitutively 
expressed in the liver under the control of a second promoter (Bekpen et al., 2005; 
Parvanova, 2005; Zeng, 2007). Irgc is an exceptional member of the family, it does not 
contain any interferon specific response elements in the promoter, and is not induced by 
IFNs, but constrictively expressed, in the adult testis, in haploid spermatids (Bekpen et 
al., 2005; Rohde, 2007). Irgc is strongly conserved and is the only full-length human 
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IRG protein (Bekpen et al., 2005; Rohde, 2007). The other human IRG protein, IRGM, 
is seriously truncated, and is not inducible by IFNs but constitutively expressed from an 
endogenous retroviral long terminal repeat (LTR) (Bekpen et al., 2005; Bekpen et al., 
2009). Therefore an immune function of IRGM appears questionable. Nevertheless 
IRGM was proposed to be involved in autophagy mediated resistance to M. tuberculosis 
(Singh et al., 2006). Further the association of IRGM with an increased susceptibility to 
Crohn's disease (autoimmune inflammatory disease of the gastrointestinal tract) is under 
investigation (Fisher et al., 2008; McCarroll et al., 2008; Parkes et al., 2007). 
 
The biochemical properties of Irga6 were extensively characterized. The protein binds 
GTP and GDP with micromolar affinity, which is caused by a high dissociation rate, 
and shows a 10 - 15 fold preference for GDP over GTP (Uthaiah et al., 2003). Irga6 
reversibly oligomerises in a GTP-dependent manner in vitro, and forms at least dimer in 
vivo (Papić, 2007; Papic et al., 2008). Irga6 shows cooperative GTP hydrolysis, 
whereby Irga6 molecules act as mutual GAPs (Uthaiah et al., 2003). No external GEFs 
or GAPs are known. These properties reassemble dynamin, Mx proteins and GBPs but 
also SRP GTPases. A residue corresponding to Gln61Ras is absent from all that proteins. 
Irga6 was crystallised, the protein consists of a Ras-like G-domain (Pai et al., 
1989), with an insertion of an additional helix (αd) between S5 and H4, and a helical-
domain (Ghosh et al., 2004). The G-domain is build up of six β-strands (S1 - S6) and 
six α-helices (H1 - H5 and αd), it contains the three conserved GTP-binding motifs 
(G1, G3 and G4) (Ghosh et al., 2004). The helical-domain consists of three N-terminal 
(αA - αC) and seven C-terminal α-helices (αF - αL); the C-terminal part of the helical-
domain is connected to the G-domain via the linker-helix (αE) (Ghosh et al., 2004). 
Only small structural changes were observed between the GDP and GppNHp (non-
hydrolysable GTP analogue)-bound state (Ghosh et al., 2004). Remarkably the bound 
nucleotide was found to be more solvent exposed in the GppNHp than in the GDP sate; 
potentially explaining the higher dissociation rate, and lower binding affinity, of GTP 
than GDP (Ghosh et al., 2004; Uthaiah et al., 2003). 
Irga6, although monomeric in solution (Uthaiah et al., 2003), crystallised as a 
rotationally symmetrical dimer (Ghosh et al., 2004) (Figure 33). The formation of the 
crystal-dimer is nucleotide independent, however the crystal-dimer-interface was 
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proposed to be involved in oligomerisation (Ghosh et al., 2004). Mutations in the 
crystal-dimer-interface were found to reduce oligomerisation, although no complete 
inhibition of complex formation was achieved (Ghosh et al., 2004). 
Only little is known about the enzymatic properties of other IRG proteins. 
Partially purified glutathione-S-transferase (GST) Irgb6 fusion protein was shown to 
hydrolyse GTP (Carlow et al., 1998). Irgm3 immunoprecipitated from IFNγ stimulated 
cells and partially purified GST Irgm3 fusion protein hydrolysed GTP (Taylor et al., 
1996). Further co-immunoprecipitation of GTP (~ 90 - 95%) and GDP (~ 5 - 10%) with 
Irgm3 from IFNγ stimulated cell was obtained (Taylor et al., 1997). It was reported that 
Irgm1 immunoprecipitated from IFNγ stimulated cells showed GTPase activity (Taylor 
et al., 1996). 
Irga6 T. gondii overlay
 
Figure 7. Irga6 accumulates on T. gondii PVM. IFNγ induced astrocytes were infected with T. gondii; 
stained for Irga6 (red) and T. gondii (green). From (Martens et al., 2005); modified. 
IRG proteins have distinct membrane association properties and subcellular 
localisations. While Irgm1, Irgm2, Irgm3 are almost completely membrane bound, Irgd 
is nearly exclusively soluble (Martens, 2004; Martens et al., 2004). Irga6 and Irgb6 have 
membrane-bound and soluble fractions (Martens et al., 2004). In uninfected IFNγ 
stimulated cells Irgm1 and Irgm2 colocalise with the Golgi apparatus, and Irgm3, Irga6 
and Irgb6 with the ER (Martens, 2004; Martens et al., 2004; Zerrahn et al., 2002). 
Further colocalisation of Irga6 with the Golgi apparatus was reported (Zerrahn et al., 
2002). The membrane targeting of the three GMS proteins is mediated by the αK helix, 
which is amphipathic in case of Irgm1 (Martens, 2004; Martens et al., 2004). Irga6 is, 
and numerous IRGs are predicted to be, N-terminally myristoylated (Bekpen et al., 
2005; Martens et al., 2004). Irga6 requires this lipid modification for membrane-binding 
specificity but not for the membrane binding itself (Martens et al., 2004). 
Overexpressed Irga6, Irgb6 and Irgb10, in absence of IFNγ, form aggregate-like 
structures (Coers et al., 2008; Hunn et al., 2008; Martens et al., 2004). The aggregation 
of Irga6 and Irgb6 could be rescued by simultaneous overexpression of the three GMS 
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proteins (Hunn et al., 2008). Direct nucleotide-dependent interactions of distinct IRG 
proteins, including GKS GKS, GKS GMS and GMS GMS interactions, were shown 
(Hunn, 2007; Hunn et al., 2008). Irga6 directly interacts with Irgm3, whereby the 
interaction is enhanced by the addition of GDP (Hunn et al., 2008). A functional model 
was established, in which GKS protein aggregates represent the activated, GTP-bound, 
and potentially oligomeric form. GMS proteins function in that model in a GDI fashion, 
arrest GKS proteins in the inactive GDP state, and prevent the sterile activation of GKS 
proteins in absence of infection (Hunn et al., 2008). 
 
Figure 8. Irga6 is fond at vesicular structures next to disrupted T. gondii PVM. Astrocytes were 
induced with IFNγ, and infected with T. gondii. Ultra-thin cryosections were labeled for Irga6 using an 
anti Irga6 antiserum and 10 nm gold coupled to protein A (open white arrowhead: T. gondii inner 
membrane complex; filled white arrowhead: T. gondii plasma membrane; black arrowhead: PVM; bar: 
250 nm). The insets show enlarged views of the boxed regions. The black arrows in the bottom left inset 
point to Irga6 labeled vesicular profiles with an apparent electron-dense coat. From (Martens et al., 2005); 
modified. 
The most impressive feature of IRG proteins is their ability to accumulate on pathogen-
containing vacuoles. Irga6 (Figure 7; Figure 8), Irgb10, Irgb6, Irgd, Irgm2 and Irgm3 
relocalise from their resting compartments to the PVM of avirulent T. gondii (Henry et 
al., 2009; Hunn et al., 2008; Ling et al., 2006; Martens et al., 2005; Melzer et al., 2008; 
Papic et al., 2008; Zhao et al., 2009a; Zhao et al., 2009b; Zhao et al., 2008) (Khaminets 
et al., manuscript in preparation), but not, or only very inefficient, to the PVM of 
virulent T. gondii (Zhao et al., 2009a; Zhao et al., 2009c) (Khaminets et al., manuscript 
in preparation). IRG proteins accumulate on the T. gondii PVM in a cooperative and 
regulated manner (Hunn et al., 2008) (Khaminets et al., manuscript in preparation). The 
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PVM of avirulent T. gondii and the parasite itself were observed to disrupt in IFNγ 
stimulated cells, whereby vesiculation and sequestration of the membranes were 
reported (Ling et al., 2006; Martens et al., 2005; Melzer et al., 2008; Zhao et al., 2009b; 
Zhao et al., 2008). Irga6 was observed on vesicular structures next to disrupted sites of 
the PVM (Figure 8); the same structures were found to be positive for the T. gondii 
PVM protein GRA7 (Martens et al., 2005). Overexpression of Irga6 and Irgb6 
accelerated the disruption, in contrast dominant negative variants of the proteins 
retarded the process (Martens et al., 2005). The disruption of the parasite causes a 
subsequent necrotic cell death, but the role of IRG proteins in this process is undefined 
(Zhao et al., 2009b). 
Irgb10 and Irga6 assemble on the inclusion of the human pathogen C. 
trachomatis, but not on the inclusion of the mouse pathogen Chlamydia muridarum (C. 
muridarum) (Coers et al., 2008) in infected mouse cells. In addition Irgb6, Irgd, Irgm2 
and Irgm3 were reported to associate with the C. trachomatis inclusion (Al-Zeer et al., 
2009), although Irgm3 was not observed on the inclusion in another study (Coers et al., 
2008). Interestingly the accumulation of several IRG proteins on the C. trachomatis 
inclusion was suggested to depend on further IFNγ induced factors (Al-Zeer et al., 
2009), a similar observation was made in context of IRG protein association with the T. 
gondii PVM; the IFNγ induced factors required in this case were other IRG proteins 
(Hunn, 2007; Hunn et al., 2008) (Khaminets et al., manuscript in preparation). The task 
of IRG proteins on the C. trachomatis inclusion is unknown. The specific accumulation 
of IRG proteins on avirulent T. gondii and the human pathogen C. trachomatis, gives 
rise to the assumption that virulent T. gondii and the mouse pathogen C. muridarum 
evolved strategies to circumvent the murine IRG resistance system (Coers et al., 2008; 
Zhao et al., 2009a; Zhao et al., 2009c) (Khaminets et al., manuscript in preparation). 
Irgm1 was found at phagosomes containing M. tuberculosis. Irgm1 is proposed 
to accelerate the fusion of the phagosomes with lysosomes, and to promote 
acidification, leading to the killing of the pathogen (MacMicking et al., 2003). However 
no pathogen derived signal seems to be required for the localisation of Irgm1 on M. 
tuberculosis phagosomes, due Irgm1 and Irgm3 were reported to associate with latex 
bead containing phagosomes (Butcher et al., 2005; Martens et al., 2004). In a study, of 
the phagosome proteome, increased levels of Irgm1, Irgm2, Irgm3 and Irga6 were found 
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at the phagosome after IFNγ stimulation, interestingly also the level of mGBP5 was 
increased (Jutras et al., 2008). 
 
Antiviral effects of Irgb6 (Carlow et al., 1998) and Irgm3 (Liu et al., 2008; Zhang et al., 
2003) (the latter in HeLa cells) overexpression, in the absence of IFNγ, were reported. 
In the light of the artificiality of the used assays, and the fact that so far no IRG 
deficient mouse was reported to be more susceptible to viral infections (Collazo et al., 
2001; Taylor et al., 2000), the relevance of the observed antiviral effects is questionable. 
Autophagy was suggested to be involved in the IRG protein mediated resistance 
to T. gondii (Ling et al., 2006), C. trachomatis (Al-Zeer et al., 2009) and M. 
tuberculosis (Gutierrez et al., 2004; Singh et al., 2006). Although a link seems to exist 
between autophagy and IRG proteins (Zhao et al., 2008) (Khaminets et al., manuscript 
in preparation), the meaning of autophagy for the IRG resistance system is unknown. 
Irgm1 was suggested to be involved in regulation of lymphocyte function and 
development; on the basis of phenotypes observed in Irgm1 deficient mice (Bafica et 
al., 2007; Feng et al., 2004; Feng et al., 2008a; Feng et al., 2008b; Santiago et al., 2005). 
Irgm1 deficient mice succumbed to Mycobacterium avium infection, in contrast Irgm1 
plus IFNγ doubly deficient mice survived (Feng et al., 2008b). The question is what 
killed the Irgm1 deficient mice; the absence of Irgm1 or the presence of a misregulated 
(Henry et al., 2009; Hunn et al., 2008) IRG resistance system? 
 
Only few interaction partners, outside of the IRG family, of IRG proteins were 
described. Irga6 were reported to interact with hook3 in a nucleotide-dependent manner 
(Kaiser et al., 2004). Hook3 is a microtubule-binding protein which participates in the 
organisation of the cis-Golgi compartment (Walenta et al., 2001). However microtubule 
integrity is not required for the accumulation of Irga6 on the T. gondii PVM (Khaminets 
et al., manuscript in preparation). Nevertheless hook3 might be an interesting target for 
further studies. Salmonella SpiC protein, which is required for survival of this 
bacterium within macrophages, and inhibition of phagosome-lysosome fusion, interacts 
with hook3. Overexpression of SpiC had the same effect as the overexpression of a 
dominant negative hook3 variant, and disrupted the Golgi apparatus morphology 
(Shotland et al., 2003). Hook3 was found to interact with the cytoplasmic domain of 
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scavenger receptor A (Sano et al., 2007). Furthermore hook3 was found to be 
redistributed to the MxA-positive compartment, in cells overexpressing MxA (Stertz et 
al., 2006). 
Irga6 was found to interact strongly, and Irgb6 very weakly, with the Golgi 
reassembly and stacking protein 2 (GORASP2) in yeast two-hybrid. The interaction of 
Irgc and GORASP2 was nucleotide-dependent (Rohde, 2007). 
The lipid droplet protein ADRP was found to interact with the C-terminal 
moiety of rat Irgd (Yamaguchi et al., 2006). Distinct mouse IRG proteins colocalise 
with lipid droplets (Julia Hunn, unpublished results). 
I.14. The aim of this study 
Immunity-related GTPases (IRGs) are important agents of resistance and mediate cell-
autonomous immunity to a number of bacterial and protozoan pathogens (Martens and 
Howard, 2006; Taylor, 2007). 
 
The protozoan parasite Toxoplasma gondii (T. gondii) is a well established model 
organism in context of IRG mediated immunity. The IRG resistance system is required 
for control of the parasite in mice during the acute and chronic phase of infection 
(Collazo et al., 2002; Collazo et al., 2001; Henry et al., 2009; Ling et al., 2006; Taylor 
et al., 2000; Zhao et al., 2009a). IRGs mediate resistance to T. gondii on the cell-
autonomous level (Butcher et al., 2005; Halonen et al., 2001; Ling et al., 2006; Martens 
et al., 2005; Melzer et al., 2008; Zhao et al., 2009a). 
IRGs accumulate on the T. gondii parasitophorous vacuole membrane (PVM), 
and participate in destruction of the PVM and the parasite itself, via vesiculation and 
stripping of the T. gondii surrounding membranes (Ling et al., 2006; Martens et al., 
2005; Melzer et al., 2008; Zhao et al., 2009b; Zhao et al., 2008). Irga6 is found together 
with a T. gondii PVM protein GRA7 on vesicular structures next to disrupted T. gondii 
membranes (Martens et al., 2005). 
 
The enzymatic properties of Irga6 are distinct from those of classical Ras-like GTPases 
(Vetter and Wittinghofer, 2001); the low nucleotide-binding affinity, nucleotide-
dependent oligomerisation and cooperative GTP hydrolysis (Uthaiah et al., 2003) are 
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well known from the dynamin superfamily of large GTPases (Praefcke and McMahon, 
2004). Dynamin oligomerises at the necks of budding vesicles; it is proposed to be a 
mechanochemical enzyme, and to mediate scission of nascent vesicles (Marks et al., 
2001; Stowell et al., 1999; Sweitzer and Hinshaw, 1998). 
The crystal structure of Irga6 was solved, the protein crystallised as a dimer 
independently of the nucleotide state (Ghosh et al., 2004). Mutations in the crystal-
dimer-interface inhibited, but failed to abolish, oligomerisation (Ghosh et al., 2004). 
The crystal-dimer-interface was proposed to participate in oligomerisation (Ghosh et al., 
2004), however it did not provide any mechanistically explanation for the observed 
activation of GTP hydrolysis in Irga6 complexes (Uthaiah et al., 2003). 
 
Oligomerisation requires at least two distinct contact surfaces between the complex 
forming molecules. This study begun with the aim to uncover the second interface 
involved in Irga6 oligomerisation, and to provide an explanation of how the GTP 
hydrolysis is activated by the interaction of Irga6 molecules. 
Nothing is known about the function IRGs in the T. gondii killing process. In 
analogy to dynamin the knowledge of the oligomeric Irga6 topology would potentially 
supply clues which could help to understand the molecular mode of function of this 
amazing protein family. 
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II.1. Material 
II.1.1. Chemicals 
Unless specified all chemicals were purchased from Roth, Fluka, Sigma, Aldrich, 
Merck, Serva, Biozym, MP Biomedicals. Water (ddH2O) derived from Milli-Q 
Synthesis (Millipore) was used. 
II.1.2. Enzymes 
Unless specified all enzymes were purchased for New England Biolabs. Pyrococcus 
furiosus (Pfu) DNA Polymerase (Promega); Thrombin (Serva); AcTEV Protease 
(Invitrogen); RNase A (Sigma); Shrimp alkaline phosphatase (SAP) (Amersham) 
II.1.3. Kits 
Rapid PCR Product Purification Kit (Boehringer); Midi Plasmid Preparation Kit 
(Qiagen); BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) 
II.1.4. Expendable items 
PEI Cellulose F thin layer chromatography (TCL) plates (Merck); Vivaspin 20 
centrifugal concentrator 10 kDa cut-off (Vivascience); Complete mini protease 
inhibitors EDTA free (Roche); Supor 200 0.2 µm filter (Pall); PageRuler Prestained 
Protein Ladder (Fermentas); PageRuler Protein Ladder (Fermentas); GeneRuler DNA 
Ladder Mix (Fermentas) 
II.1.5. Media and Buffer 
Luria-Bertani (LB) medium (Bertani, 1951) - low salt modification - (5 g NaCl, 10 g 
bacto tryptone, 5 g yeast extract, distilled water 1 L, for plates additionally 15g agar) 
Buffers were made with ddH2O, filtered through a 0.2 µm filter and degassed. 
Phosphate buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 10.1 mM Na2HPO4, 1.8 
mM KH2PO4, pH 7.4); elution-buffer (50 mM Tris/HCl pH 8, 10 mM reduced 
glutathione); B1 (50 mM Tris/HCl, 5 mM MgCl2, pH 7.4) 
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II.1.6. Bacterial strains 
Escherichia coli (E. coli) DH5α: 80dlacZ ∆M15, recA1, endA1, gyrA96, thi-1, hsdR17 
(rB-, mB+), supE44, relA1, deoR, ∆(lacZYA-argF)U169; E. coli BL21: B, F-, hsdS (rB-, 
mB-), gal, dcm, ompT 
II.1.7. Nucleotides 
GTP (Roth and Sigma); GDP (Sigma); XTP, XDP, 2'deoxy-GTP, mant-GTP, mant-
GDP, mant-GTPγS, 2'mant-3'deoxy-GTP, 2'deoxy-3'mant-GTP, mant-XTP and mant-
XDP (Jena Bioscience); 3'deoxy-GTP (Jena Bioscience and Trilink Biotechnologies); 
2'3'dideoxy-GTP (Amersham), α32P-GTP (Amersham, Hartmann Analytic and Perkin 
Elmer); γ32P-3'dGTP (Hartmann Analytic) 
II.1.8. Immunoreagents 
Primary immunoreagents: 165 (Uthaiah, 2002) rabbit polyclonal anti Irga6; A20 (Santa 
Cruz Biotechnology) goat polyclonal anti Irgb6; 2078 (Eurogentec) rabbit polyclonal 
anti Irgd. Secondary immunoreagents: donkey anti rabbit horseradish peroxidase (HRP) 
(Amersham Bioscience); donkey anti goat HRP (Santa Cruz). 
II.1.9. Vectors 
pGEX-4T-2 (Amersham); pEGFP-N3 (Clontech) 
II.1.10. Mutagenesis primer 
Primer used for site directed mutagenesis; 5'-3' sequences of forward primer are listed; 
5'-3' sequences of backward primer are equivalent to reverse complement sequences of 
forward primer. 
K9E-S10R gggtcagctgttctcttcacctgagcgtgatgagaataatgatttgccc 
S18R gaataatgatttgccccgcagctttactgg 
R31E-K32E ggttattttaagaaatttaatacgggagaagaaatcatttctcaagagatcctcaatttg 
E37R gaaaaatcatttctcaaaggatcctcaatttg 
E43R caagagatcctcaatttgattagattaaggatgagaaaagggaatattc 
N50R ggatgagaaaagggaggattcagttgacaaac 
Q52R gaaaagggaatattcgcttgacaaactctgc 
S56R cagttgacaaaccgtgcaatcagtgatgc 
E64K gtgatgcattaaaaaaaatcgatagtagtgtgc 
E77A gctcaatgttgctgtcaccggggcgacgggatcagggaagtcc 
E77Q gtgctcaatgttgctgtcaccgggcagacgggatcagggaagtccagcttc 
E77D gtgctcaatgttgctgtcaccggggacacgggatcagggaagtccagcttc 
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E77N gtgctcaatgttgctgtcaccgggaacacgggatcagggaagtccagcttc 
T78A gtgctcaatgttgctgtcaccggggaggcgggatcagggaagtccagcttcatcaatac 
T88R ggatcagggaagtccagcttcatcaatcgcctgagaggcattgggaatgaagaagaagg 
E97R gggaatgaagaacgaggtgcagctaaaactggg 
K101E gaagaagaaggtgcagctgaaactggggtggtggaggtaacc 
G103R ggaatgaagaagaaggtgcagctaaaactagggtggtggaggtaaccatggaaagacatc 
E106A gctaaaactggggtggtggcggtaaccatggaaag 
E106D ggtgcagctaaaactggggtggtggacgtaaccatggaaagacatcc 
E106N ggtgcagctaaaactggggtggtgaacgtaaccatggaaagacatcc 
E106Q ggtgcagctaaaactggggtggtgcaggtaaccatggaaagacatcc 
E106H ggtgcagctaaaactggggtggtgcacgtaaccatggaaagacatcc 
E106K gctaaaactggggtggtgaaggtaaccatggaaag 
E106R gctaaaactggggtggtgcgggtaaccatggaaag 
M109A ggtggaggtaaccgcggaaagacatccatac 
E110R-R111E ctggggtggtggaggtaaccatgagagaacatccatacaaacaccccaatataccc 
K115E ggtaaccatggaaagacatccatacgaacaccccaatatacccaatgtgg 
S132R gggacctgcctgggattggaaggacaaatttcccaccaaac 
E142R ccaaacacttacctgcggaaaatgaagttctatg 
K145E cctggagaaaatggagttctatgagtacgatttc 
E148R gaaaatgaagttctatcggtacgatttcttcattattatttcg 
D150R ggagaaaatgaagttctatgagtaccgtttcttcattattatttcggccacacgc 
R159A cgatttcttcattattatttcggccacagccttcaagaaaaatgatatagacattgcc 
R159K cgatttcttcattattatttcggccacaaagttcaagaaaaatgatatagacattgcc 
R159D cgatttcttcattattatttcggccacagacttcaagaaaaatgatatagacattgcc 
R159E cattattatttcggccacagaattcaagaaaaatgatatag 
R159N cgatttcttcattattatttcggccacaaacttcaagaaaaatgatatagacattgcc 
R159Q cgatttcttcattattatttcggccacacaattcaagaaaaatgatatagacattg 
K161E cggccacacgcttcgagaaaaatgatatagac 
K162E gccacacgcttcaaggaaaatgatatagacattgc 
D164A cggccacacgcttcaagaaaaatgctatagacattgccaaagcaatcagc 
D164V cggccacacgcttcaagaaaaatgttatagacattgccaaagcaatcagc 
D164H cggccacacgcttcaagaaaaatcatatagacattgccaaagcaatcagc 
D164N cggccacacgcttcaagaaaaataatatagacattgccaaagcaatcagc 
D164Q cggccacacgcttcaagaaaaatcaaatagacattgccaaagcaatcagc 
D164E cggccacacgcttcaagaaaaatgagatagacattgccaaagcaatcagc 
D164K cggccacacgcttcaagaaaaataaaatagacattgccaaagcaatcagc 
D164R cggccacacgcttcaagaaaaatcgtatagacattgccaaagcaatcagc 
K169E gaaaaatgatatagacattgccgaagcaatcagcatgatg 
S172R-M173A-K175E-E177R gatatagacattgccaaagcaatcagagcgatggagaagcgattctacttcgtgagaaccaaggtggac 
M173E cattgccaaagcaatcagcgagatgaagaaggaattctac 
M173R cattgccaaagcaatcagcaggatgaagaaggaattctac 
M173W cattgccaaagcaatcagctggatgaagaaggaattctac 
K175E gcaatcagcatgatggagaaggaattctacttcg 
K176E gcaatcagcatgatgaaggaggaattctacttcgtg 
E177R caaagcaatcagcatgatgaagaagcgattctacttcgtgagaaccaaggtgg 
D186N gtgagaaccaaggtgaattctgacataacaaatg 
N191R ggtggactctgacataacaagagaagcagatggcaaacctc 
K196D gaagcagatggcgaccctcaaacctttgac 
K202A cctcaaacctttgacgcagaaaaggtcctgc 
E203R cctttgacaaaagaaaggtcctgcagg 
R210E gacaaagaaaaggtcctgcaggacatcgagcttaactgtgtgaacacctttaggg 
R218E-E219R ccgccttaactgtgtgaacacctttgagaggaatggcattgctgagccaccaatc 
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R218E-E219R-E224R ccgccttaactgtgtgaacacctttgagaggaatggcattgctcggccaccaatcttcctgctctctaac 
E224R cacctttagggagaatggcattgctcggccaccaatcttcctgctctctaac 
H237D caaaaatgtttgtaactatgacttccccg 
V242R gtttgtcactatgacttcccccgcctgatggacaagctgataagtgacc 
V242R-D245R-D250R gtttgtcactatgacttcccccgcctgatgcgcaagctgataagtcgcctccctatctacaagagacac 
D245R gtcactatgacttccccgtcctgatgcgcaagctgataagtgacctccctatc 
K246E ctatgacttccccgtcctgatggacgagctgataagtgacctccctatctac 
D250R cccgtcctgatggacaagctgataagtcgcctccctatctacaagagacac 
K255E gctgataagtgacctccctatctacgagagacacaattttatggtctccttaccc 
N265R gagacacaattttatggtctccttaccccgtatcacagattcagtcattgaaaagaagc 
S269R ggtctccttacccaatatcacagatcgagtcattgaaaagaagcggcaatttc 
R275E cagattcagtcattgaaaagaaggagcaatttctgaagcagaggatttggc 
E285R gcggcaatttctgaagcagaggatttggctgcgaggatttgctgctgacctagtg 
N293R ggaaggatttgctgctgacctagtgcgtatcatcccttctctgacctttctcttgg 
S304R cccttctctgacctttctcttggaccgtgatttggagactctgaagaaaagcatg 
K310E-K311E cttggacagtgatttggagactctggaggaaagcatgaaattctaccgcactgtg 
T325R-S326R ccgcactgtgtttggagtggatgaaagacgtttgcagagattagctagggactggg 
E335R ctttgcagagattagctagggactggcgaatagaggtggatcaggtggaggcc 
K346E ggtggatcaggtggaggccatgatagaatctcctgctgtgttcaaacctacag 
D355R-E356R-E357R aatctcctgctgtgttcaaacctacacgtcgacgaacaatacaagaaaggctttcaagat 
L372R-A373R gctttcaagatatattcaggagttctgtcggcgtaatgggtacttacttcctaaaaatag 
K407E ggtgactgaggatgctaaaactcttcttgaagagatatgtttaagaaactag 
a6c1_EGFP_delSalI ggccgactcgagcggccgcatcgtgacgtcgccggtaccgcgggcccgggatccatcgcc 
EGFP_addSalI cggcatggacgagctgtacaagtaagtcgaccgcgactctagatcataatcagccatacc 
a6cGFP_5AgeI_d ctaaaactcttcttaaagagatatgtttaaccggtggccgactcgagcggccgcatcgtg 
a6cGFP_3AgeI_dc ggccgactcgagcggccgcatcgtgacaccggtggtaccgcgggcccgggatccatcgcc 
a6cGFP_3AgeI_dcl ggtaccgcgggcccgggatccatcgccaccggtgtgagcaagggcgaggagctgttcacc 
AgeI_L291V292 ggatttggctggaaggatttgctgctgacaccggtaatatcatcccttctctgacctttc 
AgeI_L291V292_T299F300 ggatttgctgctgacaccggtaatatcatcccttctctgaccggtctcttggacagtgatttggagactc 
TEV_lnk_b6 gtggcgaccatcctccaaaatcggatgagaacctctacttccagggtctggttccgcgtggatccccagg 
II.1.11. Generation of the expression constructs 
The vectors pGEX-4T-2/Irga6, pGEX-4T-2/Irga6-His (Uthaiah et al., 2003), pGEX-4T-
2/Irga6-D186N (Uthaiah, 2002), pGEX-4T-2/Irga6-L44R-S172R, pGEX-4T-2/Irga6-
K48A, pGEX-4T-2/Irga6-K48E, pGEX-4T-2/Irga6-M173A (Ghosh et al., 2004), 
pGEX-4T-2/Irgb6, pGEX-4T-2/Irgd and pGEX-4T-2/Irgm3 were generated by Dr. 
Revathy Uthaiah. The vectors pGEX-4T-2/Irga6-E64K, pGEX-4T-2/Irga6-E97R, 
pGEX-4T-2/Irga6-E106R, pGEX-4T-2/Irga6-K196D, pGEX-4T-2/Irga6-K202A, 
pGEX-4T-2/Irga6-E203R und pGEX-4T-2/Irga6-H237D were generated by Dr. 
Andreas Schmidt. The pEGFP-N3/Irga6-cTag1 vector was generated by Dr. Sascha 
Martens. 
 
Generation of pGEX-4T-2/Irga6-cTag1-linker-EGFP. Site directed mutagenesis was 
used, to remove the SalI cleavage site between cTag1 and linker, and to introduce a new 
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one behind of EGFP, in the pEGFP-N3/Irga6-cTag1 vector (SalI / Irga6 / cTag1 (11 
residues) / SalI / linker (12 residues) / EGFP); primer pair one a6c1_EGFP_delSalI; 
primer pair two EGFP_addSalI. The modified pEGFP-N3/Irga6-cTag1 vector was SalI 
digested; the insert ligated into SalI pre-cut pGEX-4T-2. 
Generation of pGEX-4T-2/Irga6-linker-EGFP. Site directed mutagenesis was 
used to introduce an AgeI cleavage site between Irga6 and cTag1, and between cTag1 
and linker, in the pGEX-4T-2/Irga6-cTag1-linker-EGFP vector; primer pair one 
a6cGFP_5AgeI_d; primer pair two a6cGFP_3AgeI_dc. The modified pGEX-4T-
2/Irga6-cTag1-linker-EGFP was AgeI digested, purified and circularised. 
Generation of pGEX-4T-2/Irga6-EGFP. Site directed mutagenesis was used to 
introduce an AgeI cleavage site between Irga6 and cTag1, and between linker and 
EGFP, in the pGEX-4T-2/Irga6-cTag1-linker-EGFP vector; primer pair one 
a6cGFP_5AgeI_d; primer pair two a6cGFP_3AgeI_dcl. The modified pGEX-4T-
2/Irga6-cTag1-linker-EGFP was AgeI digested, purified and circularised. 
 
Generation of pGEX-4T-2/Irga6-∆loop-αFαG. Site directed mutagenesis was used to 
introduce two AgeI cleavage sites in the pGEX-4T-2/Irga6 vector; primer pair one 
AgeI_L291V292; primer pair two AgeI_L291V292_T299F300. The modified pGEX-
4T-2/Irga6 was AgeI digested, purified and circularised. 
 
Generation of pGEX-4T-2/Irgb6-TevUp. Site directed mutagenesis was used to 
introduce a TEV protease cleavage site upstream of the thrombin cleavage site in the 
pGEX-4T-2/Irgb6 vector; primer pair TEV_lnk_b6 (not Irgb6 specific; can be used for 
any pGEX-4T-2 construct). 
II.1.12. Equipment 
Aminco-Bowman 2 Luminescence Spectrometer (SLM Instruments); DM45 
Spectrofluorimeter (Olis); French Press (Thermo Scientific); EmulsiFlex-C5 
microfluidiser (Avestin); BAS 1000 phosphor imager analysis system (Fuji); Typhoon 
Trio scanner (Amersham); Ultrospec 2100 pro spectrophotometer (Amersham); pH-
meter 761 Calimatic (Knick); Sonorex RK 102 P (Bandelin); ÄTKA fast performance 
liquid chromatography (FPLC) (Amersham); FPLC System (Pharmacia); Ettan LC high 
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performance liquid chromatography (HPLC) (Amersham); SMART System 
(Pharmacia); Phillips 208 80-kV electron microscope; Axioplan II fluorescence 
microscope equipped with an AxioCam MRm camera (Zeiss); 
GSTrap FF 5 ml (Amersham); HiLoad 26/60 Superdex 75 prep grade 
(Amersham); HiLoad 26/60 Superdex 200 prep grade (Amersham); MiniQ 4.6/50 PE 
(Amersham); MiniQ PC 3.2/3 (Amersham) 
II.1.13. Software 
PyMOL v0.99 (DeLano Scientific) was used for image generation; Deep View (Swiss-
PdbViewer) v3.7 (Guex and Peitsch, 1997) was used for generation of the catalytic-
Irga6-dimer model; SWISS-MODEL (Arnold et al., 2006; Guex and Peitsch, 1997; 
Kopp and Schwede, 2004; Schwede et al., 2003) was used for generation of homology 
models; CNSsolve (Brunger et al., 1998) module buried surface (Lee and Richards, 
1971); ConSurf (Glaser et al., 2003; Landau et al., 2005); SigmaPlot v9 (Systat); 
DYNAMICS v6 (Protein Solutions); AIDA Image Analyser v3 (Raytest); ImageQuant 
TL v7 (Amersham); Unicorn v4.12 (Amersham); ImageJ v1.4 (Wayne Rasband, 
National Institutes of Health); ChemSketch v11 (ACDLABS) 
II.2. Methods; mutagenesis and cloning 
II.2.1. Site directed mutagenesis 
Site directed mutagenesis was performed using a modified protocol supplied with the 
QuickChange XL Site-Directed Mutagenesis Kit (Stratagne). The amplification was 
carried out using 20 ng of the template plasmid, 125 ng of the sense and antisense 
oligonucleotide primer and 2.5 units Pyrococcus furiosus (Pfu) DNA Polymerase 
(Promega) in a total volume of 50 µl. The following polymerase chain reaction (PCR) 
program was used: 95°C 30 sec, 15 cycles (95°C 30 sec, 55°C 1 min, 72°C 15 min), 
72°C 15 min. The template DNA, of bacterial origin, was digested with 40 units DpnI 
(New England Biolabs) for two hour at 37°C. 5 µl of the reaction was used to transform 
competent DH5α cells. 
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II.2.2. Restriction digest 
All restriction enzymes originated from New England Biolabs, and were used according 
to manufacturers recommendation. 
II.2.3. Ligation 
Insert DNA was ligated into a pre-cut and, with shrimp alkaline phosphatase 
(Amersham), de-phosphorylated vector (molar ratio 3:1) using T4-DNA ligase (New 
England Biolabs) according to manufacturers recommendation at 16°C overnight. 
Alternatively ligation was performed to circularise a pre-cut, not de-phosphorylated, 
vector. 
II.2.4. Agarose gel electrophoresis 
DNA was analysed by agarose gel electrophoresis in TAE (40 mM Tris pH 7.5, 0.5 mM 
EDTA). Migration of DNA was visualized by bromphenol blue. Ethidium bromide (0.3 
µg/ml gel) was used to stain the DNA. 
II.2.5. Purification of DNA fragments from agarose gels 
DNA fragments were extracted from agarose gel blocks using the Rapid PCR Product 
Purification Kit (Boehringer) according to manufacturers protocols. 
II.2.6. Plasmid DNA isolation 
For small-scale isolation of plasmid DNA 1.5 ml of a bacteria overnight culture was 
pelleted by centrifugation at 23000 g for 5 min. The pellet was resuspended in 100 µl P1 
(50 mM Tris pH 8, 10 mM EDTA, 100 µg/ml RNase A (Sigma)). 100 µl P2 (200 mM 
NaOH, 1% SDS) were added, samples were mixed carefully and incubated for 5 min at 
room temperature (RT). 140 µl P3 (3 M KAc pH 5.5) were added and the reaction spun 
for 15 min at 23000 g. The supernatant was transferred into a clean tube and 700 µl 
100% ethanol were added; the DNA was pelleted for 15 min at 23000 g. The pellet was 
washed with 1 ml of 70% ethanol for 5 min at 23000 g. The pellet was air-dried and 
resuspended in 10 mM Tris pH 8.5. 
For preparation of large amounts of plasmid DNA the Midi Plasmid Preparation 
Kit (Qiagen) was used according to manufactures instructions. 
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II.2.7. Sequencing 
All generated constructs were verified by sequencing. The BigDye Terminator v3.1 
Cycle Sequencing Kit (Applied Biosystems), based on dideoxy-chain termination 
(Sanger et al., 1977), was used; 0.5 µg of template DNA, 10 pmole of the respective 
primer and 2 µl BigDye Terminator Ready Reaction Mix were combined in a total 
volume of 10 µl. The following PCR program was used: 25 cycles (96°C 30 sec, 50°C 
15 sec, 60°C 4 min). Sequencing was performed with the ABI3730 sequencer at the 
Cologne Center for Genomics. 
II.2.8. Determination of the DNA concentration 
The absorption at 260 nm (A260) was measured, in a quartz cuvette with a path length of 
1 cm, using a spectrophotometer. The absorption at 280 nm (A280) was measured to 
control the purity of the DNA. For pure DNA the quotient of A260 and A280 is 1.8. 
Equation 1 was used to calculate the DNA concentration. 
Equation 1. DNA concentration. The formula was used to calculate the DNA concentration (c); 
absorption at 260 nm (A260); dilution factor (df); path length 1 cm. 
df
ml
gAc ⋅⋅= µ50260  
II.2.9. Preparation of competent bacteria 
A single colony of the DH5α or BL21 E. coli strain was grown overnight at 37°C in LB 
medium with 20 mM MgSO4 and 10 mM KCl. A 1 to 100 dilution of the culture in the 
before mentioned medium was gown at 37°C to an OD600nm of 0.45. The culture was 
chilled on ice for 10 min, and pelleted at 2800 g for 5 min at 4°C. The pellet was 
resuspended in cold TFB I (30 mM KOAc, 50 mM MnCl2, 100 mM RbCl, 10 mM 
CaCl2, 15% (v/v) glycerol, pH 5.8) and incubated on ice for 5 min; 30 ml TFB I were 
used per 100 ml culture. The bacteria were pelleted at 2800 g for 5 min at 4°C, and 
resuspended in cold TFB II (10 mM NaMOPS pH 7, 75 mM CaCl2, 10 mM RbCl, 15% 
(v/v) glycerol); 4 ml TFB II were used per 100 ml culture. 100 µl aliquots were shock 
frozen and stored at -80°C. 
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II.2.10. Transformation of competent bacteria 
Competent bacteria were thawed, and incubated with plasmid DNA for 20 min on ice. 
The bacteria were heat-shocked for 2 min at 42°C and subsequently chilled on ice for 2 
min. 400 µl LB medium were added and the bacteria were shaken for 20 min at 37°C. 
The bacteria were plated on an agar plate containing the appropriate antibiotics. 
II.3. Methods; protein expression and purification 
II.3.1. SDS-polyacrylamide gel electrophoresis 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970) was carried 
out, under denaturating conditions, in the presence of 1% SDS on 10 - 12% 
polyacrylamide gels. Protein samples were boiled for 5 min in loading buffer (50 mM 
Tris/HCl pH 6.8, 0.7% β-mercaptoethanol, 1% SDS, 5% glycerol, 0.0025%, (w/v) 
bromphenol blue) prior to loading. 
II.3.2. Coomassie staining 
SDS-PAGE gels were stained in (0.1% (w/v) Coomassie Brilliant Blue R-250, 40% 
(v/v) ethanol, 10% (v/v) acetic acid) for 30 min at RT. Excess staining was removed by 
incubation in (40% (v/v) ethanol, 10% (v/v) acetic acid) for an appropriate time at RT. 
II.3.3. Western blotting 
After SDS-PAGE proteins were transferred to a nitrocellulose membrane 
(Schleicher&Schuell) by electroblotting. The protein size standard was located on the 
membrane after stained with Ponceau S (0.1% (w/v) Ponceau-S, 5% (v/v) acetic acid). 
The membrane was blocked in PBS, containing 5% (w/v) milk powder, 0.1% (v/v) 
Tween20, for 1 hour at RT. Antisera and antibodies were diluted in PBS containing 
10% (v/v) fetal calf serum (FCS) and 0.1% (v/v) Tween20. Protein bands were 
visualized using the enhanced chemiluminescence substrate. 
II.3.4. Expression of recombinant proteins 
All proteins were expressed as N-terminal glutathione-S-transferase (GST) fusions 
using the pGEX-4T-2 vector (Amersham) in the E. coli strain BL21; in case of Irgb6 a 
modified form of the vector was used, carrying an inserted TEV protease cleavage site 
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upstream of the thrombin cleavage site. Transformed cells were grown in LB medium 
with 100 µg/ml ampicillin (Roth) at 37°C to an OD600nm of 0.8 - 1.2; the proteins were 
expressed at 18°C overnight after induction with 0.1 mM isopropyl-β-D-thiogalactoside 
(IPTG). The cells were harvested at 5000 g for 15 min at 4°C and frozen at -20°C. 
II.3.5. Purification of recombinant Irga6 
The cells were resuspended in PBS containing 2 mM dithiothreitol (DTT) and complete 
mini protease inhibitors EDTA free (Roche); 10 ml per 1 L culture. The microfluidiser 
EmulsiFlex-C5 (Avestin) was used at a pressure of 150 MPa to lyse the cells. The 
lysates were cleared by centrifugation with 50000 g for 60 min at 4°C. The soluble 
fraction was purified on the glutathione-sepharose affinity column GSTrap FF 5 ml 
(Amersham) equilibrated with PBS containing 2 mM DTT. The GST was cleaved off, 
on the column, with 100 unit thrombin (Serva) overnight at 4°C. Free Irga6 was eluted 
with PBS containing 2 mM DTT. The fractions were analysed by SDS-PAGE and 
Coomassie staining. Protein containing fractions were pulled (for partial purification the 
procedure was stopped at that stage; for full purification continued) and subjected to 
size exclusion chromatography on the HiLoad 26/60 Superdex 75 prep grade column 
(Amersham) equilibrated with B1 or PBS containing 2 mM DTT. The fractions were 
analysed by SDS-PAGE and Coomassie staining. Monomeric protein containing 
fractions were pulled. The protein carries the N-terminal extension GSPGIPGSTT 
resulting from the thrombin cleavage. 
II.3.6. Purification of recombinant GST-Irga6 
The cells were resuspended in PBS containing 2 mM DTT and complete mini protease 
inhibitors EDTA free (Roche); 10 ml per 1 L culture. The microfluidiser EmulsiFlex-C5 
(Avestin) was used at a pressure of 150 MPa to lyse the cells. The lysates were cleared 
by centrifugation with 50000 g for 60 min at 4°C. The soluble fraction was purified on 
the glutathione-sepharose affinity column GSTrap FF 5 ml (Amersham) equilibrated 
with PBS containing 2 mM DTT. The GST-Irga6 fusion protein was eluted with 
elution-buffer. The fractions were analysed by SDS-PAGE and Coomassie staining. 
Protein containing fractions were pulled and subjected to size exclusion 
chromatography on the HiLoad 26/60 Superdex 200 prep grade column (Amersham) 
equilibrated with B1 containing 2 mM DTT. The fractions were analysed by SDS-
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PAGE and Coomassie staining. The protein fractions containing GST-Irga6/GST-Irga6 
homodimer and GST-Irga6/GST heterodimer were pooled separately. 
II.3.7. Purification of recombinant Irga6-EGFP 
The cells were resuspended in PBS containing 2 mM DTT and complete mini protease 
inhibitors EDTA free (Roche); 10 ml per 1 L culture. The microfluidiser EmulsiFlex-C5 
(Avestin) was used at a pressure of 150 MPa to lyse the cells. The lysates were cleared 
by centrifugation with 50000 g for 60 min at 4°C. The soluble fraction was purified on 
the glutathione-sepharose affinity column GSTrap FF 5 ml (Amersham) equilibrated 
with PBS containing 2 mM DTT. The GST was cleaved off, on the column, with 100 
unit thrombin (Serva) overnight at 4°C. Free Irga6-EGFP was eluted with PBS 
containing 2 mM DTT. The fractions were analysed by SDS-PAGE and Coomassie 
staining. Protein containing fractions were pulled and subjected to size exclusion 
chromatography on the HiLoad 26/60 Superdex 200 prep grade column (Amersham) 
equilibrated with PBS containing 2 mM DTT. The fractions were analysed by SDS-
PAGE and Coomassie staining. Monomeric protein containing fractions were pulled. 
The protein carries the N-terminal extension GSPGIPGSTT resulting from the thrombin 
cleavage. 
II.3.8. Purification of recombinant Irgb6 
The cells were resuspended in PBS containing 2 mM DTT and complete mini protease 
inhibitors EDTA free (Roche); 10 ml per 1 L culture. The microfluidiser EmulsiFlex-C5 
(Avestin) was used at a pressure of 150 MPa to lyse the cells. The lysates were cleared 
by centrifugation with 50000 g for 60 min at 4°C. The soluble fraction was purified on 
the glutathione-sepharose affinity column GSTrap FF 5 ml (Amersham) equilibrated 
with PBS containing 2 mM DTT. The GST-Irgb6 fusion protein was eluted with 
elution-buffer. The fractions were analysed by SDS-PAGE and Coomassie staining. 
Protein containing fractions were pulled; the GST was cleaved off with 200 unit AcTEV 
Protease (Invitrogen) overnight at 4°C; subjected to size exclusion chromatography on 
the HiLoad 26/60 Superdex 75 prep grade column (Amersham) equilibrated with PBS 
containing 2 mM DTT, and passed through a GSTrap FF 5 ml column equilibrated with 
PBS containing 2 mM DTT to remove the GST. The fractions were analysed by SDS-
PAGE and Coomassie staining. Monomeric protein containing fractions were pulled. 
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The protein carries the N-terminal extension GLVPRGSPGIPGSTT resulting from the 
TEV protease cleavage. 
II.3.9. Purification of recombinant Irgd 
The cells were resuspended in PBS containing 2 mM DTT and complete mini protease 
inhibitors EDTA free (Roche); 10 ml per 1 L culture. The microfluidiser EmulsiFlex-C5 
(Avestin) was used at a pressure of 150 MPa to lyse the cells. The lysates were cleared 
by centrifugation with 50000 g for 60 min at 4°C. The soluble fraction was purified on 
the glutathione-sepharose affinity column GSTrap FF 5 ml (Amersham) equilibrated 
with PBS containing 2 mM DTT. The GST-Irgd fusion protein was eluted with elution-
buffer. The fractions were analysed by SDS-PAGE and Coomassie staining. Protein 
containing fractions were pulled; the GST was cleaved off with 50 unit thrombin 
(Serva) overnight at 4°C; subjected to size exclusion chromatography on the HiLoad 
26/60 Superdex 75 prep grade column (Amersham) equilibrated with PBS containing 2 
mM DTT, and passed through a GSTrap FF 5 ml column equilibrated with PBS 
containing 2 mM DTT to remove the GST. The fractions were analysed by SDS-PAGE 
and Coomassie staining. Monomeric protein containing fractions were pulled. The 
protein carries the N-terminal extension GSPGIPGSTT resulting from the thrombin 
cleavage. 
II.3.10. Purification of recombinant GST-Irgm3 
The cells were resuspended in B1 containing 2 mM DTT and 1% Triton X-100 and 
complete mini protease inhibitors EDTA free (Roche); 10 ml per 1 L culture. The 
French Press (Thermo Scientific) was used at a pressure of 10000 psi to lyse the cells. 
The lysates were cleared by centrifugation with 50000 g for 60 min at 4°C. The soluble 
fraction was purified on the glutathione-sepharose affinity column GSTrap FF 5 ml 
(Amersham) equilibrated with PBS containing 2 mM DTT. The GST-Irgm3 fusion 
protein was eluted with elution-buffer. The fractions were analysed by SDS-PAGE and 
Coomassie staining. Protein containing fractions were pulled and subjected to size 
exclusion chromatography on the HiLoad 26/60 Superdex 200 prep grade column 
(Amersham) equilibrated with B1 containing 2 mM DTT. The fractions were analysed 
by SDS-PAGE and Coomassie staining. Not excluded protein containing fractions were 
pulled. 
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II.3.11. Concentration of proteins 
Proteins were concentrated by a centrifugal concentrator Vivaspin 20 (Vivascience) 
with a 10 kDa cut-off with 5000 g at 4°C. 
II.3.12. Determination of the protein concentration 
The absorption at 280 nm (A280) was measured, in a quartz cuvette with a path length of 
1 cm, using a spectrophotometer. Equation 2 was used to calculate the protein 
concentration. 
Equation 2. Protein concentration. The formula, according to Lambert-Beer law, was used to calculate 
the protein concentration (c); absorption at 280 nm (A280); protein specific (Table 1) molar extinction 
coefficient (ε280) M-1cm-1 at 280 nm; dilution factor (df); path length (pl) 1 cm. 
df
pl
Ac ⋅⋅= 280
280
ε  
Table 1. Molar extinction coefficients. The specific molar extinction coefficient (ε280) M-1cm-1 of 
proteins used in this study. 
protein ε280 (M-1cm-1) 
Irga6 35230 
Irgb6 40230 
Irgd 33150 
GST 41160 
GST-Irga6 76630 
GST-Irgm3 95670 
Irga6-EGFP 55480 
II.3.13. Freezing and storage of proteins 
Protein aliquots were shock-frozen in liquid nitrogen and stored at -80°C. 
II.4. Methods; biochemical and biophysical 
II.4.1. Analysis of protein oligomerisation by light scattering 
Protein oligomerisation (temperature, protein and nucleotide concentration are indicated 
in figure legends) was monitored, in B1 with 2 mM DTT, by conventional light 
scattering at 350 or 600 nm using Aminco-Bowman 2 Luminescence Spectrometer 
(SLM Instruments) or DM45 Spectrofluorimeter (Olis) at a fixed angle of 90°. 10x B1, 
ddH2O and the nucleotides were degassed by ultrasonication. Samples were cleared by 
ultracentrifugation prior to addition of nucleotides. 
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II.4.2. Analysis of protein oligomerisation by dynamic light scattering 
Protein oligomerisation (temperature, protein and nucleotide concentration are indicated 
in figure legends) was monitored, in B1 with 2 mM DTT, by dynamin light scattering 
(DLS) using DynaPro molecular sizing instrument (Protein Solutions). Data were 
analysed with DYNAMICS v6 software (Protein Solutions). The hydrodynamic radius 
was calculated from the translational diffusion coefficient, obtained by autocorrelation 
of the data, using the Stokes-Einstein equation. 10x B1, ddH2O and the nucleotides 
were degassed by ultrasonication. Samples were cleared by ultracentrifugation prior to 
addition of nucleotides. 
II.4.3. GTP hydrolysis assay by TLC 
The reaction (temperature, protein and nucleotide concentration are indicated in figure 
legends) was performed, in B1 with 2 mM DTT, with trace amounts of radioactively 
labeled nucleotide. At indicated time points aliquots were removed and spotted onto PEI 
Cellulose F thin layer chromatography (TCL) plates (Merck). Plates were run in 1 M 
acetic acid, 0.8 M LiCl. Signals were detected using BAS 1000 phosphor imager 
analysis system (Fuji) and quantified with AIDA Image Analyser v3 software (Raytest), 
or detected using Typhoon Trio scanner (Amersham) and quantified with ImageQuant 
TL v7 software (Amersham). 
II.4.4. GTP hydrolysis assay by HPLC 
The reaction (temperature, protein and nucleotide concentration are indicated in figure 
legends) was performed in B1 with 2 mM DTT. At indicated time points aliquots were 
removed; the reaction was stopped by tenfold dilution in chilled (4°C) 10 mM NaOH. 
High performance liquid chromatography (HPLC) was carried out; nucleotides were 
separated by ion exchange chromatography on the MiniQ 4.6/50 PE column 
(Amersham) or the MiniQ PC 3.2/3 column (Amersham) in 10 mM NaOH over a NaCl 
gradient. Absorption at 254 nm was monitored; peak areas were quantified with the 
Unicorn v4.12 software (Amersham) or the SMART System software (Pharmacia). 
II.4.5. Nucleotide-binding affinity measurement 
The nucleotide-binding affinities were measured by equilibrium titration using 2'/3'-O-
(N-methyl-anthraniloyl) (mant) labeled nucleotides (Jena Bioscience). Protein was 
35 
II. Material and methods 
titrated, in a range from 0 to 80 µM, against 0.5 µM mant nucleotide, in B1 with 2 mM 
DTT at 20°C. The fluorescence of mant nucleotides, excited at 360 nm, was monitored 
at 450 nm using Aminco-Bowman 2 Luminescence Spectrometer (SLM Instruments). 
The equilibrium dissociation constants (Kd) were obtained by fitting a quadratic 
function (Herrmann and Nassar, 1996) (Equation 3) using SigmaPlot v9 software 
(Systat). 
Equation 3. Quadratic function for Kd. The quadratic function is derived (Herrmann and Nassar, 1996) 
from the definition of the dissociation constant (Kd) (Equation 4); measured fluorescence (f); initial 
fluorescence (fi); final fluorescence (ff); constant nucleotide concentration (n); protein concentration (p). 
Kd, fi and ff are to be fitted by the software. 
( ) ( )
n
pnKpnKpn
ffff ddifi ⋅
⋅⋅−++−++⋅−+=
2
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II.4.6. Electron microscopy 
5 µM Irga6 and 1 mM GTP were incubated in B1 with 2 mM DTT for 10 min at 37°C. 
The reaction was performed in presence or absence of 1 mg/ml Folch liposomes 
(Sigma). Samples were blotted onto glow-discharged formvar-carbon-coated 400-mesh 
grids (Canemco and Marivac), negatively stained with 5% uranyl acetate and imaged on 
a Phillips 208 80-kV electron microscope. 
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III. Results 
III.1. The catalytic-interface is part of the G-domain 
Irga6 forms oligomers, in a GTP-dependent manner in vitro, in which substrate 
hydrolysis is activated (Uthaiah et al., 2003). It is poorly understood how the complexes 
are formed and how catalysis is activated through the interaction of Irga6 molecules. 
 
In order to get more insight into the mechanism of complex formation a number of 
solvent exposed residues at potential interaction surfaces were mutagenised. The 
mutations G103R, S132R, K161E, K162E, N191R and K196D essentially abolished 
oligomerisation of Irga6 and the mutated proteins showed only very low GTP 
hydrolysis rates (Figure 9), in a range from 0.02 to 0.2 min-1. The mutations E64K, 
E97R, K101E, M109A, K145E, K202A, E203R and H237D had no significant effect on 
oligomerisation or GTP hydrolysis (Figure 9). 
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Figure 9. The G-domain is involved in complex formation. (A) Oligomerisation of 80 µM WT or 
mutant Irga6 was monitored by light scattering in the presence of 10 mM GTP at 37°C. (B) Hydrolysis of 
10 mM GTP (with trace amounts of α32P-GTP) was measured in the presence of 80 µM WT or mutant 
Irga6 at 37°C. Samples were assayed by TLC and autoradiography. 
The residues Gly103, Ser132, Lys161, Lys162, Asn191 and Lys196 are localised in the 
G-domain, close to the nucleotide-binding site (Figure 11 A), and define an interface, 
called from now on the catalytic-interface. No GTP-dependent increase of 
hydrodynamic radius were observed for the mutants G103R, S132R, K161E, N191R 
and K196D (Figure 50 A, B, C, E and F) by dynamic light scattering (DLS). This result 
suggests that the catalytic-interface is a dimerisation interface which forms first during 
the oligomerisation process. 
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Despite their proximity to the nucleotide-binding pocket, no significant effect on the 
nucleotide-binding affinity of the mutants G103R, S132R, K162E and K196D, and only 
a slight decrease for the mutants K161E and N191R, was recorded (Table 2). 
Table 2. Nucleotide-binding affinity of oligomerisation impaired Irga6 mutants. Dissociation 
constant (Kd) measured by equilibrium titration and the calculated (Equation 8) corresponding Irga6-
nucleotide-complex concentration (complex) at [Irga6]0 = 80 µM and [nucleotide]0 = 10 mM. The mean 
values of at least two independent experiments are shown. 
Irga6 nucleotide Kd (µM) complex (µM) 
WT mant-GTPγS 18.3 ± 5.1 79.9 
E77A mant-GTPγS 33.9 ± 5.9 79.7 
G103R mant-GTPγS 21.3 ± 9.4 79.8 
E106R mant-GTPγS 13.2 ± 4.6 79.9 
S132R mant-GTPγS 20 ± 10.6 79.8 
R159E mant-GTPγS 41.2 ± 12.7 79.7 
K161E mant-GTPγS 46.6 ± 18.4 79.6 
K162E mant-GTPγS 22.9 ± 6.9 79.8 
D164A mant-GTPγS 24.8 ± 4.7 79.8 
N191R mant-GTPγS 34.1 ± 11 79.7 
K196D mant-GTPγS 26.8 ± 9.7 79.8 
R31E-K32E mant-GTPγS 54.5 ± 7.7 79.6 
K169E mant-GTPγS 47.9 ± 5.8 79.6 
K176E mant-GTPγS 112.8 ± 31 79.1 
R210E mant-GTPγS 158.5 ± 61.1 78.7 
K246E mant-GTPγS 48.2 ± 4 79.6 
R31E-K32E-K246E mant-GTPγS 30 ± 6.2 79.8 
R31E-K32E-K176E-K246E mant-GTPγS 47.1 ± 3.4 79.6 
R31E-K32E-K176E-R210E-K246E mant-GTPγS 91.5 ± 14.4 79.3 
S172R-M173A-K175E-E177R mant-GTPγS 34.9 ±9.5 79.7 
 
Although the decreased nucleotide-binding affinities may contribute to, they are 
considered unlikely to be alone responsible for, the loss of oligomerisation of the two 
mutants K161E and N191R. The variations of the dissociation constants (Kd) are 
expected to have nearly no influence on the amount of protein-nucleotide-complex 
formed under the chosen experimental conditions with 10 mM GTP (Figure 63; Table 
2). But the half-life of formed complexes is expected to be shorter; consequently the 
probability of nucleotide-induced conformational changes decreases. Therefore some 
part of the inhibitory effect, of the K161E and N191R mutations on oligomerisation, 
could be accounted to the decreased nucleotide-binding affinities. The G4-motif mutant 
Irga6-D186N, which has a significantly lower binding affinity for guanine based 
nucleotides (Table 3), oligomerised relatively efficiently after stimulation with GTP 
(Figure 26 A). Further mutants of the secondary-patch (Paragraph III.13), R31E-K32E, 
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K169E, K176E, R210E and K246E, which have significantly decreased nucleotide-
binding affinities (Table 2), showed an impaired but recordable oligomerisation (Figure 
36 B; Figure 54 A - E). 
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Figure 10. Conservation of the Irga6 surface. The molecular surface of the Irga6 crystal-dimer-
interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) is shown. ConSurf (Glaser et al., 2003; 
Landau et al., 2005) was used with an alignment of selected mouse IRGs (Figure 12) to calculate the 
conservation score of Irga6 residues. Conserved residues are coloured in magenta, variable in cyan. The 
nucleotide is shown as atomic stick figure. (A - F) The same orientations of the molecule are shown as in 
Figure 11. 
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Figure 11. Position of mutated residues. Mutated residues are shown in the Irga6 (ribbon presentation) 
crystal-dimer-interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004). The N-terminal part of the 
helical-domain is coloured in cyan, the G-domain in light-blue, the linker-helix in gray and the C-terminal 
part of the helical-domain in dark blue. Surface formed by the listed residues is shown. Glu77, Gly103, 
Glu106, Ser132, Arg159, Lys161, Asp164, Asn191 and Lys196 which define the catalytic-interface (red). 
Lys162 which is located at the border of the catalytic-interface and the secondary-patch (orange). Arg31, 
Lys32, Lys169, Lys176, Arg210 and Lys246 which define the secondary-patch (yellow). Ser18, Glu37, 
Glu43, Leu44, Lys48, Asn50, Gln52, Ser56, Glu64, Thr88, Glu97, Lys101, Met109, Glu110, Arg111, 
Lys115, Glu142, Lys145, Glu148, Asp150, Ser172, Ala173 (instead of Met173), Lys175, Glu177, 
Lys202, Glu203, Arg218, Glu219, Glu224, His237, Val242, Asp245, Asp250, Lys255, Asn265, Ser269, 
Arg275, Glu285, Asn293, Ser304, Lys310, Lys311, Thr325, Ser326, Glu335, Lys346, Asp355, Glu356, 
Glu357, Leu372, Ala373 and Lys407 which mutated had no significant effect on oligomerisation (green). 
Lys9 and Ser10 are not resolved in the crystal structure. The nucleotide is shown as atomic stick figure. 
(A) Front view of the G-domain. (B) Rear view; A rotated by 180° around y-axis. (C) Top view; A 
rotated by 90° around x-axis. (D) Bottom view; C rotated by 180° around y-axis. (E) Right view; A 
rotated by 90° around y-axis. (F) Left view; E rotated by 180° around y-axis. 
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Figure 12. Amino acid alignment of selected mouse IRGs. Amino acid alignment of Irga1, Irga2, 
Irga3, Irga4, Irga6, Irga7, Irga8, Irgb1, Irgb2, Irgb3, Irgb4, Irgb5, Irgb6, Irgb8, Irgb9, Irgb10, Irgd, Irgm1, 
Irgm2 and Irgm3 from the C57BL/6 mouse. Irgc is not induced by IFNγ, Irga5 and Irgb7 are pseudogenes 
(Bekpen et al., 2005) and were excluded. Residues relevant for the crystal-dimer-interface (CDI) (Figure 
14 C and D) are highlighted (yellow [1] - red [6]; indication how often they form part of the CDI out of 6 
subunits (in 3 dimeric structures)). Residues of the calculated catalytic-interface model (CIM) (Figure 14 
A and B) are marked (black X). Residues mutagenised (MUT) in this study (Figure 11) are shown (green 
[0] no effect on oligomerisation; yellow [1] inhibition of oligomerisation, secondary-patch; orange [2] 
inhibition of oligomerisation, secondary-patch / catalytic-interface; red [3] inhibition of oligomerisation, 
catalytic-interface). The calculated conservation score (CON) (Figure 10) is displayed (cyan [1] - 
magenta [9]; variable - conserved). The G1, G3, G4 and G5-motifs are highlighted by a red box. The 
GKS and GMS subfamilies are separated by a green line. 
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III.2. Model of the catalytic-Irga6-dimer 
The catalytic-interface of Irga6 is localised in the G-domain (Figure 11). Numerous 
GTPases were shown to form complexes via an interaction of two G-domains. They can 
be subdivided into distinct classes based on the relative orientation of, and the distance 
between, the bound nucleotides. The group in which the bound nucleotides are parallel 
oriented and do not interact includes human guanylate-binding protein 1 (hGBP1) 
(Ghosh et al., 2006), bacterial dynamin-like protein (BDLP) (Low and Lowe, 2006), 
HypB (Gasper et al., 2006), MeaB (Hubbard et al., 2007), SEPT2 (Sirajuddin et al., 
2007) and Toc34 (Sun et al., 2002). The group in which the bound nucleotides are 
oriented antiparallel and interact directly with each other consists thus far only of the 
signal recognition particle (SRP) GTPases Ffh, FtsY (Egea et al., 2004; Focia et al., 
2006; Focia et al., 2004; Gawronski-Salerno and Freymann, 2007) and FlhF (Bange et 
al., 2007). However a model, that employs a similar nucleotide configuration, was 
suggested for Roc-COR (Gotthardt et al., 2008). An antiparallel orientation of two 
distant nucleotides was found in MnmE (Scrima and Wittinghofer, 2006). 
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Figure 13. Construction of the catalytic-Irga6-dimer model. Closeup views of the nucleotide-binding 
regions involved in formation of the catalytic dimers (ribbon presentation). (A) Crystal structure of the 
Ffh (green) FtsY (red) heterodimer (PDB 1RJ9) (Egea et al., 2004). (B) Two molecules (yellow and blue) 
of the Irga6 crystal-dimer-interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) were adjusted at the 
Ffh-FtsY heterodimer, to give the best overlay for the bound nucleotides. (C) The model of the catalytic-
Irga6-dimer is shown. Nucleotides are shown as atomic stick figures. The trans interactions of the 
3'hydroxyls with the γ-phosphates are represented as dotted black lines. 
Irga6 resembles Ffh (SRP) and FtsY (SRP receptor / SRα) in some respects. Ffh and 
FtsY have a wide-open nucleotide-binding pocket in nucleotide-bound state (Freymann 
et al., 1997; Montoya et al., 1997; Moser et al., 1997; Shan et al., 2004). The nucleotide-
binding pocket of Irga6 is more open in the GppNHp than in the GDP state (Ghosh et 
al., 2004). This circumstance is probably responsible for the, nearly identical, low 
nucleotide-binding affinities, caused by a high dissociation rate, of Ffh (Jagath et al., 
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2000), FtsY (Moser et al., 1997) and Irga6 (Uthaiah et al., 2003). Irga6 and FtsY bind 
GDP more tightly than GTP (Moser et al., 1997; Uthaiah et al., 2003). Ffh and FtsY 
form GTP-dependent heterodimer, and function as mutual GAPs in the complexes 
(Powers and Walter, 1995). Irga6 molecules work as mutual GAPs in GTP-dependent 
oligomeric complexes (Uthaiah et al., 2003). No external GEFs or GAPs are known for 
Ffh, FtsY and Irga6. 
The several common biochemical and structural properties suggest that the 
mechanism of cooperative hydrolysis known from Ffh and FtsY could be most relevant 
for understanding the catalytic mechanism of Irga6. The key to this idea is the catalytic 
interaction between the two opposed GTP molecules in antiparallel orientation. 
Coordinates of the nucleotides from the crystal structure of the Ffh-FtsY heterodimer 
(Egea et al., 2004) (Figure 13 A) were used to align the nucleotides bound by two Irga6 
molecules (Figure 13 B). The Irga6-M173A GppNHp (non-hydrolysable GTP 
analogue) complex (Ghosh et al., 2004), which crystallised as a monomer and provided 
the only structure with all residues between Glu12 and Asn413 resolved, was used for 
this construction. In the resulting catalytic-Irga6-dimer model (Figure 13 C; Figure 15) 
the two Irga6 molecules complement each other well. There is only one noteworthy 
conflict within this model interface caused by the side chain of Arg159 (Figure 29 A). 
This issue is addressed later (Paragraph III.9). 
 
The buried surface area (Figure 14 A and B) in the hypothetical complex (Figure 15) is 
2400 Å2. The catalytic-interface is distinct form the crystal-dimer-interface (Paragraph 
III.12) (Figure 12; Figure 14). The residues which when mutated had a high impact on 
oligomerisation (Glu77 (Figure 28 A), Gly103 (Figure 9 A), Glu106 (Figure 21 A), 
Ser132, Arg159 (Figure 30 A), Lys161, Lys162 and Asn191) are located within, or in 
the case of Lys196, proximal to, the model catalytic-interface (Figure 15; Figure 14 A; 
Figure 11 A). The mutation of the residue Lys101, which is predicted to be in the outer 
part of the interface (Figure 14 A; Figure 15 A and B), had no effect on oligomerisation 
(Figure 9 A). This inconsistent result indicates the limitation of the presented structural 
model, which is unable to take account of conformational changes that, by analogy with 
Ffh-FtsY, are expected in Irga6 during complex formation. Lys101 is part of the flexible 
switch I region, therefore a conformational change of this residue is plausible. 
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Figure 14. Relative position of catalytic- and crystal-dimer-interface. The Irga6 crystal-dimer-
interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) is shown (ribbon presentation). Protein 
domains are colour coded as in Figure 11. The nucleotide is shown as atomic stick figure. The surface 
formed by the listed residues is shown. Residues buried in the interface of the catalytic-Irga6-dimer 
model were calculated with CNSsolve (Brunger et al., 1998) module buried surface (Lee and Richards, 
1971) with a probe radius of 1.4 Å. Glu77, Thr78, Gly79, Asn94, Glu95, Lys101, Thr102, Gly103, 
Glu106, Val107, Gly131, Ser132, Thr133, Pro136, Pro137, Ala157, Thr158, Arg159, Phe160, Lys161, 
Lys162, Asn163, Asp166, Lys184, Asp186, Ser187, Asp188, Thr190, Asn191, Asp194, Gly195 and 
Lys233 are shown in magenta. Residues buried in the crystal-dimer-interface were calculated by the same 
method. Asn14, Ser18, Gln36, Glu37, Asn40, Leu41, Glu43, Leu44, Arg47, Lys48, Pro137, Asn138, 
Thr139, Leu141, Glu142, Tyr147, Asp166, Ala168, Lys169, Ala170, Ser172, Ala173 (instead of 
Met173), Met174, Lys175, Lys176, Glu177, Phe178, Arg218, Gly221, Ile222, Ala223 and Glu224 are 
shown. Three dimeric crystal structures of Irga6 are available (PDB 1TPZ, 1TQ2 and 1TQD) (Ghosh et 
al., 2004) therefore each residue can be maximum six time involved in this interface. Residues highly 
relevant for the crystal dimmer interface are shown in red, less relevant in yellow. (A and C) Front view 
of the G-domain. (B and D) Left view. 
Interaction interfaces are commonly conserved (Armon et al., 2001); consistent with 
this, the area of the catalytic-interface (Figure 14 A; Figure 10 A; Figure 11 A) is the 
strongest conserved part of the Irga6 surface (Figure 10). The catalytic-interface 
comprises mainly charged and hydrophilic residues (Figure 12; Figure 14 A). 
Consistent with this, oligomerisation of Irga6 was found to be retarded by rising NaCl 
concentrations (Figure 61). Salts neutralize electric charges and minimize electrostatic 
interactions between protein molecules. 
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Figure 15. Position of mutated residues in the catalytic-Irga6-dimer model. Model of the catalytic-
Irga6-dimer; two molecules of the Irga6 crystal-dimer-interface mutant M173A (PDB 1TQ6) (Ghosh et 
al., 2004) are shown (ribbon presentation). Protein domains are colour coded as in Figure 11. Mutated 
residues of both molecules are shown as described in Figure 11. The nucleotides are shown as atomic 
stick figures. (A) Front view. (B) Top view; A rotated by 90° around x-axis. (C) Bottom view; B rotated 
by 180° around x-axis. 
III.3. The mant-group interferes with complex formation 
The space between the SRP GTPase dimer subunits is tightly packed and contains the 
bound nucleotides (Egea et al., 2004; Focia et al., 2006; Focia et al., 2004), as is also the 
case for the proposed catalytic-Irga6-dimer model (Figure 13 C; Figure 15). At the core 
of the suggested model the 2' and 3'hydroxyl of GTP ribose form part of the contact 
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surface including the catalytically important reciprocal trans interactions between the 
3'hydroxyls and the γ-phosphates. Bulky modifications of the nucleotide at the 2' or 
3'hydroxyl would therefore be expected to interfere with oligomerisation. 
 
Oligomerisation of Irga6 in presence of 2'/3'-O-(N-methyl-anthraniloyl)-GTP (mant-
GTP) was investigated. Mant is a fluorescent group bound via the 2' or 3'oxygen to the 
GTP ribose in mant-GTP (Figure 16 B). Consistent with the lack of free space between 
the subunits of the catalytic-Irga6-dimer model, mant-GTP was unable to stimulate 
oligomerisation of Irga6 (Figure 16 A). This finding argues that the GTP ribose is part 
of the interaction interface of Irga6 oligomer subunits. 
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Figure 16. The mant-group interferes with complex formation. (A) Oligomerisation of 80 µM WT 
Irga6 was monitored by light scattering in the presence of 10 mM GTP or mant-GTP at 37°C. (B) Mant-
GTP; the mant-group is attached via the 2' respectively 3'oxygen to the GTP ribose. The attachment 
places are shown with dotted arrows. 
The inhibitory effect of the mant-group is not caused by reduced nucleotide binding, 
since the affinities of Irga6 to mant-GTP and -GDP measured by equilibrium titration 
were shown to be the same as native GTP and GDP measured by isothermal titration 
calorimetry (Uthaiah et al., 2003). 
III.4. The 3'hydroxyl is required for oligomerisation and hydrolysis 
The model of the catalytic-Irga6-dimer is based on hypothetical reciprocal trans 
interactions between the 3'hydroxyls and the γ-phosphates of the opposed nucleotides, 
analogous to those shown to be crucial for the reciprocal activation of GTP hydrolysis 
between the paired GTPases, Ffh and FtsY (Egea et al., 2004). 
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Figure 17. The 3'hydroxyl is essential for oligomerisation and hydrolysis. (A) Oligomerisation of 80 
µM WT Irga6 was monitored by light scattering in the presence of 10 mM GTP, 2'dGTP, 3'dGTP or 
2'3'ddGTP at 37°C. (B) Hydrolysis of 10 mM GTP, 2'dGTP, 3'dGTP or 2'3'ddGTP was measured in the 
presence of 80 µM WT Irga6 at 37°C. Samples were assayed by HPLC. (C) Oligomerisation of 80 µM 
WT Irga6 was monitored in the presence of 10 mM GTP, 2'dGTP, 3'dGTP or 2'3'ddGTP by DLS at 37°C. 
(D) Hydrolysis of 10 mM GTP or 2'dGTP was measured after 30 minutes in the presence of various 
concentrations of WT Irga6 at 37°C. Samples were assayed by HPLC. 
The influence of the 2' and 3'hydroxyl on Irga6 oligomerisation and GTP hydrolysis 
was investigated with the appropriate deoxyribonucleotides. Oligomerisation of Irga6 
could be stimulated with GTP and 2'deoxy-GTP (2'dGTP), both nucleotides which 
contain the 3'hydroxyl. In contrast no complex formation was observed in presence of 
3'deoxy-GTP (3'dGTP) and 2'3'dideoxy-GTP (2'3'ddGTP), two nucleotides lacking the 
3'hydroxyl (Figure 17 A and C). Consistent with these results, only basal hydrolysis 
rates, of about 0.02 min-1, of 3'dGTP and 2'3'ddGTP were found (Figure 17 B). 
Reduction of oligomerisation rate was observed in presence of 2'dGTP (Figure 
17 A and C), consistent with the idea that the 2'hydroxyl is part of the catalytic-
interface, as suggested by the model. In agreement with the lower oligomerisation, the 
rate of hydrolysis of 2'dGTP was also reduced; nevertheless the 2'hydroxyl is not 
required for cooperative hydrolysis (Figure 17 D). 
 
The removal of the 2' or 3'hydroxyl of the GTP ribose decreased the nucleotide-binding 
affinity slightly (Table 3). However, as argued before for the two mutants K161E and 
N191R (Paragraph III.1), the Kd variation is considered unlikely to be alone responsible 
for the observed inability of 3'dGTP and 2'3'ddGTP to stimulate Irga6 oligomerisation. 
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Table 3. Binding of guanine and xanthine nucleotides to WT and Irga6-D186N. Kd value (µM) 
measured by equilibrium titration. The mean values of at least two independent experiments are shown. 
nucleotide / Irga6 WT D186N 
mant-GTP 26.6 ± 5 96.9 ± 16 
2'deoxy-3'mant-GTP 38.3 ± 7.7  
2'mant-3'deoxy-GTP 58.4 ± 11.6  
mant-GDP 1.4 ± 0.1 62.6 ± 28.3 
mant-XTP 58.5 ± 8.1 11.2 ± 0.8 
mant-XDP 10 ± 1.2 0.8 ± 0.3 
 
III.5. The 3'hydroxyl is required in trans only 
In case of the Ffh-FtsY heterodimer it was shown that the essential activation function 
of the 3'hydroxyl is mediated in trans (Egea et al., 2004), and this is also a further 
prediction of the catalytic-Irga6-dimer model. 
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Figure 18. The 3'hydroxyl is required in trans but not in cis. (A) Hydrolysis of 1 mM 3'dGTP (with 
trace amounts of γ32P-3'dGTP) was measured in the presence of 50 µM WT Irga6 at 37°C. The 
experiment was performed with and without the addition of 1 mM unlabeled GTP, 2'dGTP, 3'dGTP or 
2'3'ddGTP. Samples were assayed by TLC and autoradiography. (B) Model of the interaction between 
labeled 3'dGTP and unlabeled GTP in the core of the catalytic-Irga6-dimer. The radioactively labeled γ-
phosphate of the 3'dGTP is marked with a gray circle. The putative activatory interaction between the 
3'hydroxyl of GTP and the γ-phosphate of 3'dGTP is represented as a dotted line. 
The next experiments therefore investigated whether the basal hydrolysis of labeled 
3'dGTP can be enhanced by addition of unlabeled GTP, 2'dGTP, 3'dGTP or 2'3'ddGTP. 
Since each Irga6 molecule has only one single nucleotide-binding site, any increase in 
3'dGTP hydrolysis must be due to an activation in trans. Furthermore the capability to 
activate hydrolysis of 3'dGTP, a nucleotide which itself does not contain the 3'hydroxyl, 
highlights the dispensability of the 3'hydroxyl in cis. Consistent with the model the 
addition of GTP and 2'dGTP stimulated the hydrolysis of labeled 3'dGTP, whereas the 
addition of 3'dGTP and 2'3'ddGTP had an inhibitory effect (Figure 18 A). Therefore the 
3'hydroxyl is required in trans but not in cis for the activation of hydrolysis. The 
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mechanism responsible for the trans activation of hydrolysis of labeled 3'dGTP by 
unlabeled GTP suggested by the catalytic-Irga6-dimer model is shown in Figure 18 B. 
III.6. Glutamate 106 is essential for the activation of GTP hydrolysis 
The basis of the catalytic-Irga6-dimer model is created by the trans interactions of the 
3'hydroxyls with the γ-phosphates. These enforce a specific relative orientation of two 
nucleotides and therefore also of the two protein molecules to which they are bound. 
The catalytic-Irga6-dimer model suggests additional trans interactions between the 
3'hydroxyls and the Glu106 residues (Figure 20 A). 
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Figure 19. Glu106 is part of the flexible switch I region. View of the nucleotide-binding region of 
Irga6 (ribbon presentation). (A) One subunit of the Irga6 crystal-dimer (PDB 1TPZ/A) (Ghosh et al., 
2004) is shown in green. (B) The Irga6 crystal-dimer-interface mutant M173A (PDB 1TQ6) (Ghosh et al., 
2004) is shown in red. Nucleotides and Glu106 are shown as atomic stick figures. 
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Figure 20. Glu106 in the model of the catalytic-Irga6-dimer. View of the nucleotide-binding region of 
Irga6 (ribbon presentation). (A) Catalytic-Irga6-dimer model; Two molecules of the Irga6 crystal-dimer-
interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) are shown (green and red). (B) Two molecules 
(yellow and blue) of one subunit of the Irga6 crystal-dimer (PDB 1TPZ/A) (Ghosh et al., 2004) were 
adjusted at the catalytic-Irga6-dimer model, to give the best overlay for the G1, G3, G4 and G5-motifs. 
(C) The theoretical model of the catalytic-Irga6-dimer in the GDP state is shown. Nucleotides and 
Glu106 are shown as atomic stick figures. The cis interaction between the Glu106 and the γ-phosphate, 
and the putative trans interactions between the 3'hydroxyl and Glu106, and 3'hydroxyl and the γ-
phosphate are represented by dotted black lines. 
Only minor conformational differences were observed between nucleotide free, GDP or 
GppNHp complexed Irga6 crystal structures (Ghosh et al., 2004). Glu106 is part of the 
flexible switch I region which undergo conformational changes (Ghosh et al., 2004) 
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(Figure 19; Figure 44). In the GDP state Glu106 is exposed and points away from the 
bound nucleotide - opened conformation (Figure 19 A; Figure 20 C; Figure 44 D and 
E). In the GppNHp state the residue can be reoriented towards the γ-phosphate, of the 
bound nucleotide - closed conformation (Figure 19 B; Figure 20 A; Figure 44 C and 
partially A). However the closed conformation is not obligatory for the GppNHp state 
(Figure 44 B). 
 
The involvement of Glu106 in the activation of GTP hydrolysis was investigated. 
Mutations of Glu106 had diverse inhibitory effects on the oligomerisation rate of Irga6. 
The mutants E106K and E106R showed the strongest effect (Figure 21 A; Figure 51 F 
and G). This suggests that Glu106 is part of the interaction interface, which is involved 
in Irga6 complex formation. 
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Figure 21. Glu106 is essential for the activation of GTP hydrolysis. (A) Oligomerisation of 80 µM 
WT or mutant Irga6 was monitored by light scattering in the presence of 10 mM GTP at 37°C. (B) 
Hydrolysis of 10 mM GTP (with trace amounts of α32P-GTP) was measured in the presence of 80 µM 
WT or mutant Irga6 at 37°C. Samples were assayed by TLC and autoradiography. 
All tested mutants of Glu106, even non-drastic like E106D and E106Q, lost the ability 
to activate GTP hydrolysis (Figure 21 B), and showed only very low GTP hydrolysis 
rates in range from 0.02 to 0.06 min-1. Remarkably also mutants which oligomerised 
were unable to activate GTP hydrolysis. This showed that Glu106 is a key residue 
which is essential for the activation of GTP hydrolysis. Out of all tested mutants, only 
mutants of Glu106 oligomerised nearly normally but were catalytically inert. 
Although Glu106 can directly interact with the bound nucleotide the nucleotide-
binding affinity was not altered by the E106R mutation (Table 2). 
 
The hypothetical catalytic-Irga6-dimer in the GDP state was constructed (Figure 20 B -
C). The spatial arrangements of Glu106 and the switch I region in the opened and 
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closed conformation are incompatible with (Figure 20 C) and permissive for (Figure 20 
A) the formation of the catalytic-Irga6-dimer respectively. It appears possible that the 
3'hydroxyl stabilizes the Glu106 residue in trans in the closed conformation, which 
allows complex formation, in an orientation which is required for the activation of a 
water molecule for the nucleophilic attack onto the γ-phosphate, and is therefore 
necessary for the activation of GTP hydrolysis in trans. Stabilization of Glu106 seems 
likely to be required, due to the fact that the residue is highly flexible (Ghosh et al., 
2004) (Figure 44; Figure 19). 
III.7. Threonine 78 is involved in oligomerisation and GTP hydrolysis 
The model of the catalytic-Irga6-dimer predicts a further interaction of the 3'hydroxyl of 
the nucleotide ribose with Thr78 in trans (Figure 22 A). Thr78 is located in the G1-
motif and interacts with the γ-phosphate in cis (Figure 22 A; Figure 44). The residue 
shows a strong conservation (Figure 12), whereby it was found to be replaced only by a 
serine in some other mouse immunity-related GTPases (IRGs) (Bekpen et al., 2005). 
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Figure 22. Thr78 is involved in the catalytic-interface. (A) View of the nucleotide-binding region of 
Irga6 (ribbon presentation). Catalytic-Irga6-dimer model; Two molecules of the Irga6 crystal-dimer-
interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) are shown (green and red). Nucleotides and 
Thr78 are shown as atomic stick figures. (B) Oligomerisation of 80 µM WT or Irga6-T78A was 
monitored by light scattering in the presence of 10 mM GTP at 37°C. (C) Hydrolysis of 10 mM GTP 
(with trace amounts of α32P-GTP) was measured in the presence of 80 µM WT or Irga6-T78A at 37°C. 
Samples were assayed by TLC and autoradiography. 
The requirement of Thr78 for the GTPase reaction was investigated by the 
comparatively mild mutation of this residue to alanine. The T78A mutant showed a 
reduced oligomerisation rate (Figure 22 B), which may be explained by the fact that 
Thr78 is part of the catalytic-interface (Figure 14 A; Figure 22 A). However an 
inhibition of nucleotide binding was not ruled out and can therefore serve as an 
alternative explanation. GTP hydrolysis was reduced by the T78A mutation (Figure 22 
C), but the substrate turnover was significantly higher than that of the catalytic-interface 
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mutants (Figure 9; Figure 28; Figure 30) or the mutants of Glu106 (Figure 21). 
Furthermore Irga6-T78A hydrolyses GTP in a cooperative manner (data not shown). 
Threonine 78 is involved in, but it is not essential for, GTP hydrolysis. It cannot 
be distinguished whether the observed effects of the T87A mutation result from the loss 
of the potential trans interaction with the 3'hydroxyl or from loss of the cis interaction 
with the γ-phosphate. 
III.8. XTP interferes with oligomerisation 
In the catalytic-Irga6-dimer model the bound nucleotides are part of the interaction 
interface of two subunits. It was shown that the GTP ribose is part of the interaction 
interface (Figure 16 A). 
 
The specificity of GTPases for guanine nucleotides is determined by a conserved 
aspartate residue in the G4-motif. This aspartate forms a hydrogen bond with the 
exocyclic amino-group of the guanine ring at the C2 position (Figure 23 A). The 
substitution of the G4 aspartate with asparagine is known to change the nucleotide 
specificity of GTPases from guanine to xanthine nucleotides (Hwang and Miller, 1987; 
Shan and Walter, 2005b; Yu et al., 1997; Zhong et al., 1995), which have an oxo-group 
at the C2 position of the base (Figure 23 B). 
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Figure 23. The nucleotide base is part of the catalytic-interface. View of the catalytic-Irga6-dimer 
model (ribbon presentation). Two molecules of the Irga6 crystal-dimer-interface mutant M173A (PDB 
1TQ6) (Ghosh et al., 2004) are shown (green and red in A, yellow and blue in B). Asp186 with two 
modeled GTP nucleotides (A) and modeled Asn186Irga6-D186N with two modeled XTP nucleotides (B) are 
shown as atomic stick figures. The interactions of Asp186 with GTP and of Asn186Irga6-D186N with XTP 
are represented by dotted black lines. 
The D251N mutation in the G4-motif of Ffh changes the binding preference of the 
protein from GTP to xanthosine-5'triphosphate (XTP). It was shown that the GTP-
initiated complex formation between the two SRP GTPases, Ffh-D251N and FtsY, is 
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inhibited by addition of XTP. The C2 amino-group is part of the interaction surface 
between Ffh and FtsY therefore the binding of XTP to Ffh-D251N alters the interface 
and inhibits complex formation (Shan and Walter, 2005b) (Figure 24). 
In particular, Asp251Ffh interacts in trans with Lys390FtsY (Figure 24 A) in the 
heterodimeric complex (Egea et al., 2004; Shan and Walter, 2005b). It was suggested 
that in GTP-bound state the mutated residue Asn251Ffh-D251N can adopt an orientation 
which allows an interaction with the Lys390FtsY (Figure 24 C), and therefore also 
complex formation. In contrast when XTP is bound the orientation of Asn251Ffh-D251N is 
potentially inverted so that the interaction with Lys390FtsY is blocked (Figure 24 B) and 
complex formation prevented (Shan and Walter, 2005b). 
A B C
Ffh
FtsY
GTP GTPXTP
FtsY FtsY
Ffh-D251N Ffh-D251N  
Figure 24. Interaction of Lys390FtsY with the side chain of Ffh residue 251. Schematic drawing of the 
interactions for the WT Ffh-FtsY complex (A) and the Ffh-D251N FtsY complex with XTP (B) or GTP 
(C) bound at the Ffh-D251N active site. The dots highlight the interaction with Lys390FtsY, and the 
dashed lines depict the hydrogen bonding interactions between residue 251 and the purine ring. From 
(Shan and Walter, 2005b); modified. 
The nucleotide-binding specificity of Irga6 was changed from guanine to xanthine 
based nucleotides by the corresponding G4-motif mutation D186N (Uthaiah, 2002) 
(Table 3). Unexpectedly Irga6-D186N hydrolysed GTP more efficiently than XTP 
(Figure 25). No XTP-initiated complex formation was observed; neither for Irga6-
D186N nor for the WT (Figure 55). 
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Figure 25. The Irga6 G4-motif mutant hydrolyses GTP faster than XTP. (A) Hydrolysis of 10 mM 
GTP (with trace amounts of α32P-GTP) was measured in the presence of 80 µM WT or mutant Irga6 at 
37°C. Samples were assayed by TLC and autoradiography. (B) Hydrolysis of 10 mM XTP was measured 
in the presence of 80 µM WT or mutant Irga6 at 37°C. Samples were assayed by HPLC. 
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Figure 26. XTP inhibits Irga6 oligomerisation and GTP hydrolysis. Oligomerisation of 80 µM WT 
(C) or Irga6-D186N (A) was monitored by light scattering in the presence of 10 mM GTP at 37°C. The 
experiment was performed with and without the addition of 1 mM or 10 mM XTP. Hydrolysis of 10 mM 
GTP (with trace amounts of α32P-GTP) was measured in the presence of 80 µM WT (D) or Irga6-D186N 
(B) at 37°C. The experiment was performed with and without the addition of 1 mM or 10 mM XTP. 
Samples were assayed by TLC and autoradiography. 
In analogy to Ffh-D251N, oligomerisation and GTPase activity of Irga6-D186N could 
be activated by GTP and both were abolished when a minor amount of XTP was added 
(Figure 26 A and B). This result shows that XTP inhibits complex formation of Irga6-
D186N and suggests that, as in the case of Ffh-FtsY, the nucleotide base is part of the 
interaction interface between the complex forming molecules. 
However GTP initiated oligomerisation and GTPase activity of WT Irga6 could 
also by inhibited by XTP addition (Figure 26 C and D), although higher XTP 
concentrations were needed and the effect was not as complete as for the D186N 
mutant. This shows that, the reason for the loss of complex formation is not only a 
wrong orientation of the G4-motif asparagine (Figure 24), as suggested for the Ffh-FtsY 
case (Shan and Walter, 2005b), but must be due to the presence of the C2 oxo- in place 
of the amino-group in the interface. 
 
In the model of the catalytic-Irga6-dimer the two closest trans neighbour residues of the 
GTP base C2 amino-group are Glu77 and Ser132 (Figure 27). A mutation of Ser132, 
S132R caused loss of oligomerisation (Figure 9 A). Mutants of Glu77 showed an 
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impaired oligomerisation and GTP hydrolysis (Figure 28; Figure 52). The nucleotide-
binding affinity was only slight reduced by the E77A mutation (Table 2). 
The inhibitory effect of XTP on complex formation could possibly be accounted 
by loss of an interaction between the C2 amino-group and Glu77 in trans (Figure 27). It 
is apparent that an oxo-group, which replaces in XTP the C2 amino-group of GTP, is not 
the preferable interaction partner for a glutamate residue. However the inhibitory effect, 
of XTP on complex formation and hydrolysis activity, could not be recovered by the 
E77Q and E77N mutations in complementation experiments (data not shown). The 
catalytic-Irga6-dimer model also suggests, that Glu77 could be involved in a trans 
interaction with Arg159 (Paragraph III.9). 
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Figure 27. Putative trans interaction of the nucleotide base with Glu77. View of the nucleotide-
binding region of Irga6 (ribbon presentation). Catalytic-Irga6-dimer model; Two molecules of the Irga6 
crystal-dimer-interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) are shown (green and red in A, 
yellow and blue in B). The theoretical model of the catalytic-Irga6-dimer in the GTP (A) and XTP (B) 
state is shown. Nucleotides, Ser132 and Glu77 are shown as atomic stick figures. The putative trans 
interactions between the C2 group of the nucleotide base and Glu77 is represented by a dotted black line. 
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Figure 28. Glu77 is involved in oligomerisation. (A) Oligomerisation of 80 µM WT or mutant Irga6 
was monitored by light scattering in the presence of 10 mM GTP at 37°C. (B) Hydrolysis of 10 mM GTP 
(with trace amounts of α32P-GTP) was measured in the presence of 80 µM WT or mutant Irga6 at 37°C. 
Samples were assayed by TLC and autoradiography. 
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III.9. Aspartate 164 and arginine 159 are involved in complex 
formation 
For the construction of the catalytic-Irga6-dimer model a rigid crystal structure was 
used. In this model the two protein molecules complement each other well; however 
there is a conflict in the hypothetical interface. The side chains of the Arg159 residues 
of the two subunits collide (Figure 29 A). 
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Figure 29. Asp164 and Arg159 in the catalytic-Irga6-dimer model. (A and B) View of the catalytic-
Irga6-dimer model (ribbon presentation). Two molecules of the Irga6 crystal-dimer-interface mutant 
M173A (PDB 1TQ6) (Ghosh et al., 2004) are shown (green and red in A, yellow and blue in B). 
Nucleotides, Arg159 of the green and the red Irga6 molecule (A) and Asp164 of the yellow and Arg159 
of blue molecule (B) are shown as atomic stick figures. (C and D) View of the nucleotide-binding region 
of Irga6. A molecule of the Irga6 crystal-dimer-interface mutant M173A (PDB 1TQ6) (Ghosh et al., 
2004) is shown (yellow in C, blue in D) (ribbon presentation). (C) The molecular surface formed by the 
residues Glu77, Thr78, Gly79, Ser80, Ile155, Ser156, Ala157, Thr158, Arg159, Phe160, Lys161, Lys162 
and Asn163 is shown. (D) Residues of the described surface, Asp164 and the nucleotide are shown as 
atomic stick figures. 
Irga6, as a protein molecule, is a flexible dynamic structure and therefore a 
conformational change during the complex formation, in analogy to Ffh-FtsY, is 
plausible. Arg159 is located close to the Asp164 residue of the other subunit (Figure 29 
B) in the catalytic-Irga6-dimer model. Asp164 forms the bottom of a pocket (Figure 29 
C), which is composed of two loops. One loop is located between Glu77 and Ser80 and 
contains a part of the G1-motif. The other loop is located between Ile155 and Asn163 
(Figure 29 D). The side chain of Asp164 contacts the backbone amide of Lys161 and 
water, which is located in the pocket. 
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Mutations of Arg159 had deleterious effects on oligomerisation and GTPase activity of 
Irga6 (Figure 30 A and B). This is consistent with the idea that this residue is an 
exposed part of the interaction interface, as suggested by the catalytic-Irga6-dimer 
model. Also mutations of Asp164 damaged oligomerisation and GTP hydrolysis (Figure 
30 A - D). Only the conservative mutation D164E had a lower effect (Figure 30 A and 
B). Interestingly the two mutations D164K and D164R caused a spontaneous protein 
aggregation at 37°C, whereas the mutants were more stable in presence of GTP than 
GDP (Figure 56); the instability exacerbated in absence of nucleotide (data not shown). 
The two mutants were stable at 20°C (Figure 53 M and N). Asp164 is not an exposed 
part of the protein surface, but is rather withdrawn in the interior of the protein; 
therefore it is striking that even a mild mutation like D164N had a very strong inhibitory 
effect (Figure 53 J). 
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Figure 30. Asp164 and Arg159 participate in oligomerisation and hydrolysis. Oligomerisation of 80 
µM WT or mutant Irga6 was monitored by light scattering in the presence of 10 mM GTP at 37°C (A) or 
20°C (C). Hydrolysis of 10 mM GTP (with trace amounts of α32P-GTP) was measured in the presence of 
80 µM WT or mutant Irga6 at 37°C (B) or 20°C (D). Samples were assayed by TLC and autoradiography. 
The nucleotide-binding affinity was slightly decreased by the R159E mutation (Table 
2). However, as argued before for the two mutants K161E and N191R (Paragraph III.1), 
the Kd variation is considered unlikely to be alone responsible for the magnitude of 
observed effect of the Arg159 mutation. Mutations of Asp164, as a residue of the 
protein core, are more worrying in respect of protein folding. However the nucleotide-
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binding affinity was not changed by the D164A mutation (Table 2), suggesting that 
there is no major conformational effect caused by the mutation of the Asp164 residue. 
 
Arg159 seems to be relatively unconstrained since it adopts different conformations in 
the different crystal structures of Irga6 (Ghosh et al., 2004) (Figure 44). It can be 
assumed that a conformational change occurs during complex formation, as a result of 
which Arg159 is reoriented, inserted into the described pocket on the opposed molecule 
to form a salt bridge with Asp164 in trans. A salt bridge formation between Arg159 
and, the pocket forming (Figure 29 D; Figure 44), Glu77 in trans appears also possible. 
As a result of this insertion a conformational effect on the loop with the G1-motif is 
reasonable, which speculatively might participate in the activation of GTP hydrolysis. 
Complementation experiments were performed; mutants of Asp164 were 
incubated with mutants of Arg159 in presence of GTP. Various combinations were 
tested, for example D164R or D164K and R159D or R159E; however no recovery of 
complex formation was observed (data not shown). There are many reasons why an 
experiment of that kind might not work. In this special case, a salt bridge formation 
between the, Asp164 substituting, positively charged residue (arginine, lysine) and 
Glu77 (Figure 29 D; Figure 44) in cis could provide an explanation. This interaction 
could neutralize the positive charge of Arg164Irga6-D164R or Lys164Irga6-D164K and also 
alter the architecture of the pocket (Figure 29 C) and the catalytic-interface (Figure 14 
A; Figure 27 A). 
 
The spontaneous temperature-dependent aggregation of the D164K und D164R mutants 
could be an indication for the hypothesized conformational change (Paragraph III.13 
and III.14), an event that is suggested to follow the dimer formation via the catalytic-
interface. The mutations potentially mimic the trans insertion of Arg159 into the pocket 
with Asp164, as suggested by the catalytic-Irga6-dimer model (Figure 29 B). This could 
speculatively cause spontaneous formation of an activated-like conformation, which is 
potentially unstable (Paragraph III.14). In this scenario the trans interaction, with 
charge neutralization, of Arg159 with Asp164 would induce the anticipated 
conformational change. 
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Proteins of the GMS subfamily were shown to negatively regulate Irga6 in vivo 
to prevent spontaneous activation of Irga6 prior to infection (Hunn et al., 2008). Further 
it was suggested that Irgm3 may interact with Irga6 via the catalytic-interface (Hunn, 
2007; Papić, 2007). It is attractive in that context, that residues corresponding to Arg159 
and Asp164 of Irga6 are replaced in Irgm1, Irgm2 and Irgm3, by glutamine and 
histidine respectively. Therefore the anticipated conformational change would not be 
expected to be induced in Irga6 by the interaction with Irgm3. Such a situation could 
possibly be one reason why the interaction between Irgm3 and Irga6 is of an inhibitory 
nature. 
Interestingly in the homology model of Irgm3 (Figure 45 A) a cis interaction 
between Asp92Irgm3, corresponding to Glu77Irga6, and His190Irgm3, corresponding to 
Asp164Irga6, can be observed. 
III.10. The N-terminus is not critical for oligomerisation 
Irga6 forms oligomeric structures in a GTP-dependent manner in vitro (Uthaiah et al., 
2003). It was shown that a GTP-dependent conformational change is taking place in the 
N-terminal region of Irga6 (Papic et al., 2008). 
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Figure 31. N-terminal GST fusion does not prevent oligomerisation. (A) Oligomerisation of 80 µM 
(monomer; Irga6 subunit) Irga6, GST-Irga6/GST-Irga6 homodimer or GST-Irga6/GST heterodimer was 
monitored by light scattering in the presence of 10 mM GTP at 37°C. (B) Hydrolysis of 10 mM GTP 
(with trace amounts of α32P-GTP) was measured in the presence of 80 µM (monomer; Irga6 subunit) 
Irga6, GST-Irga6/GST-Irga6 homodimer or GST-Irga6/GST heterodimer at 37°C. Samples were assayed 
by TLC and autoradiography. (C) Schematic drawing of the GST-Irga6/GST-Irga6 homodimer and the 
GST-Irga6/GST heterodimer. The dimer subunits are shown in green and red. 
It was of interest if the N-terminal region of Irga6 is directly involved in complex 
formation. Irga6 was purified as N-terminal fusion with glutathione-S-transferase (GST) 
(Figure 58). Since GST is a dimeric protein (Lim et al., 1994), the GST-Irga6 fusion 
protein is purified as a non-covalent dimer (data not shown). In addition to the expected 
GST-Irga6/GST-Irga6 homodimer (Figure 31 C) a GST-Irga6/GST heterodimer was 
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purified (data not shown); presumably resulting from protein degradation or incomplete 
protein biosynthesis. 
No inhibition of oligomerisation or GTPase activity was detected for any of the 
GST-Irga6 fusion proteins (Figure 31 A and B). Enhanced complex formation and GTP 
hydrolysis were observed for the GST-Irga6/GST-Irga6 homodimer. The higher activity 
of this protein may be explained by the preformed dimer and the locally increased Irga6 
concentration. The ability of the GST-Irga6 fusion proteins to oligomerise shows that 
the N-terminus itself is not involved in the interaction of Irga6 molecules. 
III.11. The C-terminus is not critical for oligomerisation 
The C-terminus of Irga6 was implicated in oligomerisation since it was found that Irga6 
modified with six histidines (Irga6-His) at the C-terminus failed to oligomerise 
normally in vitro (Uthaiah et al., 2003). Nucleotide binding was not affected by the 
histidine tag (Uthaiah et al., 2003). 
 
The influence of the histidine tag on oligomerisation of Irga6 was reinvestigated. Irga6-
His was found to be inhibited in oligomerisation and GTPase activity (Figure 60), 
although the observed effect was not as complete as reported before (Uthaiah et al., 
2003). The more strict experimental conditions (Paragraph III.12) used in this study are 
potentially responsible for the observed complex formation of Irga6-His. 
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Figure 32. C-terminal EGFP fusion does not prevent oligomerisation. (A) Oligomerisation of 80 µM 
Irga6, Irga6-cTag1-linker-EGFP, Irga6-linker-EGFP or Irga6-EGFP (Figure 59) was monitored by light 
scattering in the presence of 10 mM GTP at 37°C. (B) Hydrolysis of 10 mM GTP was measured in the 
presence of 80 µM Irga6, Irga6-cTag1-linker-EGFP, Irga6-linker-EGFP or Irga6-EGFP at 37°C. Samples 
were assayed by HPLC. 
The requirement of the C-terminus for complex formation was further addressed by the 
fusion of enhanced-green-fluorescent protein (EGFP) to the C-terminus of Irga6. Three 
Irga6-EGFP fusion proteins were generated, which differed in the length of the linker 
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between Irga6 and EGFP (Figure 59). The shortest fusion protein lacked a linker. All 
three fusion proteins were purified in monomeric form (data not shown). 
No reduction of oligomerisation or GTP hydrolysis was observed for any of the 
Irga6-EGFP fusion proteins (Figure 32). Therefore the C-terminus itself is not involved 
in the interaction of Irga6 molecules. 
However a linker between Irga6 and EGFP, including cTag1, does seem to be 
required to prevent aggregation of the protein in vivo (Sascha Martens, unpublished 
results) (Zhao et al., 2009b), and interestingly the removal of the spacer between Irga6 
and EGFP caused an accelerated oligomerisation in vitro (Figure 32 A). 
III.12. The crystal-dimer-interface is not required for oligomerisation 
In the preceding part of this study the catalytic-interface which is formed between the 
interacting Irga6 molecules was defined (Paragraph III.1). Further a model was 
proposed of how the molecules are oriented in the complex (Paragraph III.2) and how 
the activation of GTP hydrolysis is achieved (Paragraph III.6). A monomeric structure 
of the Irga6-M173A mutant was used for the construction of the catalytic-Irga6-dimer 
model. However WT Irga6, although monomeric in solution (Uthaiah et al., 2003), 
crystallised as a dimer (Figure 33) and the crystal-dimer-interface was suggested to 
participate in oligomer formation (Ghosh et al., 2004). In an earlier study, mutations in 
the crystal-dimer-interface were found to reduce oligomerisation, although no complete 
inhibition of the oligomerisation process was unambiguously demonstrated (Ghosh et 
al., 2004). 
 
Figure 33. The Irga6 crystal-dimer. Structure of the Irga6-GDP dimer (ribbon presentation). Secondary 
structure elements involved in the dimer interfaces I and II are labeled. The 2-fold noncrystallographic 
symmetry axis is shown. The G-domain is coloured in light-blue and the N- and C-terminal helical 
regions are coloured in cyan and dark-blue respectively. The linker-helix connecting the G-domain and C-
terminal helical region is shown in gray. GDP and Mg2+ are shown as atomic stick figures and a yellow 
sphere respectively. From (Ghosh et al., 2004); modified. 
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Figure 34. Position of mutated residues in the crystal-dimer. The Irga6 crystal-dimer (PDB 1TPZ) 
(Ghosh et al., 2004) is shown (ribbon presentation). Protein domains are colour coded as in Figure 11. 
Mutated residues of both molecules are shown as described in Figure 11. Lys9, Ser10, Lys196 of both 
subunits and Lys202 of the second subunit are not shown, since they are not resolved in the crystal 
structure. The nucleotides are shown as atomic stick figures. (A) Top view. (B) Front view of the two G-
domains; orientation A rotated by 90° around the x-axis. (C) Left view; orientation B rotated by 90° 
around the y-axis. 
The knowledge of two interfaces would make it possible to reconstruct a potential 
structure of the Irga6 oligomer. Therefore four Irga6 mutants (L44R-S172R, K48A, 
K48E and M173A) of the crystal-dimer-interface, which were used before (Ghosh et al., 
2004), were re-assayed. None of these mutants substantially reduced oligomerisation or 
GTP hydrolysis by Irga6 (Figure 35). Probably the more stringent conditions under 
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which the mutants were re-assayed provide a reasonable explanation for the 
discrepancy. In the former report 50 µM protein was incubated with 400 µM GTP at 
20°C during conventional light scattering experiments; for DLS assays 50 µM protein 
was incubated with 1 mM GTP at 4°C (Ghosh et al., 2004), in this study 80 µM protein 
was incubated with 10 mM GTP at 37°C. The oligomerisation rate of Irga6 is greatly 
enhanced by increasing temperature, protein and nucleotide concentrations (Figure 49), 
making these conditions more stringent for the detection of significant inhibition. 
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Figure 35. Mutations in the crystal-dimer-interface do not prevent oligomerisation. (A) 
Oligomerisation of 80 µM WT or mutant Irga6 was monitored by light scattering in the presence of 10 
mM GTP at 37°C. (B) Hydrolysis of 10 mM GTP (with trace amounts of α32P-GTP) was measured in the 
presence of 80 µM WT or mutant Irga6 at 37°C. Samples were assayed by TLC and autoradiography. 
These results strongly urge that the crystal-dimer-interface is not the oligomerisation-
interface. The crystal-dimer-interface consists of two separate part-interfaces one in the 
helical-domain and one in the G-domain (Figure 14 D; Figure 33; Figure 34). The 
allover conservation of the interface is not high and is particularly low in the helical-
domain interaction surface (Figure 14 C and D; Figure 10 A and F; Figure 12). 
Interaction surfaces of proteins with proteins and other molecules, as for example the 
nucleotide-binding pocket of Irga6, are commonly conserved (Armon et al., 2001). In 
the helical-domain part the residues Glu37, Glu43, Leu44 and Lys48 (K48A and K48E) 
(Figure 14 D; Figure 11 F; Figure 34) were mutated without a significant effect on 
oligomerisation (Figure 35 A; Figure 36 A). Out of nine mutated residues Glu142, 
Lys169, Ser172, Met173 (M173A, M173E, M173R and M173W), Lys175, Lys176, 
Glu177, Arg218 and Glu224 (Figure 14 C and D; Figure 11 A and F; Figure 34) in the 
G-domain part only the mutations of Lys169 and Lys176 inhibited the oligomerisation 
(Figure 36 A and B). It should be recognized that the G-domain part of the crystal-
dimer-interface partially overlaps with the secondary-patch (Paragraph III.13) (Figure 
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14 C and D; Figure 11 A and F; Figure 37 B) and the effect on oligomerisation seen 
there is presumably of the same nature. 
 
The interactions between the two crystal-dimer subunits in the G-domain part are 
largely of a hydrophobic nature (Ghosh et al., 2004). The crystallisation process is an 
ordered protein aggregation, interactions between the crystal forming molecules are 
obligatory. Polyethylene glycol (PEG), used in the crystallisation (Ghosh et al., 2004), 
is hydroscopic and enhances hydrophobic interactions. The formation of the crystal-
dimer is not nucleotide-dependent (Ghosh et al., 2004), whereas the oligomerisation of 
Irga6 requires GTP binding (Uthaiah et al., 2003). In summary, it should probably now 
be considered that the crystal-dimer-interface is a product of the crystallisation process 
itself, rather than reflecting an important intermediate in the nucleotide-dependent 
oligomerisation. 
III.13. The oligomerisation-interface is not evident on the protein 
surface 
The catalytic-interface which is involved in complex formation was defined (Paragraph 
III.1); however the formation of an oligomeric structure requires at least two interfaces. 
The crystal-dimer-interface is not crucial for oligomerisation (Paragraph III.12), 
therefore another interface required for oligomerisation was sought. 
 
The mutagenesis study of Irga6 surface residues, including also more residues in the 
crystal-dimer-interface, was extended with the intention of revealing the true 
oligomerisation-interface. In order to screen more mutants the purification procedure 
was simplified. Generally Irga6 is purified in two steps, by glutathione affinity 
chromatography and by size exclusion chromatography (full purification). It was now 
controlled whether Irga6 that was purified by affinity chromatography only (partial 
purification) would display the same oligomerisation properties as fully purified protein. 
In consistency with results obtained before (Figure 9 A), partially purified WT Irga6 
did, whereas the K196D mutant did not, oligomerise (Figure 36 A left panel). 
Additional mutants were partially purified and tested for oligomerisation. Five mutants 
R31E-K32E, K169E, K176E, R210E and K246E were found to inhibit the 
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oligomerisation of Irga6, whereas the mutants K9E-S10R, S18R, E37R, E43R, N50R, 
Q52R, S56R, T88R, E110R-R111E, K115E, E142R, E148R, D150R, M173E, M173R, 
M173W, K175E, E177R, R218E-E219R, E224R, V242R, D245R, D250R, K255E, 
N265R, S269R, R275E, E285R, N293R, S304R, K310E-K311E, T325R-S236R, 
E335R, K346E, D355R-E356R-E357R, L372R-A373R and K407E had no significant 
effect (Figure 36 A right panel). The candidate mutants were repurified by the full 
purification procedure and the impairment of oligomerisation and GTP hydrolysis was 
confirmed (Figure 36 B and C). 
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Figure 36. Mutagenesis screen of surface residues. (A) Oligomerisation of partially purified 80 µM 
WT or mutant Irga6 was monitored by light scattering in the presence of 10 mM GTP at 37°C. Left panel; 
a positive WT and a negative K196D control (Figure 9 A) are shown. Right panel; tested Irga6 mutants 
are shown. (B and D) Oligomerisation of 80 µM WT or secondary-patch mutant Irga6 was monitored by 
light scattering in the presence of 10 mM GTP at 37°C. The proteins used in this and the following 
GTPase assay were fully purified. (C and E) Hydrolysis of 10 mM GTP (with trace amounts of α32P-
GTP) was measured in the presence of 80 µM WT or secondary-patch mutant Irga6 at 37°C. Samples 
were assayed by TLC and autoradiography. 
The residues Arg31, Lys32, Lys169, Lys176, Arg210 and Lys246 cluster in one region 
of the Irga6 surface (called from now on the secondary-patch). Unlike the catalytic-
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interface this area is perforated by residues which, when mutated, had no effect on 
oligomerisation (Figure 11; Figure 37). The reduction of oligomerisation and GTP 
hydrolysis by the mutations that define the secondary-patch was not as drastic (Figure 
36 B and C; Figure 54 A - E) as observed for the mutations in the catalytic-interface 
(Figure 9; Figure 21; Figure 28; Figure 30; Figure 50; Figure 51; Figure 52; Figure 53). 
The secondary-patch appeared drastically different from the catalytic-interface raising 
the question whether this area of the Irga6 surface can really act as an interaction 
interface? One assumption was that the secondary-patch is an interface with a very high 
affinity, and therefore mutations of one or two residue might not be sufficient to prevent 
complex formation. The mutations R31E-K32E, K176E, R210E and K246E were 
therefore combined. K169E was not included because of the proximity of the Lys169 to 
the catalytic-interface (Figure 11 A; Figure 15 A and C). Oligomerisation and GTP 
hydrolysis were further inhibited by the combination of secondary-patch mutants 
(Figure 36 D and E; Figure 54 F - H). 
Extension of the R31E-K32E-K176E-K246E mutant, by the R210E mutation, 
destabilized the protein (Figure 36 D and E; Figure 54 G and H). Arg210 forms an 
intramolecular salt bridge with Asp239 (Figure 57 A and B). The mutation D239R 
caused spontaneous protein aggregation at 37°C, but not at 20°C (Figure 57 C - F). 
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Figure 37. Position of mutated residues within the secondary-patch. The Irga6 crystal-dimer-interface 
mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) is shown (ribbon presentation). Protein domains are 
colour coded as in Figure 11. Mutated residues are shown as described in Figure 11 with the exception 
that the residues Ser172, Met173, Lys176, Glu177, Arg218, Glu219, Glu224, Val242, Asp245 and 
Asp250, which are located in the area of the secondary-patch, but single mutated did not significantly 
affected oligomerisation, are coloured in purple. The nucleotide is shown as atomic stick figure. (A) 
Bottom view. (B) Left view. 
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To gain more insight into the nature of the secondary-patch, mutations of residues, 
which are located within the area of the secondary-patch (Figure 11; Figure 37) but did 
not inhibit oligomerisation (S172R, M173A, K175E, E177R, R218E, E219R, E224R, 
V242R, D245R and D250R), were combined. The mutant S172R-M173A-K175E-
E177R inhibited oligomerisation and GTPase activity (Figure 38), but no complete 
blockage of complex formation was obtained (Figure 54 I). The two mutants R218E-
E219R-E224R and V242R-D245R-D250R showed no inhibition of oligomerisation and 
GTPase activity (Figure 38). 
Two further combined mutants were generated. The mutant R218E-E219R-
E224R-V242R-D245R-D250R showed robust oligomerisation, but the GTPase activity 
was somewhat decreased (Figure 38). Surprisingly the mutant S172R-M173A-K175E-
E177R-R218E-E219R-E224R-V242R-D245R-D250R, which includes the S172R-
M173A-K175E-E177R mutation, showed substantial oligomerisation, although the 
GTPase activity stayed reduced (Figure 38). The high oligomerisation, of the two 
further combined mutants, (Figure 38 A) is not correlated to a high GTP hydrolysis rate 
(Figure 38 B); it appears likely that a part of the recorded scattered light (Figure 38 A) 
originates form protein aggregation or denaturation. 
It can be excluded that the secondary-patch is the oligomerisation-interface, due 
to the fact that a substantial part of the secondary-patch area could be replaced without 
being able to prevent oligomerisation. 
80µM Irga6; 10mM GTP; 37°C
Time (min.)
0 30 60 90 120
S
ca
tte
re
d
lig
ht
(a
.u
.)
0
5e+5
1e+6
2e+6
2e+6
80µM Irga6; 10mM GTP; 37°C
Time (min.)
0 30 60 90 120
G
T
P
(m
M
)
0
2
4
6
8
10
wt
S172R-M173A-K175E-E177R
R218E-E219R-E224R
V242R-D245R-D250R
R218E-E219R-E224R
V242R-D245R-D250R
S172R-M173A-K175E-E177R
R218E-E219R-E224R
V242R-D245R-D250R
A B
 
Figure 38. The secondary-patch is not crucial for oligomerisation. (A) Oligomerisation of 80 µM WT 
or mutant Irga6 was monitored by light scattering in the presence of 10 mM GTP at 37°C. (B) Hydrolysis 
of 10 mM GTP (with trace amounts of α32P-GTP) was measured in the presence of 80 µM WT or mutant 
Irga6 at 37°C. Samples were assayed by TLC and autoradiography. 
The nucleotide-binding affinity was slightly reduced by the R31E-K32E, K169E, 
K246E, R31E-K32E-K246E, R31E-K32E-K176E-K246E and S172R-M173A-K175E-
E177R mutations and significantly affected by the K176E, R210E and R31E-K32E-
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K176E-R210E-K246E mutations (Table 2). Although the decreased binding affinities 
possibly contribute to the observed inhibition of oligomerisation they alone appear 
unlikely, in analogy to the two mutants K161E and N191R (Paragraph III.1), to provide 
a sufficient explanation. A conformational influence of the secondary-patch mutants on 
the G-domain folding could be suggested, due to the fact that mutations reduce the 
nucleotide-binding affinity, but the mutated residues are localised distant to the 
nucleotide-binding pocket (Figure 11). 
 
It may be that the secondary-patch does not contribute directly to an interface that is 
acquired during the process of complex formation, but that the inhibitory effect of the 
secondary-patch mutants on oligomerisation results from an alteration of the G-domain 
folding and possibly also from an injury to the catalytic-interface. 
Alternatively the secondary-patch could be involved in a conformational change 
that follows dimer formation via the catalytic-interface, and exposes the 
oligomerisation-interface. Arguably therefore, the definitive oligomerisation-interface is 
not apparent on the surface of the known Irga6 crystal structures and its exposure is a 
process that is potentially impaired by the secondary-patch mutations. 
III.14. Enhanced Irga6 
The catalytic-interface, which is involved in complex formation, was revealed 
(Paragraph III.1), but the mutagenesis of Irga6 surface residues (Paragraph III.13) failed 
to uncover the second interface which is required for oligomerisation. This indicates 
that the oligomerisation-interface is probably not present as such on the surface of 
monomeric Irga6 as seen in the crystal structures (Ghosh et al., 2004), but that it 
becomes exposed during a conformational change, postulated to take place during 
formation of the catalytic-Irga6-dimer. 
It would be of great interest to obtain a form of Irga6 which forms GTP-
dependent dimer, and does not further oligomerise. This protein could be potentially 
used for crystallographic analysis of the catalytic-interface. 
 
Irga6 overexpressed in cells in the absence of interferon-γ (IFNγ) forms aggregate-like 
structures (Martens et al., 2004). It is likely that these structures contain the pre-
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activated oligomeric form of Irga6 (Hunn et al., 2008; Martens et al., 2004; Papic et al., 
2008). Consistent formation of aggregate-like structures was not observed when 
nucleotide-binding deficient mutants (G76V-G81V and S83N) of Irga6 were 
overexpressed (Hunn et al., 2008; Martens et al., 2004; Papic et al., 2008). The 
formation of aggregates was also not observed for a truncated form of Irga6 (M1-F287; 
∆CD), lacking the whole C-terminal-domain following the αF helix (Figure 39 A; 
Figure 6) (Martens et al., 2004). 
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Figure 39. Truncation of the αFαG-loop enhances oligomerisation. (A) A molecule of the Irga6 
crystal-dimer-interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) is shown (ribbon presentation). 
Protein domains are colour coded as in Figure 11. The residues Leu291, Val292, Asn293, Ile294, Ile295, 
Pro296, Ser297, Leu298, Thr299, Phe300 and the nucleotide are shown as atomic stick figures. The loop 
between Leu291 and Phe300 is marked in red. Top view. (B) Oligomerisation of 80 µM WT or mutant 
Irga6 was monitored by light scattering in the presence of 10 mM GTP at 37°C. (D) Hydrolysis of 10 mM 
GTP (with trace amounts of α32P-GTP) was measured in the presence of 80 µM WT or mutant Irga6 at 
37°C. Samples were assayed by TLC and autoradiography. 
The purification of Irga6-∆CD failed because the protein was largely insoluble (data not 
shown). Also the purification of two other truncated forms, Irga6-GD (G-domain; S67-
P252) (soluble, but excluded during size exclusion chromatography) and Irga6-GDL 
(G-domain linker-helix; S67-T267) (largely insoluble), failed (data not shown). 
The αF helix is connected to the αG helix, and the following C-terminal-
domain, by an extensive loop (Figure 39 A), which interestingly is shorter in the GMS 
subfamily (Figure 12). The loop was shortened by eight residues, through the 
replacement of 291LVNIIPSLTF300 by TG (Irga6-∆loop-αFαG). The Irga6-∆loop-αFαG 
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protein was stable and showed no tendency for spontaneous aggregation (data not 
shown). Surprisingly the shortened protein, showed enhanced GTP-dependent 
oligomerisation and GTPase activity (Figure 39 B and C). 
Thus the shortening of the loop arguably promoted, and did not, as anticipated, 
prevent the postulated conformational change, which is suggested to expose the 
oligomerisation-interface (Paragraph III.13). One possible explanation is that the 
shortening of the loop caused an increased strain in the Irga6 structure, which in turn 
potentially reduced the energy required for the postulated opening of the Irga6 structure 
and the exposure of the so far hidden oligomerisation-interface. 
One interesting observation, under the chosen experimental conditions, was that 
WT Irga6 oligomers failed to disassembly completely. But Irga6-∆loop-αFαG showed 
an almost complete disassembly (Figure 39 B), as also observed to a lesser extent for 
the GST-Irga6/GST-Irga6 homodimer, which also showed enhanced GTPase activity 
(Figure 31). This could indicate that the oligomeric form of Irga6 is unstable and has a 
tendency to aggregate or denature, which could be accounted by the exposure of a 
hydrophobic surface. The half-life of the oligomer is shorter in the GTPase enhanced 
Irga6 variants, thus the protein by hydrolysing GTP and disassembling faster, gives less 
time to aggregate or denature. 
III.15. Biochemical characterization of Irgb6 and Irgd 
There are 23 IRG genes in C57BL/6 mouse genome (Bekpen et al., 2005), until now 
only one, Irga6, was studied in detail by biochemical means (Ghosh et al., 2004; Hunn 
et al., 2008; Papic et al., 2008; Uthaiah et al., 2003) and only a limited knowledge about 
Irgm3 (Taylor et al., 1996; Taylor et al., 1997) and Irgb6 is available (Carlow et al., 
1998). The IRGs are divided into the GMS and the GKS subfamily (Boehm et al., 
1998). The GKS subfamily can be further subdivided into the “a”, the “b”, the “c” and 
the “d” group (Bekpen et al., 2005). Thus far no biochemical characterization of the “c” 
and the “d” group members was performed. 
 
Irgb6 and Irgd were expressed in Escherichia coli (E. coli) and purified by glutathione 
affinity chromatography and by size exclusion chromatography. Both proteins behaved 
70 
III. Results 
as circa 50 kDa monomers on size exclusion chromatography in absence of nucleotide 
(data not shown). 
The binding of mant-GDP and mant-GTPγS was measured by equilibrium 
titration. Irgb6 and Irgd both bound mant-GTPγS in the micromolar range (Table 4), 
with affinities comparable to Irga6 (Uthaiah et al., 2003). In contrast to Irga6, which 
showed a roughly tenfold preference for mant-GDP (Uthaiah et al., 2003), Irgb6 and 
Irgd bound mant-GDP and mant-GTPγS with approximately the same affinity (Table 4). 
Table 4. Nucleotide-binding properties of Irgb6 and Irgd. Kd value (µM) measured by equilibrium 
titration. The mean values of two independent experiments are shown. 
protein / nucleotide mant-GDP mant-GTPγS 
Irga6 2.6 ± 0.8 28.5 ± 5.8 
Irgb6 43.8 ± 0.2 34.1 ± 6.8 
Irgd 13.6 ± 0.6 17.7 ± 2.1 
 
As extensively investigated, Irga6 forms complexes in a GTP-dependent manner in vivo 
(Papic et al., 2008) and in vitro (Ghosh et al., 2004; Hunn et al., 2008; Uthaiah et al., 
2003) (and this study). The Irga6 self interaction was also confirmed in a yeast two-
hybrid system (Hunn et al., 2008). Furthermore a self interaction of Irgb6 but not of 
Irgd was also detected (Hunn et al., 2008). Irga6 (Martens et al., 2004), Irgb6 (Hunn et 
al., 2008) and Irgb10 (Coers et al., 2008) also form aggregate-like structures when 
expressed in cells in absence of IFNγ, which was not observed in the case of Irgd 
(Hunn, 2007). 
The ability of Irgb6 and Irgd to form complexes in vitro was investigated. Irga6, 
Irgb6 and Irgd were stable at 20°C (Figure 40 A - C), but all three proteins showed a 
slight tendency to aggregate at 37°C (Figure 40 D - F). Remarkably Irgd was more 
stable in presence of GTP than GDP (Figure 40 F). As expected no GTP initiated 
complex formation was observed in the case of Irgd (Figure 40 C and F). Irgb6 showed 
a slightly GTP accelerated increase in hydrodynamic radius at 37°C (Figure 40 E), but 
no sign of complex formation at 20°C (Figure 40 B). It is unclear whether this slight 
effect represented true complex formation, since it is possible that Irgb6 was simply 
more stable in presence of GDP than GTP at 37°C. From the yeast two-hybrid data 
(Hunn, 2007; Hunn et al., 2008) Irgb6 was expected to self interact, but it needs further 
investigation to clarify if Irgb6 is capable to form homomeric complexes in vitro. 
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The recombinant Irgd and Irgb6 proteins are tagged at the N-terminus with 
GSPGIPGSTT(M) and GLVPRGSPGIPGSTT(M) respectively. Irgb6, N-terminally 
fused to a DNA-binding domain and an activation domain respectively, self interacted 
in a yeast two-hybrid system (Hunn et al., 2008). Still, it cannot be excluded that these 
N-terminal extensions inhibit complex formation, although it is not expected in analogy 
to Irga6. The N-terminal fusion to GST does not inhibit GTP-dependent complex 
formation of Irga6 (Figure 31), and recombinant Irga6 with the N-terminal 
GSPGIPGSTT(M) tag (used in this study) oligomerises to the same extent as tag-less 
protein (data not shown). It is possible that the self interaction of Irgd and Irgb6 requires 
a membrane substrate or another cellular factor. 
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Figure 40. No convincing oligomerisation was observed for Irgb6 and Irgd. Oligomerisation of 50 
µM mutated Irga6, Irgb6 or Irgd was monitored in the presence of 10 mM GDP or GTP by DLS at 20°C 
(A - C) or 37°C ( D - E). 
Irga6 hydrolyses GTP in a cooperative manner (Uthaiah et al., 2003). The cooperativity 
is coupled to complex formation, as shown for the mutants of the catalytic-interface 
(Figure 9; Figure 28; Figure 30). 
The GTP hydrolysis by Irgb6 and Irgd was measured. Irgd showed, as expected 
due to the lack of complex formation (Figure 40 C and F), basal GTP hydrolysis and no 
cooperativity (Figure 41). Irgb6 hydrolysed 1 mM GTP with apparently the same 
kinetics as Irga6 (Figure 41 A), but a substantial difference in hydrolysis efficiency was 
observed at 10 mM GTP. At the higher nucleotide concentration Irga6 hydrolysed the 
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substrate approximately two fold faster than Irgb6 (Figure 41 B). No cooperativity of 
GTP hydrolysis was observed for Irgb6, but the protein displayed a relatively high 
specific activity (Figure 41 C and D). 
No obvious cooperativity was detected for Irga6 at 1 mM GTP (Figure 41 C), 
although the hydrolysis rate was substantially higher than the basal rate of 0.02 min-1 
(Paragraph III.1, III.4 and III.6), suggesting cooperative hydrolysis. A clear 
cooperativity at 10 mM GTP was detected (Figure 41 D). This inconsistency is 
potentially best explained by the different ratio between the GTP substrate and the GDP 
product in the two experiments. In the experiment with 1 mM GTP the level of the 
substrate drops very fast, in addition the reaction is inhibited by the emerging GDP, to 
which Irga6 has an approximately tenfold higher affinity (Uthaiah et al., 2003). This 
unfavorable situation is reached far later in the experiment with 10 mM GTP, the 
reaction is less inhibited by GDP and the cooperativity can be more easily detected. 
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Figure 41. GTPase activity of Irgb6 and Irgd. Hydrolysis of 1 mM (A) or 10 mM (B) GTP (with trace 
amounts of α32P-GTP) was measured in the presence of 50 µM Irga6, Irgb6 or Irgd at 37°C. Samples 
were assayed by TLC and autoradiography. Hydrolysis of 1 mM (C) or 10 mM (D) GTP was measured 
after 30 minutes in the presence of various concentrations of Irga6, Irgb6 or Irgd at 37°C. Samples were 
assayed by TLC and autoradiography. 
III.16. Mutual influences of IRG Proteins on GTPase activity 
Numerous IRG proteins are expressed in mouse cells after stimulation with IFNγ 
(Bekpen et al., 2005; Boehm et al., 1998). It was shown that distinct IRG family 
members can directly interact, and that these interactions are required for the correct 
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function of at least Irga6, Irgb6 and Irgd (Hunn, 2007; Hunn et al., 2008). Among others 
the interaction of Irga6 with Irgb6 and a weak interaction of Irgb6 with Irgd were shown 
by yeast two-hybrid (Hunn et al., 2008). 
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Figure 42. Mutual influences of IRG proteins on GTP hydrolysis. Hydrolysis of 10 mM GTP (with 
trace amounts of α32P-GTP) was measured in the presence of 50 µM Irga6, Irgb6, Irgd or a pair of IRG 
Proteins (50µM + 50µM) at 37°C. Samples were assayed by TLC and autoradiography. 
The GTP hydrolysis by Irga6, Irgb6 and Irgd alone, and of pair wise mixtures of the 
proteins, was measured. The addition of Irgd to Irga6 or Irgb6 had no significant effect 
on the GTP hydrolysis. The total GTP hydrolysis was in the range of Irga6 or Irgb6 
alone (Figure 42). It is difficult to judge from this experiment (Figure 42) whether there 
is an influence of Irgd on GTP hydrolysis by Irga6 or Irgb6, however a small but 
consistent inhibitory effect of Irgd on the GTPase activity was observed in connection 
with Irga6, Irgb6 and GST-Irgm3 in another experiment (Figure 43 A, B and D). 
The mixture of Irga6 and Irgb6 hydrolysed GTP to a comparable extent as Irga6 
alone (Figure 42; Figure 43 A). It is interesting, that although two relatively efficient 
GTPases were combined, in such a way that the total amount of protein was twice as 
high, no increase of total GTP hydrolysis was observed. Remarkably, no accelerated 
GTP hydrolysis was recorded in the experiment with the great excess of GTP substrate, 
not even at early time points where the reciprocal inhibition of the two GTPases by the 
GDP product can be neglected (Figure 42). 
These results imply not only that there might be a negative regulation of Irga6 
and Irgb6 by Irgd, but also that Irga6 is inhibited by the interaction with Irgb6. In case 
of Irga6 the attenuation of complex formation offers a potential explanation for the 
observed inhibitory effect, since Irga6 oligomerisation is required for efficient GTP 
hydrolysis (Uthaiah et al., 2003). Under the assumption that Irga6-Irgb6 and Irga6-Irgd 
heterodimer, which are less active, are formed, it could be argued, that the GTPase 
activity is not accelerated and attenuated respectively because the heterodimer 
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formation competes with homo-oligomerisation of Irga6, while only the latter causes 
accelerated GTP hydrolysis. 
 
The IRG proteins are subdivided into two subfamilies according to their G1-motif 
(Bekpen et al., 2005; Boehm et al., 1998). The GKS subfamily members have the 
common G1-motif (also known as Walker A and Phosphate-binding loop), whereas in 
the GMS subfamily the universally conserved lysine in this motif is replaced by a 
methionine (Bekpen et al., 2005; Boehm et al., 1998). The GMS proteins were shown to 
be required for proper function of Irga6 and Irgb6 (Hunn et al., 2008). Irgm3 was shown 
to interact with Irga6 and Irgb6 in yeast two-hybrid, furthermore the interaction between 
Irgm3 and Irga6 was confirmed by pull-down and co-immunoprecipitation experiments 
(Hunn et al., 2008). 
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Figure 43. Mutual influences of IRG proteins on GTP hydrolysis. Hydrolysis of 1 mM GTP (with 
trace amounts of α32P-GTP) was measured in the presence of 13 µM Irga6, Irgb6, Irgd, GST-Irgm3 or a 
pair of IRG Proteins (13µM + 13µM) at 37°C. Samples were assayed by TLC and autoradiography. 
GST-Irgm3 protein was expressed in E. coli and purified by glutathione affinity 
chromatography and by size exclusion chromatography in a non-aggregated form (data 
not shown). Irgm3 was shown earlier to bind and hydrolyse GTP (Taylor et al., 1996; 
Taylor et al., 1997). Here the GTPase activity of Irgm3 was confirmed (Figure 43 D), 
although the results obtained with GST-Irgm3 must be considered preliminary at that 
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moment. Furthermore, following the example of Irga6, the hydrolytic activity of native 
Irgm3 might be lower that of the GST-Irgm3 fusion (Paragraph III.10). 
The GMS proteins were suggested to work in a GDP dissociation inhibitor 
(GDI)-like manner and to prevent preliminary activation of Irga6 and Irgb6 in vivo 
(Hunn et al., 2008). This raised the question whether Irgm3 negatively influence the 
GTPase activity of Irga6 and Irgb6. Indeed, the addition of GST-Irgm3 to Irga6 and to 
Irgb6 had a substantial inhibitory effect on the GTPase activity (Figure 43 A and B). 
Although in both cases two hydrolytically active GTPases were mixed, so that the total 
GTPase concentration was doubled, the total hydrolytic activity dropped even below the 
level of the slower one (GST-Irgm3) alone (Figure 43 D). The addition of Irgd to Irga6, 
Irgb6 or GST-Irgm3 resulted in a slightly inhibited total GTPase activity (Figure 43 A, 
B and D). 
The initial rate of GTP hydrolysis in the Irga6 GST-Irgm3 experiment is 
somewhat high (Figure 43 A). The interaction of Irga6 with Irgm3 was found to be 
enhanced by addition of GDP (Hunn et al., 2008). It is possible that an efficient 
inhibition of Irga6 by GST-Irgm3 requires a certain quantity of GDP, which is produced 
in course of the experiment. These preliminary results are in agreement with the 
suggested GDI function of the GMS proteins (Hunn et al., 2008). 
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IV. Discussion 
IV.1. Process of Irga6 complex formation 
Irga6 forms oligomers in a GTP-dependent manner and the hydrolysis of the GTP 
substrate is activated in the complexes (Uthaiah et al., 2003). However the process of 
complex formation and the mechanism of GTP hydrolysis activation are not understood. 
 
The mutagenesis study of Irga6 surface residues uncovered the catalytic-interface which 
is the platform for the interaction of Irga6 molecules (Paragraph III.1). The revealed 
surface is part of the G-domain and comprises the nucleotide-binding site, including the 
switch I and II regions (Figure 11). It was shown that the nucleotide is part of the 
interface (Paragraph III.3 and III.8; Figure 16). 
The switch regions are the natural interaction sites of GTPases with effectors 
molecules (Vetter and Wittinghofer, 2001). In general, although with exceptions 
(Goldberg, 1999), GTPase activating proteins (GAPs) interact with target GTPases via 
the nucleotide-binding site (Pan et al., 2006; Rittinger et al., 1997; Scheffzek et al., 
1997; Scrima et al., 2008; Seewald et al., 2002; Tesmer et al., 1997). Taking in account 
that Irga6 molecules act as mutual GAPs (Uthaiah et al., 2003) it is not surprising to 
find the catalytic-interface right there. 
Numerous GTPases (Gasper et al., 2006; Ghosh et al., 2006; Hubbard et al., 
2007; Low and Lowe, 2006; Scrima and Wittinghofer, 2006; Sirajuddin et al., 2007; 
Sun et al., 2002) and also ATPases (Daumke et al., 2007; Leonard et al., 2005; 
Schindelin et al., 1997) were found to form complexes via the interaction of two 
nucleotide-binding domains, whereby the bound nucleotides are not contacting each 
other. In contrast the signal recognition particle (SRP) GTPases form G-domain to G-
domain dimer so that the two bound nucleotides interact directly in an antiparallel 
fashion (Bange et al., 2007; Egea et al., 2004; Focia et al., 2006; Focia et al., 2004; 
Gawronski-Salerno and Freymann, 2007). 
Multiple common structural and biochemical features between the SRP GTPases 
and Irga6 led to the construction (Figure 13) of a model of the catalytic-Irga6-dimer 
based on the relative orientation of the two nucleotides buried in the SRP-SRα complex 
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(Paragraph III.2). The obtained mutagenesis data is consistent with the proposed model 
(Figure 15). The key for the mutual GAP activation of GTP hydrolysis by SRP and SRα 
in the dimeric complex is the reciprocal trans interaction between the 3'hydroxyl of the 
GTP ribose and the γ-phosphate of the two nucleotides (Egea et al., 2004). In analogy to 
the SRP-SRα system (Egea et al., 2004) it was shown that the 3'hydroxyl is absolutely 
required for complex formation and GTP hydrolysis by Irga6 (Paragraph III.4; Figure 
17), and this in trans only (Paragraph III.5; Figure 18). Furthermore Irga6 resembles 
SRP (Shan and Walter, 2005b) in the context of blocking of complex formation by 
XTP, which further confirms that the nucleotide is part of the interaction interface 
(Paragraph III.8; Figure 26). 
 
The interaction interface of two Irga6 molecules is completed by the binding of GTP. 
Furthermore the nucleotide binding induces conformational changes, foremost in the 
switch I and II regions (Ghosh et al., 2004) (Figure 19; Figure 44). The switch I, 
including Glu106, is brought into an orientation with is compatible with the formation 
of the catalytic-Irga6-dimer as suggested by the model (Figure 20). Remarkably, due to 
the switch I conformation, the nucleotide-binding pocket is more open in the GppNHp 
than in the GDP state (Ghosh et al., 2004). This finding is consistent both with the lower 
affinity of triphosphate-nucleotides and with the anticipated trans interaction of the 
3'hydroxyl and the γ-phosphate, and reminiscent of the SRP GTPases (Moser et al., 
1997; Shan et al., 2004). The model of the catalytic-Irga6-dimer implies the following 
scenario of complex formation, although not necessarily in the given order: 
(i) The 3'hydroxyl contacts the γ-phosphate, Thr78 and Glu106 in trans 
(Figure 20 A; Figure 22 A). The interactions bring the Glu106 and the 
γ-phosphate in the relative orientation required for catalysis. The 
interactions are potentially involved in the stabilization of the switch I 
(Glu106) and of the P-loop (Thr78) (Figure 44). Glu106 and Thr78 
were found to be involved in complex formation (Figure 21 A; Figure 
22 B). 
(ii) The exocyclic amino-group of the nucleotide guanine ring at the C2 
position interacts in trans with Glu77 and Ser132 (Figure 27 A). The 
interactions potentially further stabilize the switch II (Ser132) and the 
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P-loop (Glu77) (Figure 44). Glu77, Ser132 and the C2 amino-group of 
the guanine ring were found to be involved in complex formation 
(Figure 9 A; Figure 26 A; Figure 28 A). 
(iii) During the complex assembly the conformation of Irga6 is suggested 
to be further modified, as also observed on formation of the SRP-SRα 
complex (Egea et al., 2004; Focia et al., 2004). Arg159 is thought to 
be reoriented and inserted into the pocket formed by 77ETGS80 and 
155ISATRFKKN163, to form a salt bridge with Asp164 in trans 
(Figure 29). Formation of a salt bridge between Arg159 and Glu77 in 
trans is also possible (Figure 29; Figure 44). The interactions 
potentially stabilize the P-loop (77ETGS80) (Figure 44) and could 
initiate further conformational changes which expose the 
oligomerisation-interface (Paragraph III.9) that is believed not to be 
present on the surface of monomeric Irga6 (Paragraph III.13). 
Arg159, Asp164 and Glu77 were found to be involved in complex 
formation (Figure 30 A and B; Figure 28 A). 
(iv) The interaction of two G-domains via the nucleotide-binding site 
buries the two substrate molecules in the complex (Figure 15); bulk 
water is sequestered from the catalytic center. 
 
Complex formation is required for cooperative GTP hydrolysis by Irga6 (Uthaiah et al., 
2003). However it is not clear if a dimeric complex is sufficient for the implementation 
of the GAP function, or whether a higher order oligomeric complex must be formed. 
Therefore it is possible that some of the above suggested events occur only when the 
oligomeric stage is reached. In addition to the suggested changes, further 
conformational rearrangements might be required for the activation of GTP hydrolysis 
that cannot be directly extrapolated from the catalytic-Irga6-dimer model. 
The N-terminal region of Irga6 undergoes GTP-dependent conformational 
rearrangements (N-terminal switch), which require N-terminal myristoylation, and are 
anticipated to expose the myristoyl-group (Papic et al., 2008). An unresolved issue 
concerns the order of events; Irga6 oligomerisation as well as the N-terminal switch 
require GTP binding (Papic et al., 2008; Uthaiah et al., 2003). Is the N-terminal switch a 
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product of GTP binding to monomeric Irga6 or is the N-terminal switch a product of 
conformational changes which occur in Irga6 during complex formation? Recombinant 
non-myristoylated Irga6 purified from Escherichia coli (E. coli) is incapable of 
undergoing this N-terminal conformational rearrangement correctly (Papić, 2007; Papic 
et al., 2008). Although the correct N-terminal switch is not required for cooperative 
GTP hydrolysis (Uthaiah et al., 2003), it is clearly relevant for the hydrolytic 
mechanism; myristoylated Irga6 in contrast to non-myristoylated protein can hydrolyse 
GDP further to GMP in virto (Papić, 2007) (Natasa Papic, unpublished results). 
It is probably that Irga6 complex formation in vivo occurs to myristoylated 
protein on a membrane substrate, due to the fact that active GTP-bound protein is found 
on the Toxoplasma gondii (T. gondii) parasitophorous vacuole membrane (PVM) 
(Martens et al., 2005; Papic et al., 2008). The potential effects of membrane binding on 
conformational rearmaments of Irga6 and on the catalysis are a further mystery. 
IV.2. Mechanism of Irga6 GTP hydrolysis activation 
It is broadly accepted that nucleotide hydrolysis in GTPases occurs via an in-line 
nucleophilic attack (SN2) of a water molecule on the γ-phosphate, however the identity 
of the general base which activates the catalytic water and the nature of the transition 
state is still under debate (Langen et al., 1992; Li and Zhang, 2004; Maegley et al., 
1996; Pai et al., 1990; Pasqualato and Cherfils, 2005; Schweins et al., 1995; Schweins et 
al., 1994; Schweins et al., 1997; Schweins and Warshel, 1996; Wittinghofer, 2006). 
 
Ras is by far the best investigated GTPase in context of structure and GTP hydrolysis, 
and therefore often serves as a model, although there are reasons to believe that the 
regulative system, with external GAPs and guanine nucleotide exchange factors (GEFs), 
observed in the Ras superfamily represents a highly evolved and specialized rather that 
a common case (Daumke et al., 2004; Gasper et al., 2009; Martens and Howard, 2006; 
Shan et al., 2009). 
Ras is an inefficient GTPase, that is highly activated by the interaction with 
RasGAP (Bollag and McCormick, 1991; Eccleston et al., 1993; Gibbs et al., 1988; 
Gideon et al., 1992; Trahey et al., 1988). One key component of Ras / RasGAP 
mediated GTP hydrolysis is Gln61Ras, its role in the positioning of the catalytic water 
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for the attack on the γ-phosphate is unambiguous (Scheffzek et al., 1997; Schweins et 
al., 1995; Trahey and McCormick, 1987). In earlier days it was suggested that this 
residue is the general base that activates the catalytic water (Pai et al., 1990), supported 
by the finding that the Q61ERas mutation accelerated the intrinsic hydrolysis rate of Ras 
20-fold (Frech et al., 1994). However the corresponding mutation in Rap was found to 
inhibit hydrolysis (Scrima et al., 2008). Glutamine is a poor base; recently a model was 
established in which the γ-phosphate of the GTP substrate acts a general base and 
abstracts a proton from the catalytic water (Langen et al., 1992; Pasqualato and Cherfils, 
2005; Schweins et al., 1995; Schweins et al., 1994; Schweins et al., 1997). A model 
exists for Gtα, in which the catalytic glutamine works as a proton shuttle in a 
concentrated mechanism; the glutamine is suggested to abstract a proton from the 
attacking water while simultaneously donating a proton to the γ-phosphate (Sondek et 
al., 1994). Alternative mechanisms were anticipated in the case of myosin, on one hand 
a serine residue was proposed to shuttle a proton between the catalytic water and the γ-
phosphate (Fisher et al., 1995), on the other hand it was suggested that a proton from the 
attacking water molecule is transferred to a second water molecule, converting it into a 
hydronium ion (Onishi et al., 2004). 
The other key component of Ras / RasGAP mediated GTP hydrolysis is an 
arginine residue (so-called arginine-finger) which is supplied in trans by RasGAP. The 
positively-charged side chain interacts with the γ-phosphate and the γ/β-phosphate 
bridging oxygen, the backbone with Gln61Ras. The arginine-finger is believed to 
stabilize the transition state (Scheffzek et al., 1997). 
There is a controversy about the nature of the transition state. In the associative 
model the bond between the catalytic water and the γ-phosphate is formed before the 
linkage between the γ- and β-phosphate is broken; in the dissociative model the order of 
events is inverted. During the GTPase reaction one negative charge of the γ-phosphate 
is transferred to the β-phosphate. In the associative transition state the negative charge 
accumulates on the non-bridging atoms of the γ-phosphate, whereas in the dissociative 
transition state the largest accumulation of negative charge occurs on the γ/β-phosphate 
bridging oxygen (Li and Zhang, 2004; Maegley et al., 1996; Wittinghofer, 2006). 
There is a parallel argument about the role of the arginine-finger in the GTPase 
reaction. In the associative model the arginine-finger stabilizes the negative charge 
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which develops on the γ-phosphate. In contrast, in the dissociative model the main role 
in the GTPase reaction is played by the backbone amide of Gly13Ras, from the P-loop 
(GxxXxGKS/T), by donating a hydrogen bond to the γ/β-phosphate bridging oxygen. In 
this scenario the main function of the arginine-finger is the stabilization of Gln61Ras, 
and in addition donation of a hydrogen bond to the γ/β-phosphate bridging oxygen 
(Maegley et al., 1996). Evidence comes from the mutation of Ala30Rab5a (corresponds to 
Gly13Ras) to proline, it was found that this mutation has the lowest hydrolysis rate of all 
possible mutants of this residue, so low that even a GTP containing crystal structure of 
Rab5a-A30P was obtained (Zhu et al., 2003). 
The associative and the dissociative models represent two extreme cases; it is 
likely that there exists a continuum of electronic configurations of the transition state, 
which potentially vary from enzyme to enzyme (Li and Zhang, 2004; Wittinghofer, 
2006). Indeed, the catalytic arginine interacts with the γ-phosphate as well as with the 
γ/β-phosphate bridging oxygen in the Ras, Rho and Giα1 system (Rittinger et al., 1997; 
Scheffzek et al., 1997; Tesmer et al., 1997), and is therefore in a proper position to 
stabilize either an associative or dissociative transition state. 
 
GAPs work in two fashions, by supplementation of missing catalytic residues (arginine-
finger; asparagine-thumb) (Daumke et al., 2004; Pan et al., 2006; Rittinger et al., 1997; 
Scheffzek et al., 1997; Scrima et al., 2008), and by reorientation and stabilization of the 
catalytic machinery which is already present in the target protein (Noel et al., 1993; 
Scheffzek et al., 1998; Seewald et al., 2002; Tesmer et al., 1997). The latter seems to be 
the case in Irga6. The model of the catalytic-Irga6-dimer suggests that the switch 
regions are stabilized by the interaction of the two Irga6 molecules (Paragraph IV.1), a 
function that is also mediated by classical GAPs (Scheffzek et al., 1998; Vetter and 
Wittinghofer, 2001). In particular the model suggests that Glu106 (switch I) is stabilized 
by the trans interaction with the 3'hydroxyl (Figure 20 A). Mutational analysis of 
Glu106 (switch I) (Figure 21) together with structural data (Figure 19 B; Figure 44 C) 
(Ghosh et al., 2004) strongly suggest that this residue activates a water molecule for the 
nucleophilic attack onto the γ-phosphate and is therefore crucial for the activation of 
GTP hydrolysis. The E106Q mutation was found to annihilate GTP hydrolysis 
activation (Figure 21); mutation of the catalytic glutamate to glutamine in an ABC 
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transporter resulted in hydrolysis deficient protein (Moody et al., 2002; Smith et al., 
2002). The finding that the 3'hydroxyl is essential for activation of GTP hydrolysis in 
trans (Figure 18) is consistent with the anticipated function of Glu106. 
Glu77 is also localised relatively close to the γ-phosphate (Figure 44), but its 
role as a general base that activates the catalytic water can be excluded (Figure 28). 
Thr108 was also suggested to be the catalytic residue (Ghosh et al., 2004). Thr108 was 
found close to the γ-phosphate in one of the crystal structures (Ghosh et al., 2004) 
(Figure 44 B). Although in the light of the results obtained for Glu106 (Figure 21) the 
suggested catalytic role of Thr108 appears unlikely, it cannot be excluded, due to the 
finding that mutations of this residue have a dramatic effect on complex formation and 
GTP hydrolysis (Lan Tong, unpublished results). In the case of human guanylate-
binding protein 1 (hGBP1) a serine residue from the switch I was suggested to activate 
the catalytic water (Ghosh et al., 2006). 
On complex formation between SRP-SRα three catalytic residues (aspartate, 
arginine and glutamine) of the switch I region, become reoriented in cis and facilitate 
GTP hydrolysis. The aspartate is suggested to activate the catalytic water molecule, the 
arginine coordinates the γ-phosphate, the glutamine coordinates the β-phosphate and the 
Mg2+ ion (Egea et al., 2004; Shan et al., 2004). Interestingly aspartate and glutamate 
residues were found to activate the catalytic water in other dimer forming GTPases 
(Gasper et al., 2006; Hubbard et al., 2007; Scrima and Wittinghofer, 2006) as also in 
ATPases (Bowler et al., 2007; Hung et al., 1998; Leipe et al., 2002; Leonard et al., 
2005; Schindelin et al., 1997). 
Although the Gln61Ras is the key component of Ras mediated GTP hydrolysis, it 
seems that its, partial (Bi et al., 2002; Schwartz and Blobel, 2003), dominance is 
restricted to classical Ras-like GTPases, due to a large number of GTPases (including 
immunity-related GTPases (IRGs), dynamin, Mx Proteins, GBPs and SRP) in which the 
corresponding residue in the switch II is replaced, usually by a hydrophobic residue 
which is facing away from the bound nucleotide (Leipe et al., 2002; Mishra et al., 
2005). 
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Figure 44. The active site of Irga6. View of the nucleotide-binding region of Irga6 (ribbon 
presentation). Nucleotides and the residues Thr75, Glu77, Thr78, Ser80, Lys82, Ser83 (residues 76 - 83; 
G1-motif), Ser84, Thr102, Glu106, Thr108, Asp126 (residues 126 - 129; G3-motif), Ile130 (corresponds 
to Gln61Ras), Ser132, Arg159, Asp164, Thr183, Lys184, Asp186 (residues 183 - 186; G4-motif), Ser231, 
Asn232 and Lys233 (residues 231 - 233; G5-motif) are shown as atomic stick figures. The backbone of 
the residues Gly76, Gly79, Gly81 and Gly129 is marked in blue. The switch I (residues 100 - 109) region 
and switch II (residues 126 - 132) region are marked in purple and green respectively. The following 
crystal structures are shown. WT Irga6 crystal-dimer with bound GppNHp (introduced into apo-protein 
crystals) (PDB 1TQ2) (Ghosh et al., 2004); subunit 1 (A), subunit 2 (B). Irga6 crystal-dimer-interface 
mutant M173A with bound GppNHp (PDB 1TQ6) (Ghosh et al., 2004) (C). WT Irga6 crystal-dimer with 
bound GDP (PDB 1TPZ) (Ghosh et al., 2004); subunit 1 (D), subunit 2 (E). Irga6 crystal-dimer-interface 
mutant K48A with bound GDP (PDB 1TQ4) (Ghosh et al., 2004) (F). WT apo-Irga6 crystal-dimer (PDB 
1TQD) (Ghosh et al., 2004); subunit 1 (G), subunit 2 (H). 
The catalytic-Irga6-dimer model does not propose any positively-charged residue, 
which could fulfil an arginine-finger-like function. The mutation of the most promising 
candidate, Lys101 in switch I, to glutamate showed no effect on complex formation and 
GTP hydrolysis (Figure 9). 
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It was proposed that the major contribution to catalysis is made by the Mg2+ ion 
and the P-loop lysine (Vetter and Wittinghofer, 2001). It was shown that neither the 
Mg2+ ion (Hunn, 2007) nor Lys82 (Hunn et al., 2008) are essential for nucleotide 
binding, but both components are crucial for GTP hydrolysis by Irga6 (Hunn et al., 
2008; Uthaiah et al., 2003). 
The non essentiality of an arginine-finger-like residue was demonstrated for Ran 
and Rap. Remarkably a tyrosine hydroxyl was found in both cases to interact with the γ-
phosphate, and in addition with the catalytic glutamine in the case of Ran (Scrima et al., 
2008; Seewald et al., 2002). The interactions recall the proposed trans interactions of 
the 3'hydroxyl with the γ-phosphate and Glu106 in the catalytic-Irga6-dimer model 
(Figure 20 A). 
The dissociative model suggests that the transition state is stabilized by 
hydrogen bond donation to the atoms where the highest negative charge accumulates 
(Maegley et al., 1996). In the case of Irga6 the backbone amide of Gly79 would donate 
a hydrogen bond to the γ/β-phosphate bridging oxygen. The transition state in Irga6 
could in general be stabilized by hydrogen bond donation; an interesting feature of the 
Irga6 P-loop is that all backbone amide-groups are oriented towards and the backbone 
oxo-groups face away from the phosphates of the bound nucleotide. Hydrogen bonds 
could be donated to the γ-phosphate from the side chain of Thr78 and Lys82, also from 
the backbone amide of Gly103, and, according to the catalytic-Irga6-dimer model, in 
addition from the 3'hydroxyl in trans. The γ/β-phosphate bridging oxygen could receive 
hydrogen bonds from the side chain of Ser80 and the backbone amide of Gly79. The β-
phosphate could be supplied with hydrogen bonds from the side chains of Ser80, Ser83, 
Ser84 and Thr102, furthermore from the backbone amide-groups of Lys82, Ser83, 
Gly81 and Ser84. Additional hydrogen bonds could be offered from Mg2+-coordinated 
water molecules, and, according to the catalytic-Irga6-dimer model, also from water 
molecules which potentially bridge the opposed nucleotides as observed in the SRP-SRα 
complex (Egea et al., 2004; Focia et al., 2004). 
 
Recombinant non-myristoylated Irga6 purified from bacteria hydrolyses GTP to GDP 
(Uthaiah et al., 2003). Remarkably recombinant myristoylated Irga6 purified from 
85 
IV. Discussion 
insect cells hydrolyses GTP to GDP and GMP, whereby GDP also serves a substrate 
(Papić, 2007) (Natasa Papic, unpublished results). 
hGBP1 hydrolyses GTP in two constitutive steps to GDP and GMP; although 
GDP does not serve as a substrate for the full length protein, it is a substrate for the 
isolated G-domain (Ghosh et al., 2006; Schwemmle and Staeheli, 1994). hGBP1 forms 
complexes in presence of GppNHp and GDP-AlFx, but as in the case of non-
myristoylated Irga6 no GDP-dependent complex formation was observed (Prakash et 
al., 2000a; Uthaiah et al., 2003). 
At present it is not known if myristoylated Irga6 forms nucleotide-dependent 
complexes; it is also not clear if a basal or the activated hydrolysis was measured 
(Natasa Papic, personal communication). The catalytic-Irga6-dimer model does not 
offer a useful explanation for the observed GMP production. It would be interesting to 
know what effects mutations of the catalytic-interface would produce on nucleotide 
hydrolysis by myristoylated Irga6. 
IV.3. Mechanism of Irgm3 GTP hydrolysis 
Among the IRG family, the so-called GMS proteins, displays a unique substitution of 
the elsewhere universally conserved P-loop lysine (Henriksen et al., 2005; Iyer et al., 
2004; Leipe et al., 2003; Leipe et al., 2002; Saraste et al., 1990; Walker et al., 1982) to 
methionine (Bekpen et al., 2005; Boehm et al., 1998). Irgm3, a member of the GMS 
subfamily, was shown to bind and hydrolyse GTP (Taylor et al., 1996; Taylor et al., 
1997) and Irgm1 may also show GTPase activity (Taylor et al., 1996). This is surprising 
in the light of findings made for mutants of other nucleotide-binding proteins, in which 
the P-loop lysine was replaced by a methionine, where the nucleotide binding was 
mostly preserved but the nucleotide hydrolysis was annihilated (Henriksen et al., 2005; 
Krell et al., 2001; Lapinski et al., 2001; Muller et al., 1996; Ozvegy-Laczka et al., 2005; 
Ozvegy et al., 2002; Szabo et al., 1998; Vertommen et al., 1996). 
 
First preliminary results confirm the finding (Taylor et al., 1996) of Irgm3 being a 
GTPase (Figure 43 D). The GMS proteins have, in addition to the P-loop methionine, 
unique substitutions compared with other IRGs (Figure 12) (Bekpen et al., 2005; Hunn, 
2007). This suggests that GMS proteins employ a distinct GTP hydrolysis mechanism. 
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A homology model of the Irgm3 G-domain was constructed on the basis of Irga6 
(Figure 45 A). Although this model is a very limited source of information, it may help 
to understand the differences between GMS and GKS type proteins. In the model the 
nucleotide guanine base is sandwiched between Phe243Irgm3 (G5-motif) and Lys200Irgm3 
(G4-motif); Asp202Irgm3 (G4-motif) interacts with the amide (N1 position) and the 
amino-group (C2 position). The Mg2+ ion is coordinated by Asp142Irgm3 (G3-motif), 
Ser98Irgm3 (G1-motif) and the γ- and β-phosphate of the nucleotide. The conformation of 
the P-loop Met98Irgm3 resembles Lys82Irga6 (G1-motif); the side chain sulphur of 
Met98Irgm3 contacts the γ-phosphate. 
The Asn95Irgm3 (G1-motif) corresponds to Ser80Irga6 and is conserved in the 
GMS proteins. (Figure 12) (Bekpen et al., 2005; Hunn, 2007), this residue could donate 
hydrogen bonds to the γ- and β-phosphate but also to the γ/β-phosphate bridging 
oxygen. Gly94Irgm3 (G1-motif) corresponds to Gly79Irga6 and is in position to donate a 
hydrogen bond to the γ/β-phosphate bridging oxygen. Therefore Asn95Irgm3 and 
Gly94Irgm3 could stabilize the transition state, according to the dissociative model 
(Maegley et al., 1996). The transition state could be further stabilized by hydrogen 
bonds from Ser93Irgm3 (G1-motif), S98Irgm3 (G1-motif), Thr117Irgm3 (switch I), 
Thr122Irgm3 (switch I) and Thr123Irgm3 (switch I). 
Interesting is the position of Arg121Irgm3, which corresponds to Glu106Irga6, it 
contacts the γ-phosphate; due to its location in the flexible switch I region it is 
imaginable that it could even shift to contact the γ/β-phosphate bridging oxygen as well. 
Remarkably this residue is conserved as an arginine or a lysine in the GMS proteins 
(Figure 12) (Bekpen et al., 2005; Hunn, 2007), which would be in agreement with a 
arginine-finger-like function. 
There is no outstanding candidate for the positioning of the catalytic water, the 
best applicants are Asp92Irgm3 (G1-motif) and the switch I threonines. The Asp92Irgm3 
corresponds to Glu77Irga6, which was shown not to be the catalytic residue in Irga6 
(Figure 28). But it is obvious that the proposed hydrolytic mechanism of Irga6 
(Paragraph IV.2) and Irgm3 differ substantially. It is furthermore imaginable that a 
group from the protein backbone could position the catalytic water, and also Arg121Irgm3 
cannot be excluded to fulfill this function. 
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Figure 45. Homology model of Irgm3. A homology model of the Irgm3 G-domain (Arg82 - Phe262) 
was created with SWISS-MODEL (Arnold et al., 2006; Guex and Peitsch, 1997; Kopp and Schwede, 
2004; Schwede et al., 2003) based on the G-domain (Ser67 - Pro252) of the Irga6-M173A crystal 
structure (PDB 1TQ6) (Ghosh et al., 2004). (A) View of the nucleotide-binding region of the Irgm3 G-
domain homology model (ribbon presentation). GppNHp and the residues Thr90, Asp92, Ser93, Asn95, 
Met97, Ser98 (residues 91 - 98; G1-motif), Ser99, Thr117, Arg121, Thr122, Thr123, Asp142 (residues 
142 - 145; G3-motif), Leu146 (corresponds to Gln61Ras), His190, Thr199, Lys200, Asp202 (residues 199 
- 202; G4-motif), Arg203, Ser241, Cys242 and Phe243 (residues 241 - 243; G5-motif) are shown as 
atomic stick figures. The backbone of the residues Gly91, Gly94, Gly96 and Gly145 is marked in blue. 
The switch I (residues 115 - 124) region and switch II (residues 142 - 148) region are marked in purple 
and green respectively. (B) A hypothetical model of an Irga6 Irgm3 heterodimer was constructed. The 
Irgm3 G-domain homology model was superimposed on one molecule of the catalytic-Irga6-dimer model 
(Figure 15). Closeup views of the nucleotide-binding regions involved in formation of the heterodimer 
(ribbon presentation). The Irga6 crystal-dimer-interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) 
is shown in green. The Irgm3 G-domain homology model is shown in red. Nucleotides, Glu77Irga6, 
Thr78Irga6, Glu106Irga6, Ser132Irga6 and Arg203Irgm3 are shown as atomic stick figures. 
IV.4. Nature of the Irga6 Irgm3 interaction 
Irga6 forms GTP-dependent homomeric complexes in vitro (Uthaiah et al., 2003) and in 
vivo (Papic et al., 2008). The mant substitution of the GTP ribose was shown to prevent 
Irga6 self interaction of recombinant purified protein in vitro (Figure 16) as well as 
cellular protein ex vivo (Papić, 2007). 
Furthermore heteromeric nucleotide-dependent interactions between Irga6 and 
other members of the IRG family were shown (Hunn et al., 2008). Irga6 interacts with 
Irgm3 in a GDP-dependent manner in vitro and in vivo (Hunn et al., 2008). Enhanced 
pull-down of cellular Irgm3 by recombinant GST-Irga6 was observed in presence of 
GDP, which was diminished in presence of mant-GDP (Hunn, 2007; Papić, 2007). This 
result indicates that the interaction between Irga6 and Irgm3 involves the bound 
nucleotide and occurs via the catalytic-interface. 
 
Irgm3 was shown to prevent the premature activation of Irga6 and Irgb6 in vivo prior to 
infection. In the light of the GDP-enhanced interaction of Irga6 and Irgm3, a GDP 
dissociation inhibitor (GDI)-like function of GMS proteins in respect to the GKS 
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proteins was proposed (Hunn et al., 2008). The complex formation of Irga6 molecules 
via the catalytic-interface (Paragraph III.1) is a GTP-dependent process and of GAP 
nature (Uthaiah et al., 2003). It is arguable that the GDP-dependent interaction between 
Irga6 (GKS) and Irgm3 (GMS) occurs also via the catalytic-interface (Hunn, 2007; 
Papić, 2007) and is of a GDI nature (Hunn et al., 2008). Two different functions seem to 
be mediated through the same interface. In this context it is important to recognize that 
although the catalytic-interface is the most conserved part of the Irga6 surface (Figure 
10), it contains specific substitutions in the GMS group (Figure 12) (Bekpen et al., 
2005; Hunn, 2007) which potentially are indicative for the different mode of interaction. 
Notable is that the three residues, Glu106Irga6, Arg159Irga6 and Asp164Irga6, which are 
considered important for Irga6 self interaction and GTP hydrolysis, are substituted by 
arginine, glutamine and histidine respectively in GMS proteins (Figure 12); the 
corresponding mutations in Irga6 (E106R, R159Q and D164H) have deleterious effects 
on GTP-dependent complex formation and hydrolysis activation (Figure 21; Figure 30). 
 
First preliminary results showed that GTP hydrolysis by Irga6 and Irgb6 is inhibited by 
Irgm3 (Figure 43 A and B). In the light of that in the experiments two GTP hydrolysing 
enzymes were combined (Irga6 plus Irgm3; Irgb6 plus Irgm3), so that the amount of 
active sites doubled, it is astonishing that the total hydrolytic activity of the system 
dropped significantly (Figure 43 A and B). The total hydrolytic activity, of the two 
combined GTPases (Figure 43 A and B), was even slightly lower, than the hydrolytic 
activity of the slower one (Irgm3) when assayed alone (Figure 43 D). The most 
plausible explanation for this observation is that there were direct inhibitory interactions 
between the combined enzymes. The observations made are in agreement with the 
proposed inhibitory GDI mode of action of GMS proteins (Hunn et al., 2008). 
In this context an interesting observation was made in the Der protein that 
contains two adjacent G-domains (Hwang and Inouye, 2001). Mutations that are 
expected to reduce nucleotide binding were introduced into either of the two G-
domains. The mutation of the G-domain-1 significantly decreased, whereas the 
mutation of the G-domain-2 slightly increased the GTPase activity of the tandem 
protein (Robinson et al., 2002). The individual G-domains were shown to have GTPase 
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activity (Robinson et al., 2002). Therefore one Der subunit may be acting as a negative 
regulator of the other. 
 
The homology model of the Irgm3 G-domain was superimposed on one subunit of the 
catalytic-Irga6-dimer model. The constructed model of the Irga6 Irgm3 heterodimer 
(Figure 45 B) contains two GppNHp nucleotides, however it appears probable that Irga6 
is GDP and Irgm3 GTP bound in this complex. GDP enhanced Irga6 Irgm3 complex 
formation; whereas GTPγS had an inhibitory effect (Hunn, 2007; Hunn et al., 2008; 
Papić, 2007; Papic et al., 2008), potentially by promoting Irga6 self interactions. It was 
shown that resting Irga6 is in the inactive GDP-bound state in vivo (Hunn et al., 2008; 
Papic et al., 2008); Irgm3 was found to be mostly bound to GTP, and therefore 
suggested to be active (Taylor et al., 1997), in interferon-γ (IFNγ) stimulated cells. 
Moreover Irgm3 GTP complexes were successfully immunoprecipitated from IFNγ 
stimulated cells (Taylor et al., 1997). This is a very surprising finding in the light of the 
low nucleotide-binding affinity of Irga6 (Uthaiah et al., 2003), Irgb6 and Irgd (Table 4), 
which was shown, in the case of Irga6, to be caused by a high nucleotide dissociation 
rate (Uthaiah et al., 2003). The nucleotide-binding affinities of GMS proteins were not 
determined. The most straightforward explanation would be a high nucleotide-binding 
affinity of Irgm3, like found for example in Ras (Bourne et al., 1991; Vetter and 
Wittinghofer, 2001). However while Ras requires a GEF for GDP GTP exchange 
(Bourne et al., 1991; Vetter and Wittinghofer, 2001), GST-Irgm3 was found to be 
capable to multiple rounds of GTP hydrolysis in absence of an external GEF (Figure 43 
D); this implies a low nucleotide-binding affinity. The other plausible explanation is 
that GTP was trapped inside of a, not necessarily homomeric, complex, in which two G-
domains interacted face to face by the nucleotide-binding site, as proposed for IRG 
proteins (Paragraph III.2) (Hunn, 2007; Papić, 2007). In such a complex it is plausible 
that nucleotide may not be lost during the immunoprecipitation. 
The conspicuous feature of the constructed Irga6 Irgm3 heterodimer model is 
the entering of Arg203Irgm3 into the active site of Irga6, in particular Glu77Irga6, 
Thr78Irga6 and Glu106Irag6 are in close proximity of the guanidinium-group of 
Arg203Irgm3 (Figure 45 B). Arg203Irgm3 is located directly after the G4-motif (Figure 45 
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A) and is conserved in the GMS proteins (Figure 12) (Bekpen et al., 2005; Hunn, 2007). 
One may speculate that Arg203Irgm3 modulates the active site of Irga6 in trans. 
One missing feature of the heterodimer model is the absence of a trans 
interaction which could replace the proposed trans interaction of Arg159Irga6 and 
Asp164Irga6 of the catalytic-Irga6-dimer model. This is consistent with the suggested 
inhibitory interaction of Irga6 and Irgm3 which prevents the premature activation of 
Irga6 in vivo (Hunn et al., 2008). It is suggested that the trans interaction between 
Arg159Irga6 and Asp164Irga6 is involved in induction of a conformational change that 
exposes the oligomerisation-interface (Paragraph III.9 and III.13). 
 
A model could be considered in which a complex between a GDP-bound GKS protein 
and a GTP-bound GMS protein is formed. The half-life of the complex, and duration of 
the GKS protein inhibition, could be controlled by the GTP hydrolysis rate of the GMS 
partner. The specific modifications of the catalytic-interface in GMS proteins (Figure 
12), in relation to GKS proteins, might potentially facilitate complex formation with 
inactive GDP-bound GKS proteins. 
 
In context of regulative interactions the four predicted tandem IRG proteins (Irgb2-
Irgb1, Irgb5-Irgb3, Irgb5-Irgb4 and Irgb9-Irgb8), encoded by the C57BL/6 mouse 
genome (Bekpen et al., 2005; Hunn, 2007) (Jing Tao Lilue, unpublished results), are of 
interest. The predicted proteins consist of two IRG subunits in a tail to head 
conformation. Remarkably in all upstream subunits (Irgb2, Irgb5 and Irgb9) the residue 
corresponding to Glu106Irga6, which is suggested to activate the catalytic water 
(Paragraph IV.2), is replaced by histidine (Figure 12) (Bekpen et al., 2005). The 
corresponding mutation E106H in Irga6 causes a loss of GTP hydrolysis activation but 
not of complex formation (Figure 21). However this histidine in the upstream subunits 
of the tandem must not necessarily interfere with hydrolysis; a histidine residue was 
shown to activates the catalytic water in EF-Tu (Daviter et al., 2003), SRβ (Schwartz 
and Blobel, 2003) and Sar1 (Bi et al., 2002). Nevertheless this modification represents a 
serious alteration of the catalytic mechanism defined for Irga6. Still even hydrolytically 
inactive upstream subunits could have regulatory functions (Daumke et al., 2004). 
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IV.5. Function of the catalytic-interface in immunity 
IRG proteins are powerful agents of resistance against intracellular pathogens (Martens 
and Howard, 2006; Taylor, 2007), but their mode of function remains obscure. In IFNγ 
stimulated cells Irga6 colocalises with the endoplasmic reticulum (ER) (Martens et al., 
2004); upon infection with T. gondii the protein accumulates in large amounts on the 
PVM (Martens et al., 2005). Destruction of the PVM and of the parasite itself (Ling et 
al., 2006; Martens et al., 2005; Melzer et al., 2008; Zhao et al., 2009b; Zhao et al., 2008) 
was observed in cells, with activated expression of the IRG proteins. Furthermore 
colocalisation of Irga6 and the T. gondii PVM protein GRA7 was reported at vesicular 
structures next to disrupted sites of the PVM (Martens et al., 2005). Overexpression of 
Irga6 accelerated the PVM destruction, whereas a dominant negative variant of the 
protein restrained the process in IFNγ stimulated cells (Martens et al., 2005). The IRG 
proteins are related to large dynamin-like GTPases in some respects (Martens and 
Howard, 2006; Taylor, 2007). Dynamin forms oligomeric ring-like structures and is 
involved in vesicle budding during the process of endocytosis (Praefcke and McMahon, 
2004). 
 
Nothing is known about of how the process of Irga6 oligomer formation is linked to 
immunity against pathogens. This issue was addressed in the context of the well 
established accumulation of Irga6 at the T. gondii PVM (Martens et al., 2005). Irga6 
deficient mouse embryonic fibroblasts (MEFs) stimulated with IFNγ and transiently 
transfected with WT or mutant Irga6 were infected with an avirulent T. gondii strain. 
WT Irga6 accumulated to a large extent on the PVM, while all but one mutant (K162E) 
of the catalytic-interface showed qualitatively and quantitatively drastically reduced 
recruitment to the PVM (Aliaksandr Khaminets, unpublished results). The mutations of 
Lys162 and the secondary-patch residues did not inhibit accumulation of Irga6 on the 
PVM (Aliaksandr Khaminets, unpublished results). Lys162 is located at the rim of the 
catalytic-interface (Figure 14 A) next to Lys169 (Figure 11 A) which is part of the 
secondary-patch. Lys162 my perhaps be considered as part of the secondary-patch 
instead of the catalytic-interface. 
The IRG proteins work as a complex system (Henry et al., 2009; Hunn et al., 
2008) (Khaminets et al., manuscript in preparation) which is hardly understood. It is 
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possible that the strong inhibitory effect of the catalytic-interface mutants on the 
accumulation of Irga6 at the PVM (Aliaksandr Khaminets, unpublished results) is not 
only caused by the loss of oligomerisation, but also through the loss of interactions with 
other IRG family members, as for example Irgm3 (Hunn, 2007; Papić, 2007). In this 
context it is suggestive that some of the highly impaired mutants of the catalytic-
interface form small aggregates in vivo (Aliaksandr Khaminets, unpublished results), as 
observed before and interpreted as a result of deficient regulation of Irga6 by the GMS 
proteins (Hunn et al., 2008), while other are smoothly distributed in the cell (Aliaksandr 
Khaminets, unpublished results). This suggests that the interaction of Irga6 with other 
IRG proteins, especially of the GMS subgroup, is impaired to a different extent by 
distinct mutants. 
The experiments were performed in Irga6 deficient cells to prevent the 
incorporation of the transfected mutant form of Irga6 into complexes of endogenous 
WT protein (Aliaksandr Khaminets, unpublished results), however potential interactions 
with other IRG proteins, like Irgb6, that can interact with Irga6 and accumulate at the 
PVM (Hunn et al., 2008), were not prevented. One possible reason for the recruitment 
of the secondary-patch mutants to the PVM is the incomplete inhibition of 
oligomerisation, another potential explanation is incorporation of the mutants into 
complexes with other IRG proteins which are targeted to the PVM. 
 
The integrity of the catalytic-interface was shown to be necessary for Irga6 self 
interaction (Paragraph III.1, III.6, III.8 and III.9). Furthermore the involvement of the 
bound nucleotide, which is part of the catalytic-interface, in Irga6 oligomerisation 
(Paragraph III.3 and III.8) and the interaction between Irga6 and Irgm3 was 
demonstrated (Hunn, 2007; Papić, 2007). The catalytic-interface is the most strongly 
conserved part of the Irga6 surface (Figure 10). It appears probable that the catalytic-
interface is the central platform for interactions between IRG proteins. 
IV.6. Biochemical properties of Irgb6 and Irgd 
Irga6 was thus far the only member of the IRG family whose biochemical properties 
were studied in detail (Uthaiah et al., 2003). The nucleotide binding of Irga6 is 
relatively weak; the nucleotide dissociation constants are in micromolar range. The 
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protein displays a 10- to 15-fold preference for GDP over GTP (Uthaiah et al., 2003). 
Irga6 oligomerises in a GTP-dependent manner in vitro, and the protein molecules act 
as mutual GAPs. Irga6 hydrolyses GTP in a cooperative manner, whereby the intrinsic 
hydrolysis rate of approximately 0.02 min-1 (Paragraph III.1, III.4 and III.6) is 
accelerated to about 2 min-1 (Uthaiah et al., 2003). 
 
The nucleotide-binding affinities of Irgb6 and Irgd were measured. The nucleotides 
dissociation constants are in the micromolar range (Table 4), and are comparable to 
Irga6 (Uthaiah et al., 2003). However neither Irgb6 nor Irgd showed a preference for di- 
over triphosphate-nucleotide (Table 4) as observed in Irga6 (Uthaiah et al., 2003). Thus 
the preference for GDP over GTP is not a general feature of the IRG proteins. 
FtsY (SRα) and Ffh (SRP) have nucleotide dissociation constants in micromolar 
range. Interestingly, while FtsY binds GDP 5- to 10-fold more strongly than GTP, Ffh 
shows no preference for diphosphate-nucleotide (Jagath et al., 2000; Moser et al., 1997). 
 
Irga6, Irgb6 and Irgb10 were observed to form aggregate-like structures when expressed 
in cells in the absence of IFNγ (Coers et al., 2008; Hunn et al., 2008; Martens et al., 
2004), but no aggregation of Irgd was observed (Hunn, 2007). Irga6 fails to accumulate 
on the PVM when expressed in the absence of IFNγ. This misbehaviour of Irga6 can be 
repaired by the simultaneous expression of the GMS proteins (Hunn et al., 2008). Irgd 
also fails to accumulate on the PVM when expressed in absence of IFNγ, but the 
accumulation could not be restored by the coexpression of the three GMS proteins 
(Hunn, 2007). However Irgd accumulated at the PVM when expressed together with the 
three GMS proteins, and Irga6 and Irgb6 (Hunn, 2007). One possible explanation is that 
Irgd cannot form complexes with itself, therefore no aggregation was observed in 
absence of IFNγ, and needs to form complexes with other members of the GKS 
subfamily to be targeted to the PVM. The findings are consistent with the suggestion 
that complex formation is required for PVM targeting (Paragraph IV.5) and that Irgd is 
the last to accumulate on the T. gondii PVM (Zhao et al., 2009c) (Khaminets et al., 
manuscript in preparation). 
From these results it was expected that Irgb6 would while Irgd would not 
oligomerise, but no convincing homo-oligomerisation of either protein was observed 
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(Figure 40). One possible reason why no oligomerisation was observed is that the 
proteins were N-terminally tagged (Paragraph III.15), although oligomerisation of Irga6 
was not attenuated by N-terminal tagging (Paragraph III.10), and also the Irgb6 self 
interaction was not prevented by N-terminal fusions used in a yeast two-hybrid 
experiment (Hunn et al., 2008). It is also possible that Irgb6 complex formation requires 
a membrane platform or a different cellular factor. At present the question of Irgb6 and 
Irgd oligomerisation cannot be conclusive answered and requires further investigation. 
Pull-down experiments (recombinant untagged with recombinant GST-tagged protein), 
which are intended to qualitatively answer questions, according Irgb6 and Irgd self 
interaction, and also according interaction between distinct IRG proteins (Irga6, Irgb6, 
Irgd and GST-Irgm3), are in preparation. 
 
Irgb6 was implicated before to possess hydrolytic activity (Carlow et al., 1998), but no 
data showing GTPase activity of Irgd was available. 
Irgb6 and Irgd have GTPase activity, however in contrast to Irga6 no 
cooperative hydrolysis was observed (Figure 41). Irgb6 showed a relatively high non-
cooperative GTP hydrolysis rate of 0.2 - 0.4 min-1 (Figure 41 C and D). The basal GTP 
hydrolysis rate of Irgd of 0.02 - 0.05 min-1 is substantially lower (Figure 41 C and D), 
and is in the same range as measured for Irga6 (Paragraph III.1, III.4 and III.6). 
Variations of the intrinsic GTP hydrolysis rate are not unprecedented; although the 
catalytic machinery of Rab5a, Rab5 and Rab7 is conserved, Rab5a exhibits a 20-fold 
higher intrinsic hydrolysis rate than Rab5 or Rab7 (Simon et al., 1996; Zhu et al., 2003). 
The absence of cooperative hydrolysis by Irgb6 and Irgd is consistent with fact that no 
oligomerisation of the proteins was detected. 
 
There are some exchanges of Irgb6 and Irgd residues in respect to the Irga6 catalytic-
interface (Figure 12). Glu77Irga6 is replaced by a glutamine in Irgd, the corresponding 
mutation E77Q in Irga6 has an incomplete inhibitory effect on complex formation 
(Figure 28). Lys161Irga6 is exchanged to a serine in Irgd; lysine is not strongly conserved 
at this position and substituted by threonine in Irga3, Irga8, Irga4 and Irga7 (Figure 12). 
Nevertheless the mutations K161E (Figure 9) and K161A (data not shown) in Irga6 
have strong inhibitory effects on complex formation. Lys162Irga6 is replaced by a 
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glutamate and leucine in Irgd and Irgb6 respectively. The lysine is relatively 
nonconserved in this position (Figure 12), still the mutation K162E in Irga6 damage 
complex formation (Figure 9). 
Although there are some modifications in the area of the catalytic-interface in 
Irgb6 and Irgd in respect to Irga6, they are considered not very dramatic; it appears 
likely that the structures of the three proteins vary to some extent, and therefore also the 
catalytic-interface is not expected to be exactly the same as in Irga6. 
IV.7. Order of complex formation 
Irga6 was shown to oligomerise in vitro (Uthaiah et al., 2003). In an oligomeric 
complex each subunit must be capable of interacting with two adjacent subunits. 
Therefore each subunit must have two distinct interaction interfaces to form an 
oligomer. Involvement of additional interface would enable the construction of 
branched oligomeric structures. However linear oligomeric Irga6 structures were seen in 
the electron microscope (Figure 62), therefore the involvement of additional interfaces 
is not considered at present, though should not be excluded. 
dimer A; assembly 
via catalytic-
interface
dimer B; assembly via 
oligomerisation-
interface
oligomer assembly via 
oligomerisation-
interface; dimer A 
building block
oligomer assembly via 
catalytic- and 
oligomerisation-interface; 
monomer building block
oligomer assembly via 
catalytic-interface; 
dimer B building block
catalytic-interface
oligomerisation-interface
monomer
 
Figure 46. Potential steps in the oligomer formation process. Irga6 subunits are shown as gray 
squares. The catalytic-interface and the oligomerisation-interface are coloured in red and green 
respectively. 
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There are three ways in which an oligomeric Irga6 structure could assemble with the 
involvement of two distinct interaction interfaces (Figure 46). One is that Irga6 first 
forms dimer via the catalytic-interface, and that the dimeric subunits assemble further 
via the oligomerisation-interface. The second possibility is that there is no certain order 
by which the interfaces are engaged during the assembly. The third possibility is that the 
order in which the interfaces are involved is inverted; the dimer forms via the 
oligomerisation-interface, and the oligomer is build of dimer subunits which interact via 
the catalytic-interface. 
 
Evidences collected in this study suggest that first a dimer subunit forms via the 
catalytic-interface, due to the finding that many mutations within the catalytic-interface 
completely inhibition Irga6 complex formation (Figure 50; Figure 51; Figure 53). 
Furthermore an extensive mutagenesis study of the Irga6 surface failed to reveal a clear-
cut oligomerisation-interface (Figure 35; Figure 36; Figure 38). Thus the 
oligomerisation-interface may not be present on the monomeric Irga6 surface, but is 
formed as a consequence of conformational changes which result from dimer formation 
via the catalytic-interface (Paragraph III.13 and III.14). 
Interestingly oligomerisation of dynamin occurs via the assembly of di- or 
tetrameric building blocks (Praefcke and McMahon, 2004). 
IV.8. Curved shape of the catalytic-Irga6-dimer model 
In context of membrane binding the curved shape of the catalytic-Irga6-dimer model 
(Figure 15 A; Figure 47 C and D) is interesting. The angled structure formed by the 
interacting dimer subunits recall shapes like the F-BAR dimer (Figure 47 A), a module 
that binds via a concave face to liposomes and deforms them into tubes (Henne et al., 
2007). A model of full length hGBP1 (Figure 47 B), of similar form, in which the 
prenylated C-termini are located on the concave surface, was suggested to be potentially 
relevant for membrane binding (Ghosh et al., 2006). 
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Figure 47. The catalytic-Irga6-dimer model in curved. (A) Surface of the F-BAR domain dimer (PDB 
2V0O) (Henne et al., 2007); the subunits are shown in cyan and purple. (B) Surface of a theoretical dimer 
of hGBP1; two molecules of monomeric full length protein (PDB 1F5N) (Prakash et al., 2000b) were 
overlaid on the G-domain dimer (PDB 2B92) (Ghosh et al., 2006) and are shown in green and red. (C) 
Surface of the catalytic-Irga6-dimer model (Figure 15); two molecules of the Irga6 crystal-dimer-
interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) are shown in yellow and blue. (D and E) 
Catalytic-Irga6-dimer model is shown (ribbon presentation). The N-terminal part of the helical-domain is 
coloured in cyan, the G-domain in light-blue, the linker-helix in gray and the C-terminal part of the 
helical-domain in dark blue. The 10D7 antibody epitope (Papic et al., 2008) (residues 20 - 25) is coloured 
in magenta. The loop between the helices αF and αG (residues 291 - 300) (Paragraph III.14; Figure 39) is 
coloured in red. The αK helix (Martens et al., 2004) (residues 359 - 374) is coloured in green. The C-
terminal-domain (Martens et al., 2004) (residues 301 - 413) following helix αF, except helix αK, is 
coloured in pink. The surface formed by the residues of the secondary-patch (Arg31, Lys32, Lys169, 
Lys176, Arg210 and Lys246) (Paragraph III.13) is shown in yellow. The surface formed by the residues 
(Glu43, Thr88, Glu110, Arg111, Asp150, Lys255, Asn265, Ile294, Ile295 and Leu298) that mutated 
inhibited accumulation of Irga6 on T. gondii PVM (Martin Fleckenstein, unpublished results) is shown in 
orange. The residues Glu43, Thr88, Glu110, Arg111, Asp150, Lys255, Asn265 and the resolved N-
terminus (Glu12) are located in the same plane, which is marked by a dotted line. The nucleotides are 
shown as atomic stick figures (A, B, C and D) Front view. (E) Bottom view (Figure 15 B). 
The bent form of the catalytic-Irga6-dimer model has some interesting features. The 
residues of the secondary-patch, which mutated do not prevent accumulation of Irga6 on 
the T. gondii PVM (Aliaksandr Khaminets, unpublished results), are located on the 
convex site of the structure (Figure 47 D). The mutations of the secondary-patch were 
suggested to inhibit complex formation through a conformational effect (Paragraph 
III.13); interestingly the secondary-patch is located on the same face of the dimer as the 
10D7 antibody epitope (Figure 47 D), a part of the protein which was shown to undergo 
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nucleotide-dependent conformational changes, and is suggested to be involved in the 
exposure of the myristoyl-group (Papic et al., 2008). 
The two Glu12 (last resolved N-terminal residues), one of each subunit, are 
located at opposite edges of the dimer, at positions from where the lipid moieties, which 
are linked to Glu12 via ten additional residues, could reach the concave face of the 
dimer (Figure 47 D). 
The C-terminal-domain following the αF helix contributes to membrane-binding 
specificity, but is not essential for general membrane binding of Irga6 (Martens et al., 
2004). An Irga6 mutant lacking this C-terminal-domain did not form aggregates in vivo 
in absence of IFNγ (Martens et al., 2004). The C-terminal-domains of two subunits are 
located at the concave surface of the dimer (Figure 47 D and E). 
The αK helix, which localise the GMS proteins to endomembranes (Martens, 
2004; Martens et al., 2004), is located next to the concave side of the dimer (Figure 47 
D and E). 
The loops (Leu291 - Phe300), of the two subunits, between the helices αF and 
αG, which connect the C-terminal-domain with the rest of the protein (Figure 39 A), are 
located at distal ends, at the concave face, of the dimer (Figure 47 D and E). A 
shortening of this loop caused an enhanced oligomerisation and GTPase activity of 
Irga6 (Figure 39 B and C). It was suggested that the shortening of the loop could cause 
increased strain in the protein structure (Paragraph III.14), which in turn could reduce 
the energy required for the postulated conformational change that exposes the 
oligomerisation-interface during dimer formation via the catalytic-interface (Paragraph 
III.13). 
The Leu291 - Phe300 loop is highly hydrophobic (Figure 12; Figure 39 A) and 
could potentially contribute to membrane binding itself; the mutations I294E-I295E and 
L298E, within the loop (Figure 47 D and E), significantly reduced the accumulation of 
Irga6 on the T. gondii PVM (Martin Fleckenstein, unpublished results). 
The mutations E43R, T88R, E110R-R111E, D150R and K255E did not prevent 
Irga6 oligomerisation (Figure 36 A), but they caused significant reduction of Irga6 
accumulation on the PVM (Martin Fleckenstein, unpublished results). The distribution 
of the mutated residues does not follow any obvious rule in context of the monomeric 
Irga6. However all mutated residues are located approximately on one plane in the 
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model of the catalytic-Irga6-dimer, partially close to the concave face (Figure 47 D). 
Interestingly also the resolved N-terminus (Glu12) lies on the same plane. 
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C-terminal domain / αG complex formation induced
conformational rearrangements
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catalytic-Irga6-dimer model speculative exposure of a hydrophobic surface
 
Figure 48. Speculative model of conformational rearrangements. (A) Schematic drawing of 
monomeric Irga6. Protein domains are represented by squares. The G-domain is shown in light-blue, the 
helical-domain and the αF helix in dark blue, the C-terminal-domain and the αG helix in pink. The loop 
between the helices αF and αG is shown as a red line. (B) Schematic drawing of the catalytic-Irga6-dimer 
model. (C) Schematic drawing of a speculative exposure of a hydrophobic surface. 
A highly speculative model could be considered, in which the loop, connecting the αF 
and αG helix, could work in a hinge-like manner to detach the C-terminal-domain, 
following the αF helix, from the rest of the molecule (Figure 48). This detachment 
would bring the residues, which mutated inhibited accumulation of Irga6 on the PVM 
(Martin Fleckenstein, unpublished results), in close proximity to the putative concave 
membrane interaction face (Figure 47 D and E; Figure 48 C). Such an opening of the 
protein structure would produce a concave hydrophobic surface which could interact 
with membranes. The formed hydrophobic surface would possibly explain the observed 
instability of oligomerised Irga6 in solution (Paragraph III.14). Interestingly the GTP 
hydrolysis rate of non-myristoylated Irga6 was found to be substantially increased in the 
presence of small amounts of the detergent Thesit (Papić, 2007), consistent with the line 
of thinking where the detergent shields a hydrophobic surface and prevent protein 
aggregation. Alternatively the Thesit micelles could function as an Irga6-binding 
platform, in this case the stimulatory effect could be explained by an increased local 
concentration of the protein, but also by conformational effects. Finally the substantial 
conformational rearrangement could create the oligomerisation-interface, which this 
study failed to reveal on the surface of monomeric Irga6 (Paragraph III.13). 
The overall size of the catalytic-Irga6-dimer model and its concave face appear 
smaller that the of the F-BAR domain dimer and of the hGBP1 dimer model (Figure 47 
A - C); however an opening of the structure and distal stretching of the C-terminal-
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domain would produce an Irga6 dimer with a wingspread (Figure 48 B and C) 
comparable to the F-BAR domain dimer and the hGBP1 dimer model. An analogous 
opening and extension of the structure were proposed to occur in the dimer of the 
bacterial dynamin-like protein (BDLP) on GTP or lipid binding (Low and Lowe, 2006). 
Further an opening of the C-terminal domain of hGBP1 was shown (Vopel et al., 2009). 
 
There are interesting similarities between the interswitch of Irga6 and of ARF1, which 
could be of relevance for the postulated opening of the Irga6 structure, the N-terminal 
switch and the exposure of the myristoyl-group (Figure 64; Figure 65; Figure 66; Figure 
67; Figure 68). 
IV.9. Analogy or homology to the hydrolytic mechanism of SRP 
GTPases 
The SRP GTPases are present in all three domains of life (Eukarya, Bacteria and 
Archaea) (Egea et al., 2005; Nagai et al., 2003). In contrast the IRG proteins were not 
found outside of the vertebrates, and although their evolutionary origin is far from 
certain it was proposed that they may be derived from prokaryotic GTPases by 
horizontal gene transfer (Bekpen et al., 2005; Martens and Howard, 2006). 
 
According to the topology of the G-domain two major classes of GTPases can be 
distinguished, the TRAFAC (translation factor) and the SIMIBI (SRP, MinD and BioD) 
class, which were already separated in last universal common ancestor (LUCA) (Leipe 
et al., 2002). IRGs belong to the TRAFAC, the SRP GTPases in contrary to the SIMIBI 
class. Therefore the SRP GTPases and the IRG proteins split probably at least 2.5 
billion years ago (Glansdorff et al., 2008). Interestingly a further TRAFAC GTPase was 
suggested to employ a SRP-like nucleotide constellation (Gotthardt et al., 2008). It is 
remarkable that the two evolutionary distant GTPase groups may share the same unique 
catalytic mechanism and provokes the question if such a specific mechanism evolved 
twice during the evolution of GTPases? 
There are no outstanding similarities between the SRP GTPases and the IRG 
proteins on the amino acid sequence level, which could suggest conservative selection 
to maintain the catalytic mechanism. The catalytic mechanism of the SRP GTPases is 
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very special in that it involves the substrate in trans (Egea et al., 2004). Although the 
proposed catalytic mechanism of Irga6 (Paragraph III.2, IV.1 and IV.2) involves the 
same unique substrate configuration, it differs also from the catalytic mechanism of the 
SRP GTPases. In contrast to SRP, in the Irga6 case the 3' hydroxyl of the GTP ribose is 
proposed to stabilize the residue that activates the catalytic water. Furthermore and 
again in contrast to SRP, the catalytic mechanism of Irga6 is proposed to not involve an 
arginine or other positively-charged residue to stabilize the transition state. However 
this variation does not necessarily mean that the catalytic mechanisms evolved 
independently; also within the clearly related Ras superfamily (Wennerberg et al., 2005) 
substantial variations of the catalytic mechanism can be observed. Sar1 and SRβ does 
not engage a glutamine for the activation of the catalytic water (Bi et al., 2002; 
Schwartz and Blobel, 2003). Ran and Rap do not involve an arginine for the 
stabilization of the transition state (Scrima et al., 2008; Seewald et al., 2002). 
Taken together no conclusive answer can be given to the initially asked 
question, the origin of the substrate constellation and the evolutionary relationship 
between the SRP GTPases and IRG proteins remains obscure. An antique configuration 
that has survived in these two proteins? 
IV.10. Function of IRG proteins 
The IRG proteins are powerful resistance factors against intracellular bacterial and 
protozoan parasites (Martens and Howard, 2006; Taylor, 2007). Although the exact 
function of the protein family is not understood mechanistically, several potential 
modes of action were proposed. 
 
The most striking phenomenon of IRG proteins is their ability to relocalise from their 
resting compartment to accumulate at pathogen-containing vacuoles upon infection. 
Irgb6, Irgb10, Irga6, Irgd, Irgm2 and Irgm3 were found at the T. gondii PVM (Henry et 
al., 2009; Hunn et al., 2008; Ling et al., 2006; Martens et al., 2005; Melzer et al., 2008; 
Papic et al., 2008; Zhao et al., 2009a; Zhao et al., 2009b; Zhao et al., 2008) (Khaminets 
et al., manuscript in preparation). The IRG proteins are suggested to be involved in the 
disruption of the pathogen-containing PVM and of the parasite itself, that occurs via 
active vesiculation and sequestration of the membranes (Ling et al., 2006; Martens et 
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al., 2005; Melzer et al., 2008; Zhao et al., 2009b; Zhao et al., 2008). In this context 
Irga6 oligomerisation (Uthaiah et al., 2003) and a potential functional relationship 
between IRG proteins and dynamin (Henry et al., 2007; MacMicking, 2004; Martens 
and Howard, 2006; Martens et al., 2005; Melzer et al., 2008; Papic et al., 2008; Taylor, 
2007; Yap et al., 2007; Zhao et al., 2009b; Zhao et al., 2009c) is of interest. Necrotic 
death of the host cell was observed after T. gondii killing, but at present it is not clear if 
IRG proteins are involved in that process (Zhao et al., 2009b). The same IRG family 
members, that accumulate on the T. gondii PVM, were reported to be associated with 
the C. trachomatis inclusion, but the task the proteins fulfil there is obscure (Al-Zeer et 
al., 2009; Coers et al., 2008). Irgm1 was found at M. tuberculosis containing 
phagosomes; the protein was suggested to promote fusion of this compartment with 
lysosomes and to promote acidification, which causes the death of the pathogen 
(MacMicking et al., 2003), but this concept was not developed further. 
IRG proteins, in connection with autophagy, were implicated to be involved in 
clearance of all three above mentioned parasites (Al-Zeer et al., 2009; Gutierrez et al., 
2004; Ling et al., 2006; Singh et al., 2006). Indeed it seems that there is an interplay 
between IRG proteins and proteins involved in autophagy (Zhao et al., 2008) 
(Khaminets et al., manuscript in preparation). Autophagy was suggested to be involved 
in immunity (Deretic, 2005; Deretic, 2006; Schmid and Munz, 2007; Swanson, 2006), 
however autophagy is also a housekeeping process (Scarlatti et al., 2009; Todde et al., 
2009; Yoshimori and Noda, 2008; Yu et al., 2008). Therefore it is not clear if the 
observed deficiency in pathogen control in absence of autophagy, represents a true lack 
of an immune mechanism, or shows a general weakness of a seriously injured organism 
(Kuma et al., 2004). IRG proteins were observed to aggregate in absence of the in 
autophagy involved protein, ATG5 (Zhao et al., 2008) (Khaminets et al., manuscript in 
preparation); a phenotype that usually indicate a misregulated IRG system (Henry et al., 
2009; Hunn et al., 2008). 
The IRG proteins are part of the innate immune system and mediate resistance at 
the cell-autonomous level (Bernstein-Hanley et al., 2006; Butcher et al., 2005; Halonen 
et al., 2001; Konen-Waisman and Howard, 2007; Ling et al., 2006; MacMicking et al., 
2003; Martens and Howard, 2006; Martens et al., 2005; Santiago et al., 2005; Taylor, 
2007; Taylor et al., 2004). However Irgm1 was proposed to participate in adaptive 
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immunity and to be involved in the regulation of lymphocyte function and development 
(Bafica et al., 2007; Feng et al., 2004; Feng et al., 2008a; Feng et al., 2008b; Santiago et 
al., 2005). The Irgm1 knockout has a spectacular effect; the Irgm1 deficient mice 
succumb to all so far tested bacterial and protozoan pathogens, indeed showing a 
phenotype as severe as IFNγ deficient mice (Collazo et al., 2001; Feng et al., 2004; 
Feng et al., 2008b; Henry et al., 2007; Henry et al., 2009; MacMicking et al., 2003; 
Martens and Howard, 2006; Santiago et al., 2005; Taylor, 2007). GMS proteins were 
shown to be crucial regulators of the IRG system and to prevent the premature 
activation of Irga6 and Irgb6 (Hunn et al., 2008). This complex situation emerged from 
the observation that Irga6 and Irgb6 aggregates were found in Irgm1 and Irgm3 
deficient cells; furthermore the aggregation was enhanced in Irgm1 plus Irgm3 double 
deficient cells (Henry et al., 2009). This shows a sterile activation of the IRG immune 
mechanism in these animals. It is valid to ask, if the observed misregulation of 
components of adaptive immunity in Irgm1 deficient mice really shows Irgm1 to be an 
important regulator in context of adaptive immunity, or whether the reported 
phenotypes show the danger of having an improperly controlled IRG immune 
mechanism? In these context it is interesting that the Irgm1 deficient mice succumb to 
Mycobacterium avium infection, whereas Irgm1 plus IFNγ doubly deficient animals can 
control the bacterium (Feng et al., 2008b). 
IFNγ, primarily secreted by activated T cells and natural killer cells, is the major 
inducer of IRG expression. However, expression of some IRG family members can be 
induced by IFNα/β, secreted by virus infected cells and activated dendritic cells (Bafica 
et al., 2007; Bekpen et al., 2005; Boehm et al., 1998; Carlow et al., 1998; Collazo et al., 
2002; Gavrilescu et al., 2004; Gilly et al., 1996; Gilly and Wall, 1992; Lafuse et al., 
1995; Lapaque et al., 2006; MacMicking et al., 2003; Martens and Howard, 2006; 
Sorace et al., 1995; Taylor et al., 1996; Zerrahn et al., 2002). A possible antiviral 
activity was reported in Irgb6 overexpressing cells (Carlow et al., 1998) and in HeLa 
cells overexpressing Irgm3 (Liu et al., 2008; Zhang et al., 2003). However the 
significance of these result is unclear, no IRG deficient mice were so far reported to be 
susceptible to viral infections (Collazo et al., 2001; Taylor et al., 2000). 
104 
V. Appendix 
V. Appendix 
V.1. Dynamic light scattering measurements 
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Figure 49. Oligomerisation of Irga6 is temperature sensitive. Oligomerisation of 50 µM Irga6 was 
monitored in the presence of 1 mM nucleotide (A - C) or 80 µM Irga6 in the presence of 10 mM 
nucleotide (D - F) by DLS at 4°C (A and D), 20°C (B and E) or 37°C (C and F). 
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Figure 50. Oligomerisation is highly impaired by the catalytic-interface mutants. (A - F) 
Oligomerisation of 80 µM mutated Irga6 was monitored in the presence of 10 mM GDP or GTP by DLS 
at 37°C. 
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80µM Irga6-E106A; 10mM nucleotide; 37°C
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Figure 51. Glu106 is involved in, but not essential for, oligomerisation. (A - G) Oligomerisation of 80 
µM mutated Irga6 was monitored in the presence of 10 mM GDP or GTP by DLS 37°C 
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Figure 52. Glu77 is involved in oligomerisation. (A - D) Oligomerisation of 80 µM mutated Irga6 was 
monitored in the presence of 10 mM GDP or GTP by DLS 37°C 
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80µM Irga6-R159A; 10mM nucleotide; 37°C
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Figure 53. Asp164 and Arg159 are involved in oligomerisation. (A - N) Oligomerisation of 80 µM 
mutated Irga6 was monitored in the presence of 10 mM GDP or GTP by DLS at 20°C or 37°C. 
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Figure 54. The secondary-patch is not essential for oligomerisation. (A - I) Oligomerisation of 80 µM 
mutated Irga6 was monitored in the presence of GDP or 10 mM GTP by DLS 37°C 
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Figure 55. XTP do not initiate complex formation. Oligomerisation of 80 µM WT (A) or Irga6-D186N 
(B) was monitored in the presence of 10 mM XDP or XTP by DLS at 37°C. 
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V.2. Aggregation sensitive Irga6 mutants 
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Figure 56. Irga6-D164K and -D164R aggregate at 37°C in the presence of GDP. (A and B) 
Oligomerisation of 80 µM mutated Irga6 was monitored in the presence of 10 mM GDP or GTP by DLS 
at 37°C. 
80µM Irga6-D239R; 37°C
Time (min.)
0 30 60 90 120
Sc
at
te
re
d 
lig
ht
 (a
. u
.)
0
2e+7
4e+7
6e+7
8e+7
1e+8
no nucleotide
10mM GTP
80µM Irga6-D239R; 20°C
Time (min.)
0 30 60 90 120
Sc
at
te
re
d 
lig
ht
 (a
. u
.)
0
2e+7
4e+7
6e+7
8e+7
1e+8
no nucleotide
10mM GTP
80µM Irga6-D239R; 10mM nucleotide; 37°C
Time (sec.)
0 300 600 900 1200 1500 1800
H
yd
ro
dy
na
m
ic
 ra
di
us
 (n
m
)
0
10
20
30
40
50
GDP
GTP
80µM Irga6-D239R; 10mM nucleotide; 20°C
Time (sec.)
0 300 600 900 1200 1500 1800
H
yd
ro
dy
na
m
ic
 ra
di
us
 (n
m
)
0
10
20
30
40
50
GDP
GTP
R210
D239
D239
R210
GppNHp
BA
DC
FE
 
Figure 57. Irga6-D239R is unstable at 37°C. (A) A molecule of the Irga6 crystal-dimer-interface 
mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) is shown (ribbon presentation). Protein domains are 
colour coded as in Figure 11. The molecule is shown in the same orientation as in Figure 11 D. The 
residues Arg210, Asp239 and the nucleotide are shown as atomic stick figures. The red box highlight the 
in (B) enlarged area. Oligomerisation of 80 µM Irga6-D239R was monitored by light scattering in the 
absence of nucleotide or presence of 10 mM GTP at 37°C (C) or 20°C (D). Oligomerisation of 80 µM 
Irga6-D239R was monitored in the presence of 10 mM GDP or GTP by DLS at 37°C (E) or 20°C (F). 
Partially purified (Paragraph III.13) Irga6-D239R was used for the measurements. 
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V.3. Irga6 fusion constructs 
MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSMAIIRYIADKHNMLGGCPKE
RAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEMLKMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKL
Thrombin cleavage site
------
VCFKKRIEAIPQIDKYLKSSKYIAWPLQGWQATFGGGDHPPKSDLVPRGSPGIPGSTTMGQLFSSPKSDENNDLPSSFTGYFKKFNTG
----------
N-terminal extension
RKIISQEILNLIELRMRKGNIQLTNSAISDALKEIDSSVLNVAVTGETGSGKSSFINTLRGIGNEEEGAAKTGVVEVTMERHPYKHPN
IPNVVFWDLPGIGSTNFPPNTYLEKMKFYEYDFFIIISATRFKKNDIDIAKAISMMKKEFYFVRTKVDSDITNEADGKPQTFDKEKVL
QDIRLNCVNTFRENGIAEPPIFLLSNKNVCHYDFPVLMDKLISDLPIYKRHNFMVSLPNITDSVIEKKRQFLKQRIWLEGFAADLVNI
IPSLTFLLDSDLETLKKSMKFYRTVFGVDETSLQRLARDWEIEVDQVEAMIKSPAVFKPTDEETIQERLSRYIQEFCLANGYLLPKNS
FLKEIFYLKYYFLDMVTEDAKTLLKEICLRN
Thrombin cleavage site
-ter inal extension
GST
Irga6  
Figure 58. Protein sequence overview of the GST-Irga6 fusion. GST is highlighted in gray. Irga6 is 
highlighted in black. The N-terminal extension of recombinant Irga6 protein, which originates from 
thrombin cleavage, is marked. 
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GSPGIPGSTTMGQLFSSPKSDENNDLPSSFTGYFKKFNTGRKIISQEILNLIELRMRKGNIQLTNSAISDALKEIDSSVLNVAVTGET
GSGKSSFINTLRGIGNEEEGAAKTGVVEVTMERHPYKHPNIPNVVFWDLPGIGSTNFPPNTYLEKMKFYEYDFFIIISATRFKKNDID
IAKAISMMKKEFYFVRTKVDSDITNEADGKPQTFDKEKVLQDIRLNCVNTFRENGIAEPPIFLLSNKNVCHYDFPVLMDKLISDLPIY
KRHNFMVSLPNITDSVIEKKRQFLKQRIWLEGFAADLVNIIPSLTFLLDSDLETLKKSMKFYRTVFGVDETSLQRLARDWEIEVDQVE
AMIKSPAVFKPTDEETIQERLSRYIQEFCLANGYLLPKNSFLKEIFYLKYYFLDMVTEDAKTLL
cTag1
-----------
Irga6-cTag1-linker-EGFP KEICLKLGRLERPHRDVAGTAGPGSIATMVSKGE
Irga6-linker-EGFP KEICL-----------TGGTAGPGSIATMVSKGE
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ELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYV
QERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADH
YQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK
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Figure 59. Protein sequence overview of the Irga6-EGFP fusions. Irga6 is highlighted in black. EGFP 
is highlighted in gray. The N-terminal extension of recombinant Irga6 protein, which originates from 
thrombin cleavage, is marked. 
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Figure 60. C-terminally hexa histidine tagged Irga6 forms oligomers. (A) Oligomerisation of 80 µM 
Irga6-His was monitored by light scattering in the presence of 10 mM GDP or GTP at 37°C. (B) 
Hydrolysis of 10 mM GTP was measured in the presence of 80 µM WT or Irga6-His at 37°C. Samples 
were assayed by HPLC. 
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V.5. Irga6 oligomers 
50µM Irga6; 10mM GTP; 37°C
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Figure 61. Oligomerisation of Irga6 is retarded by growing NaCl concentrations. (A) 
Oligomerisation of 50 µM WT Irga6 was monitored by light scattering in the presence of 10 mM GTP 
and various NaCl concentrations at 37°C. (B - F) 50 µM WT Irga6 were incubated with 10 mM GTP and 
various NaCl concentrations at 37°C for 60 minutes. The complexes were trapped by addition of 1.5 mM 
AlCl3 and 10 mM NaF and investigated in light microscope. Phase contrast images are shown. 
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Figure 62. Non-myristoylated Irga6 forms GTP-dependent filamentous structures. 5 µM Irga6 were 
incubated in the presence (B and E) or absence (A and D) of 1 mM GTP, with (D and E) or without (A 
and B) 1 mg/ml Folch total brain lipid vesicles for 10 minutes at 37°C. Samples were blotted onto glow-
discharged formvar-carbon-coated 400-mesh grids, negatively stained with 5% uranyl acetate and 
visualized by transmission electron microscopy. (C) Enlargement of red box highlighted area in panel B. 
(F) Enlargement of red box highlighted area in panel E. 
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V.6. Influence of the Kd value on the protein-nucleotide-complex 
Equation 4. Definition of Kd. Definition of the dissociation constant (Kd). 
complex
freefree
d pn
npK ⋅=  
Equation 5. Derivation. Nucleotide free protein (pfree) is equal to protein at time point zero (p0) minus 
protein involved in the protein-nucleotide-complex (pncomplex). 
complexfree pnpp −= 0  
Equation 6. Derivation. Unbound nucleotide (nfree) is equal to nucleotide at time point zero (n0) minus 
nucleotide bound in the protein-nucleotide-complex. 
complexfree pnnn −= 0  
Equation 7. Derivation. Equation 5 and Equation 6 placed in Equation 4. ( ) ( )
complex
complexcomplex
d pn
pnnpnpK −⋅−=
00
 
Equation 8. Protein-nucleotide-complex. Equation 7 solved for protein-nucleotide-complex. 
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Figure 63. Influence of the Kd value on formed protein-nucleotide-complex. Equation 8 was used to 
estimate the proportion of protein-nucleotide-complex which is formed, at given dissociation constants 
(range 0 - 1000 µM) and distinct nucleotide concentrations (range 0 - 10 mM) and two protein 
concentrations. The calculations were performed for 80 µM (A) and 50 µM (B) protein. 
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Figure 64. ARF1 interswitch conformations. Model of N-terminal helix exposure by ARF1 (Goldberg, 
1998). ARF1 in GDP (A) and GTP (B) state is shown (ribbon presentation). Switch I and II are coloured 
in cyan and blue respectively. The interswitch is coloured in red. From (Gillingham and Munro, 2007); 
modified. 
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Figure 65. Position of the Irga6 interswitch. The N-terminal part of the helical-domain is coloured in 
cyan, the G-domain in light-blue, the linker-helix in gray and the C-terminal part of the helical-domain in 
dark blue. The switch I (residues 100 - 109) and II (residues 126 - 132) are coloured in green and orange 
respectively. The interswitch (residues 110 - 125) is coloured in yellow. The loop between the helices αF 
and αG (residues 291 - 300) is coloured in red. The C-terminal-domain (Martens et al., 2004) (residues 
301 - 413) following helix αF is coloured in pink. (A) Top view. (B) Rear view. 
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Figure 66. Comparisons of the interswitches. (A) ARF1 in GDP state (PDB 1HUR) (Amor et al., 
1994). (B) ARF1-∆17-Q71L in GTP state (PDB 1O3Y) (Shiba et al., 2003). (C) G-domain and linker-
helix (residues 67 - 264) of the Irga6 crystal-dimer-interface mutant M173A in GppNHp state (PDB 
1TQ6) (Ghosh et al., 2004). (D) Ras in GppNHp state (PDB 5P21) (Pai et al., 1990). Ribbon 
presentations of the molecules are shown. The interswitches are coloured in red. The ARF1 N-terminal 
region is coloured in green. The Irga6 linker-helix is coloured in yellow. 
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Figure 67. The Irga6 interswitch ends in a groove formed by αC, αF and αG. The Irga6 crystal-
dimer-interface mutant M173A (PDB 1TQ6) (Ghosh et al., 2004) is shown. (A and B) ribbon 
presentation. (C and D) molecular surface. The interswitch is coloured in red. The Irga6 linker-helix is 
coloured in yellow. The C-terminal-domain (Martens et al., 2004) is coloured in pink. The first resolved 
residue Glu12 is shown in blue. The molecular surface formed by the helices αC, αF and αG is dotted. A 
myristic acid structure and a hypothetical structure of the peptide 2GQLFSSPKSD11 are shown. (A and 
C) Top view. (B and D) Rear view. 
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Figure 68. Position of the interswitch in the catalytic-Irga6-dimer model. Catalytic-Irga6-dimer 
model is shown (ribbon presentation). The interswitch is coloured in red. The Irga6 linker-helix is 
coloured in yellow. The C-terminal-domain (Martens et al., 2004) is coloured in pink. (A) Front view. (B) 
Bottom view. 
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VIII. Abbreviations 
2'3'ddGTP 2'3'dideoxy-GTP 
2'dGTP 2'deoxy-GTP 
3'dGTP 3'deoxy-GTP 
ARF ADP-ribosylation factor 
ATPase adenosine triphosphatase 
BDLP bacterial dynamin-like protein 
C. muridarum Chlamydia muridarum 
C. trachomatis Chlamydia trachomatis 
CD C-terminal-domain 
CDI crystal-dimer-interface 
CID central interactive domain 
CIM catalytic-interface model 
CON conservation score 
DLP dynamin-like protein 
DLS dynamic light scattering 
DNA deoxyribonucleic acid 
DTT dithiothreitol 
E. coli Escherichia coli 
EDTA ethylenediaminetetraacetic acid 
EGF epidermal growth factor 
EGFP enhanced-green-fluorescent protein 
ER endoplasmic reticulum 
FCS fetal calf serum 
Ffh prokaryotic signal recognition particle 
FPLC fast performance liquid chromatography 
FtsY prokaryotic signal recognition particle receptor 
GAP GTPase activating protein 
GAS interferon-γ-activated site 
GBP guanylate-binding protein 
GD G-domain 
GDI GDP dissociation inhibitor 
GDL G-domain linker-helix 
G-domain GTPase domain 
GDP guanosine 5'-diphosphate 
GED GTPase effector domain 
GEF guanine nucleotide exchange factor 
GKS IRG with classical G1-motif 
GMP guanosine 5'-monophosphate 
GMS IRG with unique G1-motif  
GORASP2 Golgi reassembly and stacking protein 2 
GPCR G protein-coupled receptor 
GppNHp guanosine 5’-[(β,γ)-imido]triphosphate 
GST glutathione-S-transferase 
GTP guanosine 5'-triphosphate 
GTPase guanosine triphosphatase 
GTPγS guanosine 5'-(3-O-thio)triphosphate 
HPLC high performance liquid chromatography 
HRP horseradish peroxidase 
IDO indole 2,3-dioxygenase 
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IFN interferon 
iNOS inducible nitric oxide synthase 
IPTG isopropyl-β-D-thiogalactoside 
IRG immunity-related GTPase 
ISRE interferon-stimulated response element 
JAK Janus kinase 
Kd dissociation constant 
LB Luria-Bertani 
LPS lipopolysaccharide 
LTR long terminal repeat 
LUCA last universal common ancestor 
M. tuberculosis Mycobacterium tuberculosis 
mant 2'/3'-O-(N-methyl-anthraniloyl) 
MEF mouse embryonic fibroblast 
MUT mutagenised residues 
Mx Myxovirus resistance 
NO nitric oxide 
OD optical density 
PAMP pathogen-associated molecular pattern 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PDB protein data bank 
PEG polyethylene glycol 
Pfu Pyrococcus furiosus 
PH pleckstrin homology 
phox phagocyte oxidase 
P-loop phosphate-binding loop 
PRD proline-rich domain 
PRR pattern recognition receptor 
PV parasitophorous vacuole 
PVM parasitophorous vacuole membrane 
RGS regulators of G protein signaling 
RNA ribonucleic acid 
RNase ribonuclease 
ROS reactive oxygen species 
RT room temperature 
SAP Shrimp alkaline phosphatase 
SDS sodium dodecyl sulfate 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
SIMIBI SRP, MinD and BioD 
SR signal recognition particle receptor 
SRP signal recognition particle 
STAT signal transducers and activators of transcription 
T. gondii Toxoplasma gondii 
TLC thin layer chromatography 
TLR Toll-like receptor 
TRAFAC translation factor 
VLIG very large inducible GTPase 
WT wild type 
XDP xanthosine 5'-diphosphate 
XTP xanthosine 5'-triphosphate 
XTPase xanthosine triphosphatase 
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Immunity-related GTPases mediate resistance against a broad spectrum of intracellular 
pathogens. Irga6 (IIGP1) accumulates on the membrane of the parasitophorous vacuole, 
which harbours the protozoan parasite Toxoplasma gondii inside of infected cells. The 
protein participates in disruption of the parasites domicile, and of the enclosed 
pathogen, via vesiculation and membrane stripping. 
The enzymatic properties of Irga6, low nucleotide-binding affinity, GTP-
dependent oligomerisation and cooperative GTP hydrolysis, are to be found in the 
dynamin superfamily of large GTPases. Dynamin oligomerises at the neck of nascent 
vesicles, and mediates their scission from the plasma membrane. 
 
This study focuses on the Irga6 complex formation process, and attempts to explain 
how the catalytic activity is stimulated by the interaction of Irga6 molecules. 
One of the contact surfaces, engaged in Irga6 complex formation, the so-called 
catalytic-interface, which is a part of the G-domain and comprises the nucleotide-
binding site, was defined. The molecular surface, provided by the bound nucleotide, 
was shown to be employed in Irga6 complex formation. 
A hypothetical model of the dimeric Irga6 topology, based on the unique 
substrate constellation and the catalytic machinery, found in the dimeric complex of the 
signal recognition particle and its receptor, was proposed. The crucial catalytic 
reciprocal interaction, made in trans by the 3'hydroxyl of the bound nucleotide ribose, 
determines the relative orientation, of the signal recognition particle and its receptor, in 
the dimeric complex. The 3'hydroxyl was shown to be essential for Irga6 complex 
formation, and activation of GTP hydrolysis in trans. The model further suggested a 
glutamate as a key catalytic residue, which activates the GTP hydrolysis. This glutamate 
was shown to be crucial for, complex formation mediated stimulation of, the enzymatic 
activity. 
The fundamental biochemical properties, of two further members of the protein 
family, Irgb6 and Irgd, were characterized. A preliminary analysis of Irgm3 
demonstrated the, elsewhere predicted, inhibitory function of this protein on GTP 
hydrolysis by Irga6 and Irgb6. 
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X. Zusammenfassung 
Immun-verwandte GTPasen (Immunity-related GTPases) vermitteln Resistenz gegen 
ein breites Spektrum intrazellulärer Pathogene. Irga6 (IIGP1) akkumuliert auf der 
Membran der parasitophoren Vakuole, welche den Protozoen Parasiten Toxoplasma 
gondii innerhalb infizierter Zellen beherbergt. Das Protein ist an der Zerstörung des 
Domizils des Parasiten und des eingeschlossenen Pathogenen über Vesikulation und 
Membran Beraubung beteiligt. 
Die enzymatischen Eigenschaften von Irga6, niedrige Nukleotid 
Bindungsaffinität, GTP anhängige Oligomerisation und kooperative GTP Hydrolyse, 
findet man in der dynamin Superfamilie der großen GTPasen. Dynamin oligomerisiert 
an den Nacken von werdenden Vesikeln und vermittelt ihre Abspaltung von der Plasma 
Membran. 
 
Diese Studie fokussiert auf den Irga6 Komplex Bildungsprozess, und versucht zu 
erklären wie die katalytische Aktivität durch die Interaktion von Irga6 Molekülen 
stimuliert wird. 
Eine von den Kontaktoberflächen, engagiert in Irga6 Komplexbildung, der so 
genannte katalytische Interface, welche ein Teil der G-Domäne ist und die Nukleotid 
Bindungsstelle umfaßt, wurde definiert. Die molekulare Oberfläche, beigetragen von 
den gebundenen Nukleotid, wurde gezeigt an der Irga6 Komplexbildung beteiligt zu 
sein. 
Ein hypothetisches Modell von der dimerischen Irga6 Topologie, basierend auf 
der einzigartigen Substrat Konstellation und der katalytischen Maschinerie, welche in 
den dimeren Komplex von den Signalerkennungspartikel und seinen Receptor gefunden 
wurde, wurde vorgeschlagen. Die entscheidenden katalytischen gegenseitigen 
Interaktionen, gemacht in trans von den 3'Hydroxyl von der gebundenen Nukleotid 
Ribose, bestimmen die relative Orientierung, von den Signalerkennungspartikel und 
seinen Receptor, in den dimeren Komplex. Der 3'Hydroxyl wurde gezeigt essenziell für 
die Irga6 Komplexbildung und Aktivierung der GTP Hydrolyse in trans zu sein. Das 
Modell suggeriert des weiteren ein Glutamat als einen katalytischen Schlüssel Rest, 
welcher die GTP Hydrolyse aktiviert. Dieser Glutamat wurde gezeigt für die, durch 
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Komplexbildung vermittelte, Stimulation der enzymatischen Aktivität entscheidend zu 
sein. 
Die fundamentalen biochemischen Eigenschaften, von zwei weiteren 
Mitgliedern der Proteinfamilie, Irgb6 und Irgd, wurden charakterisiert. Eine präliminäre 
Analyse von Irgm3 demonstrierte, die woanders vorhergesehene, hemmende 
Funktionsweise des Proteins auf die GTP Hydrolyse durch Irga6 und Irgb6. 
142 
XI. Acknowledgements 
XI. Acknowledgements 
First of all, I would like to thank Prof. Dr. Jonathan C. Howard for giving me a great 
opportunity to spend the wonderful inspiring time in his lab, for taking me along to 
science, and for his support and advices. 
 
Thank Prof. Dr. Thomas Langer and Prof. Dr. Guy Dodson for reviewing my thesis and 
being in my examination board 
 
Thank Prof. Dr. Helmut W. Klein for taking over the chairmanship in my examination 
board 
 
Thank Dr. Matthias Cramer, Bettina Montazem and Karoline Bendig for help in all 
bureaucratic matters. 
 
Thank Dr. Eva Wolf, Christiane Theiß, Dr. Sven Hennig and Nicole Kucera for the 
hospitality in Dortmund and help with protein crystallisation. 
 
Thank Prof. Dr. Harvey T. McMahon and Dr. Sascha Martens for the hospitality in 
Cambridge and help with electron microscopy. 
 
Thank Prof. Dr. Reinhard Krämer and Dr. Sascha Nicklisch for the hospitality in the 
Institute of Biochemistry and coffee. 
 
Thank Prof. Dr. Thomas Langer and Dr. Steffen Augustin for the hospitality in the next 
corridor and help with the HPLC. 
 
Thank Rita Lange and Gaby Vopper for their valuable experience and the enormous 
support with cloning and protein purification. 
 
Thank Dr. Robert Finking and Dr. Gerrit Praefcke for the help in all matters of protein 
purification and biochemistry. 
 
Dr. Andreas Schmidt for beginning the project and generation of the first flourishing 
mutants. 
 
Aliaksandr Khaminets and Martin Fleckenstein for putting the mutants into life. 
 
Martin Fleckenstein and Julian Klein for support in matters of Irgd and Irgb6 
 
Dr. Julia P. Hunn, Dr. Natasa Papic, Dr. Yang Zhao and Aliaksandr Khaminets for 
discussions. 
 
All current and former members of the lab for help and friendly atmosphere. 
 
My family and parents for support, encouragement and devotion. 
143 
XII. Erklärung 
XII. Erklärung 
Ich versichere, dass ich die von mir vorgelegte Dissertation selbständig angefertigt, die 
benutzten Quellen und Hilfsmittel vollständig angegeben und die Stellen der Arbeit − 
einschließlich Tabellen, Karten und Abbildungen −, die anderen Werken im Wortlaut 
oder dem Sinn nach entnommen sind, in jedem Einzelfall als Entlehnung kenntlich 
gemacht habe; dass diese Dissertation noch keiner anderen Fakultät oder Universität zur 
Prüfung vorgelegen hat; dass sie − abgesehen von unten angegebenen Teilpublikationen 
− noch nicht veröffentlicht worden ist sowie, dass ich eine solche Veröffentlichung vor 
Abschluss des Promotionsverfahrens nicht vornehmen werde. Die Bestimmungen der 
Promotionsordnung sind mir bekannt. Die von mir vorgelegte Dissertation ist von Prof. 
Dr. Jonathan C. Howard betreut worden. 
 
Köln, Mai 2009 
144 
XIII. Lebenslauf 
XIII. Lebenslauf 
 
Name:    Nikolaus Pawlowski (Mikołaj Pawłowski) 
Email:    niko@fr33.net 
Geburtsdatum:  29.08.1977 
Geburtsort:   Danzig (Gdańsk), Polen 
 
 
 
Ausbildung 
 
1984 – 1989   Grundschule Nummer 2 in Danzig 
1989 – 1990   Johann Amos Comenius Hauptschule in Köln 
    Adolph Kolping Hauptschule in Köln 
1990 – 1991   Heinrich Schieffer Hauptschule in Köln 
1991 – 1995   Käthe Kollwitz Realschule in Köln 
    Abschluss: Realschulabschluss 
1995 – Jun. 1998  Friedrich Wilhelm Gymnasium in Köln 
    Abschluss: Allgemeine Hochschulreife 
Aug. 1998 – Sep. 1999 Zivildienst beim Arbeiter Samariter Bund in Köln 
Okt. 1999 – Apr. 2005 Studium der Biologie an der Universität zu Köln 
Diplomarbeit in Fachrichtung Genetik (Titel: „Struktur- 
und Funktionsstudien der Resistenz GTPase IIGP1“) am 
Institut für Genetik der Universität zu Köln, 
Abteilung von Prof. Dr. Jonathan C. Howard 
Abschluss: Diplom Biologe 
Mai 2005   Promotionsstudiengang Biologie in Fachrichtung Genetik 
am Institut für Genetik der Universität zu Köln, 
Abteilung von Prof. Dr. Jonathan C. Howard 
 
145 
